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Abstract 
Background: The quality-adjusted life year (QALY) framework has been challenged for use in 
economic evaluation because of its narrow focus on health-related aspects of quality of life, thus 
ignoring potential ‘non-health’ benefits associated with treatments and interventions. With the 
development of new preference-based measures, such as the ICEpop CAPability (ICECAP) 
instruments that adopt a broader evaluative space, the aim of this thesis was to examine 
methodological considerations and applied implications for outcome measurement in health 
economics when applying measures that extend beyond health. 
Methods: A narrative review provides an overview of challenges involved for broadening the 
evaluative space of the QALY and the progress that has been made in this area. A critical 
interpretive synthesis (CIS) is then presented that conceptualized benefits beyond the health-
related QALY, followed by three empirical analyses, each using a different dataset: (i) regression 
analyses testing the complementarity of a preference-based health-related quality of life (HRQoL) 
measure, the EQ-5D-5L, and a measure of capability wellbeing for older adults, the ICECAP-O, 
within the context of public health; (ii) exploratory factor analyses investigating the overlap 
between the ICECAP-A and five preference-based HRQoL measures; and (iii) path analyses to 
further explore the relationship between two HRQoL measures (EQ-5D-5L and AQoL-8D) and 
two wellbeing measures (ICECAP-A and subjective wellbeing). 
Results: The CIS conceptualized non-health benefits into four themes: (i) benefits affecting a 
person’s wellbeing (psychological wellbeing, subjective wellbeing, empowerment, and capability 
wellbeing); (ii) benefits derived from the process of health care delivery; (iii) benefits beyond the 
affected individual; and (iv) benefits beyond the health care sector. Three key findings were made 
from the empirical analyses that further explored wellbeing measures. Firstly, the ICECAP-O is 
more sensitive to environmental features (i.e., social cohesion and street connectivity) when 
compared with the EQ-5D-5L; secondly, the ICECAP-A contains domains in its descriptive 
system that are not measured by most HRQoL measures, except for the AQoL-8D; and thirdly, 
HRQoL and wellbeing measures are affected in a different way by different secondary health 
conditions but a similar relationship was found between the ICECAP-A and AQoL-8D. 
Conclusion: The thesis concludes that the application of wellbeing measures in economic 
evaluations requires careful consideration due to the risk of double counting. The capability 
approach has the potential to extend the QALY but the operationalization of this approach – and 
other non-health benefits within or outside the QALY framework – requires further research. 
Keywords:  Quality-adjusted life year; non-health benefits; economic evaluation; outcome 
measurement; capability wellbeing; health-related quality of life. 
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Chapter 1. Thesis overview 
1.1. Introduction to the thesis 
This thesis contributes to an emerging field of research concerned with the 
evaluative space of the quality-adjusted life year (QALY). QALYs have been used in the 
assessment of health interventions primarily to adjust someone’s life expectancy based on 
levels of health-related quality of life (HRQoL) (Sassi, 2006; Weinstein et al., 2009). The 
underlying idea of the QALY is that a year of life spent in full health is worth one QALY 
and a year of life lived in a state less than full health is worth less than one (Brazier et al., 
2017). In order to determine QALYs, numerous preference-based HRQoL measures 
exist, which all provide estimates on the relative value that people place on living in 
particular health states (Neumann et al., 2000).  
The starting point for this thesis was the widely recognized concern that the 
evaluative space of the QALY focuses too narrowly on health-related aspects of quality 
of life (QoL) (Al-Janabi et al., 2012; Goranitis et al., 2017; Payne et al., 2013). The 
evaluative space is generally concerned with the identification of the ‘objects of value’ 
(Sen, 1993). Applied to HRQoL, the evaluative space depends on the scope of the 
evaluative factors concerning a person’s life as defined by the dimensions of HRQoL 
included in preference-based HRQoL measures. It is argued that adopting an evaluative 
framework that is concerned with health (and only health) when conducting economic 
evaluations may result in suboptimal resource allocation decisions because other ‘non-
health’ benefits of health care interventions are not considered (Coast et al., 2008a). As a 
response to this concern, new measures have been developed that offer a broader 
evaluative space, i.e., one that is not limited to health alone. This shift from preference-
based HRQoL measures towards a broader set of outcomes in economic evaluation 
provides an opportunity for further examination of methodological considerations and 
applied implications for outcome measurement in health economics. 
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This thesis explores potential challenges associated with broadening the 
evaluative space of the QALY and provides an overview of broader non-health benefits 
that currently do not fit within the QALY framework. Based on three empirical studies 
conducted as part of this thesis, further evidence is provided in terms of the additional 
information offered by newly developed measures that adopt a broader evaluative space, 
when compared with preference-based HRQoL measures that are currently used to derive 
QALYs. Given that preference-based HRQoL instruments differ greatly in their coverage 
of dimensions, the comparative analyses in this thesis comprise a number of different 
HRQoL measures and a wide range of methods are employed to shed more light on the 
relationship between these alternative measures. Finally, this thesis discusses practical 
implications for the field of health economics and economic evaluation as well as areas 
for further research. 
1.2. Economic evaluation of health care interventions 
Health care resources are scarce relative to needs, which requires some form of 
rationing. An aging population and expensive technological advances have increased the 
cost pressures in health care to the extent that explicit rationing of services is inevitable 
(Coast & Donovan, 1996). In the absence of effective markets for most health care 
services, it is necessary to make decisions regarding the allocation of resources across 
different kinds of services (Jan, 1998). Health care is an economic good in the sense that 
delivering more of one type of care (from a fixed budget) displaces care elsewhere in the 
system. This reflects the concept of opportunity cost, which is the value of the 
consequences forgone by choosing to deploy resources in one way rather than in their 
best alternative use (Mooney & Drummond, 1982).  
Over recent decades, attempts have been made in many countries to improve the 
allocation of health care resources using economic evaluation. An economic evaluation 
can help to inform the process of shifting resources to where they are most efficiently 
allocated. An economic evaluation is the comparative assessment of the costs and 
benefits of alternative health care interventions (Drummond et al., 2015). The term 
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‘benefits’ is also referred to as ‘consequences’, ‘outcomes’, or ‘effects’ within the 
economic evaluation literature. Evaluations that consider both costs and benefits can be 
considered ‘full’ economic evaluations, of which there are three distinct types: cost-
effectiveness analysis (CEA), cost-utility analysis (CUA), and cost-benefit analysis 
(CBA) (Drummond et al., 2015). Within these three types of evaluation, the unit for 
measuring the benefits of health care is the key distinguishing feature. The scope of 
benefits within the three types of evaluation moves from uni-dimensional outcomes 
measured in natural units in CEA (e.g., life years or depression-free days), to a two-
dimensional unit capturing HRQoL and length of life as measured by QALYs in CUA, to 
benefits measured in monetary terms in CBA (Lancsar & Louviere, 2008). Two other 
types of economic evaluation exist in the literature: the cost-consequences analysis 
(CCA) and the cost-minimization analysis (CMA). In a CMA, equivalence in benefits is 
assumed in comparative groups. A CCA provides a multi-dimensional listing of costs and 
benefits in a disaggregated form. Both types of evaluation have faced criticism; CMA for 
the ambiguous evidence of clinical equivalence and CCA for the absence of a full 
synthesis of benefits and costs. As such, strictly speaking, both types cannot be 
considered as a full economic evaluation (Drummond et al., 2015). However, while 
CMAs are rarely conducted nowadays (Briggs & O'Brien, 2001), the CCA is gaining 
more attention in health care policy (further details to follow) (Coast, 2004). 
Despite the existence of many types of outcome measures in economic evaluation, 
the QALY has become the dominant approach to evaluate the cost-effectiveness of health 
care interventions (Payne & Thompson, 2013). While CEA can limit comparability 
across clinical contexts due to the use of condition-specific measures, shortcomings of 
the CBA include the difficulty in assigning monetary values to health care benefits (Coast 
et al., 2008d). The use of an outcome metric that is capable of allowing comparisons 
across clinical areas has led to the widespread adoption of the QALY (Round, 2012). 
CUA, based on QALYs, is currently the recommended approach by numerous health 
technology assessment (HTA) agencies, including the Canadian Agency for Drugs and 
Technologies in Health (CADTH) in Canada (CADTH, 2017) and the National Institute 
for Health and Care Excellence (NICE) in the UK (NICE, 2013).  
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1.3. Preferences and health state valuations 
Within the CUA framework, preferences play a key role and form a fundamental 
component of the QALY calculation. In order to assess the value of a range of 
interventions, the impact of the intervention on an individual’s health state is measured 
and valued, where more preferred health states receive greater weights (Whitehead & Ali, 
2010). Preference weights for health states are anchored on a 0-1 scale, with 0 being the 
value of ‘dead’ and 1 being the value of ‘full health’, with negative scores possible, i.e., 
states worse than dead (Neumann et al., 2000). A year of ‘full health’ (i.e., a health state 
equal to one throughout a 12-month period) is, therefore, equivalent to one QALY.  
To measure the value of a particular health state, a number of preference-
elicitation techniques have been developed. Three common approaches are the visual 
analogues scale (VAS), time trade-off (TTO), and standard gamble (SG) (Whitehead & 
Ali, 2010). The VAS is a form of a rating scale and is seen as the simplest direct 
elicitation technique, where the upper end of the scale indicates the ‘best imaginable 
health’ and the lower end of the scale the ‘worst imaginable health’. While the EuroQol 
Group traditionally utilized these anchor points, other end-points can be applied such as 
‘full health’ and ‘dead’ (Brazier et al., 2017). Individuals are then asked where on the 
scale they would place the health state that needs to be valued. The TTO technique, on 
the other hand, provides individuals with two alternative options. One option describes a 
life in an impaired health state for a certain time period and the second option describes a 
life in full health for a shorter period of time. This shorter period of time in full health is 
varied until the individual is indifferent between those two alternatives. The value of the 
health states is then represented by the ratio of the two periods, i.e., the number of years 
in full health divided by the number of years in the impaired health state (Attema et al., 
2013). The standard gamble also offers individuals two alternatives, where the choice is 
between a continuation of life in the current health state to be valued and a gamble. The 
gamble offers the possibility of full health or immediate death, which are the anchor 
points required for use within the QALY framework. The probabilities associated with 
the gamble are varied until the individual is indifferent between the two alternatives, 
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where the indifference point becomes the value of the health state (Gafni, 1994). 
Although all three techniques are used to elicit preferences for health states, only SG 
provides utilities based on the expected utility theory (EUT) of von Neumann and 
Morgenstern, which requires choices to be made under uncertainty (von Neumann & 
Morgenstern, 1944). The VAS and TTO provide ‘values’, which are obtained under 
conditions of certainty (Drummond et al., 2015). For consistency reasons, the term utility 
will be used throughout this thesis, referring to the numerical representation of a person’s 
choice behaviour (Gafni & Birch, 1995). 
In clinical research, the three approaches described above (also referred to as 
direct preference elicitation approaches) require many resources and are not always 
practical, as patient preferences would need to be elicited each time a study is carried out 
(Arnold et al., 2009). For these reasons, numerous indirect approaches have been 
developed, which provide so-called ‘off-the-shelf’ values, using standardized HRQoL 
questionnaires (Neumann et al., 2000). Here, values are available for every health state 
defined by the descriptive classification system (i.e., the items and response levels in the 
questionnaire). Examples of such descriptive classification systems include the 15D 
(Sintonen, 2001), Assessment of Quality of Life 8-dimension (AQoL-8D) (Richardson et 
al., 2009), EQ-5D (3 level (EQ-5D-3L) or  5 level (EQ-5D-5L)) (Herdman et al., 2011; 
Rabin & de Charro, 2001), Health Utilities Index Mark 2 (HUI-2) or Mark 3 (HUI-3) 
(Feeny et al., 2002), Quality of Well-Being Scale Self-Administered (QWB-SA) (Seiber 
et al., 2008), and SF-6D (Brazier et al., 2002; Brazier & Roberts, 2004).  
In order to apply these questionnaires across different disease groups, they need to 
be generic and, as such, the descriptive classification systems must capture a broad range 
of health dimensions to reflect people’s multidimensional health states. For that reason, 
these standardized questionnaires are often called multi-attribute utility instruments 
(MAUIs), utility measures, or preference-based HRQoL instruments. The latter term will 
be used throughout this thesis. The weights to score these standardized health state 
classifications are obtained using one (or a combination) of direct elicitation techniques. 
As such, preference-based HRQoL measures consist of a descriptive system (referring to 
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the questionnaire) and a valuation system, which scores each health state as defined by 
the questionnaire and provides a single value (Brazier et al., 1999). A large number of 
valuation studies have been conducted in many countries, with the aim of developing 
national valuation sets, also known as social tariffs (Engel et al., 2016).  
An important question in such valuation tasks is who should value health states. 
Different sources are possible including patients, their carers, health professionals and the 
general public (Brazier et al., 2017; Dolan, 1999). Currently, preferences for health states 
of indirect preference-based HRQoL measures, such as the EQ-5D, are obtained from the 
general population because of individuals’ status as potential patients and payers of 
publicly funded health care (Versteegh & Brouwer, 2016). However, evidence has shown 
that there are discrepancies in health state values between the general public and patients 
(Peeters & Stiggelbout, 2010; Ratcliffe et al., 2007). While a distinction is usually made 
between the sources of preferences (patients versus general population), another 
consideration is made in terms of what is valued. Different scenarios are identified in 
Table 1.1. The general public is generally asked to value a hypothetical health state by 
imagining what the state would be like (cell A). The description of health states is usually 
derived from existing classification systems, such as the EQ-5D-5L. Patient preferences 
refer to patients valuing their own health state, which they are currently experiencing 
(cell D) with the use of direct elicitation techniques such as SG or TTO. While cell B 
(patients valuing hypothetical health states) and cell C (members of the general public 
who have experiences with specific health states) are also possible, it is important to 
understand that there are fundamental differences between preferences in cell A and D. 
Further discussion on this topic will follow in Chapter 6. International health economic 
guidelines vary between jurisdictions, where preferences from the general public are 
explicitly required in the UK and the Netherlands, while other countries, like Sweden, 
prefer patient preferences (Versteegh & Brouwer, 2016). 
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Table 1.1. Classification of preferences by population and what is valued 
 General public Patients 
Hypothetical health state A B 
Experienced (own) health state C D 
 
1.4.  The evaluative space of the QALY 
QALYs are seen as a measure of health and the descriptive systems of preference-
based measures from which QALYs are derived typically focus only on outcomes 
affecting a person’s health or HRQoL. The World Health Organization (WHO) defines 
health as “a state of complete physical, mental and social well-being, and not merely the 
absence of disease and infirmity” (WHO, 1948). More recently, the WHO described 
health in terms of impairment, disability, and participation (WHO, 2001). The most 
widely used preference-based HRQoL measures (i.e., EQ-5D-3L, HUI-2 and HUI-3, and 
SF-6D (Richardson et al., 2015c)) focus on these aspects of health, although differences 
exist in terms of how these aspects are incorporated into the respective descriptive 
classification system (Brazier et al., 2007). For example, the HUI can be described as a 
measure of the ‘within-skin aspects of health’ (Furlong et al., 2001), focusing primarily 
on impairment and disability (vision, hearing, speech, ambulation, dexterity, emotion, 
cognition, and pain). Alternatively, the EQ-5D (3 level or 5 level) contains aspects of 
impairment (pain/discomfort, and anxiety/depression), disability (mobility and self-care), 
and participation (usual activities). These three aspects can also be found in the SF-6D 
through the incorporation of pain and mental health (impairment), physical functioning 
and vitality (disability) and role limitation and social functioning (participation).  
Figure 1.1 provides a graphical presentation of the term HRQoL as reflected by 
existing preference-based HRQoL. Using an example of a person who suffers from 
rheumatism, the Figure shows to what extent preference-based HRQoL measures 
combine aspects of WHO’s definition of health in their respective descriptive 
classification systems. The figure also shows that although health care can impact a 
 8 
person’s broader QoL, when it comes to the evaluation of health care interventions using 
preference-based HRQoL measures, the focus is restricted to HRQoL. The term HRQoL 
refers in this context to aspects of QoL that can be affected by health (i.e., aspects 
affected by the presence of disease and treatment) (Brazier et al., 2007).   
 
 
Figure 1.1. Graphical presentation of the term HRQoL as reflected by existing 
preference-based HRQoL measures 
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Besides the focus on impairment, ability and participation, preference-based 
HRQoL measures differ also in their scope of the evaluative factors concerning a 
person’s life, as defined by the dimensions of HRQoL included in preference-based 
HRQoL measures. Table 1.2 provides an overview of dimensions included in six 
preference-based HRQoL measures. It shows that different HRQoL measures contain 
different physical and psychosocial dimensions. Given that preference-based HRQoL 
measures are used to derive utility weights for the QALY calculation, these measures, 
ultimately, determine the evaluative space of the QALY (Whitehurst & Engel, 2017).  
Table 1.2. Dimensions of six preference-based HRQoL measures (derived from 
Richardson et al. 2015a) a 
Dimension EQ-5D-5L SF-6D HUI-3 15D AQoL-8D QWB 
Physical       
Physical ability/ mobility/ 
vitality/ coping/ control 
* * ** ** ** ** 
Bodily function/self-care *   *** *  
Pain/discomfort * * * * **  
Senses   ** ** **  
Usual activities/ work * *  * **  
Communication   * * *  
Psychosocial       
Sleeping    * **  
Depression/anxiety/anger * * * *** *** *** *  
General satisfaction     *** *  
Self-esteem     *** **  
Cognition/memory ability   *    
Social 
function/relationships 
 *   *** ** * 
(Family) Role  *   *  
Intimacy/sexual 
relationships 
   * *  
Total items/symptoms 5 6 8 15 35 b 
a The number of asterisks (*) indicates the number of items measuring the dimension in the respective 
instrument. 
b QWB has 3 items relating to mobility and physical and social health, plus 27 symptom groups. 
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1.4.1. Perceived limitations of the health-related QALY 
It has been claimed that focusing on health-related aspects of QoL only for health 
care allocation decisions may result in suboptimal decisions because it does not capture 
broader benefits that may result from an intervention (Coast et al., 2008a). Methods for 
the economic evaluation of health care interventions have existed for a number of years 
but these have mainly been applied to more narrowly defined ‘clinical’ interventions, 
such as drugs, devices and medical procedures. The attempt to evaluate interventions that 
are more complex has faced challenges, mainly because benefits cannot be simply 
measured in terms of health (Byford & Sefton, 2003; Husereau et al., 2014; Payne et al., 
2013). Complex interventions are distinguished from simple interventions, such as 
pharmaceuticals, in that they often involve several interacting components, difficult 
behaviours in those delivering (or receiving) the intervention, more than one group or 
organizational levels targeted by the intervention, and numerous outcomes (Craig et al., 
2008). Treatments for drug users can be considered as a complex intervention, which not 
only result in health benefits for the affected individuals, but also for society in terms of 
the behaviour change of the drug user, which leads, for example, to crime reduction 
(Payne et al., 2013). Similar in genetic services, which have important benefits for 
individuals and their families regarding knowledge about the diagnosis, prognosis and 
risk of having a condition (Payne et al., 2013). In addition to the increased complexity of 
interventions, it can be observed that health care is shifting from curing towards caring. 
While cure is concerned with improvements in health functionings, care often helps sick 
people to maintain dignity (Dolan & Olsen, 2002).  
With a shift towards care, services without measurable impact on health status are 
increasingly demanded (Kotzian, 2009). The provision of social care services is one such 
area. Social care is usually provided to individuals with physical or sensory impairments, 
learning difficulties and mental health problems (Netten et al., 2012). For individuals 
with such conditions, the distinction between ‘health needs’ and ‘social service needs’ is 
often unclear and a shift towards an integrated approach to health and social care is 
observable in countries such as the UK (Mason et al., 2015). The aim of social care 
services is to compensate a person for their lost functional ability (rather than try to 
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restore it), since most people using social care services have conditions that involve a 
permanent or declining loss of functional ability (Netten et al., 2012). As such, social 
care services may not contribute to health per se but to QoL more generally (Grewal et 
al., 2006), helping individuals with the types of tasks and activities associated with their 
daily activities. 
Another area that often provides benefits beyond health emerges from the public 
health field. It has been observed that in the public health sector the use of preference-
based HRQoL measures neglects relevant benefits of interventions (Goebbels et al., 
2012; Lorgelly et al., 2008). Health promotion, for example, aims to improve an 
individual’s ability to make informed decisions and increases control over his/her 
personal life. The evaluation of complex interventions, such as public health programs, is 
particularly challenging as they not only combine educational, social and political 
strategies but also because benefits are often occurring outside the health care sector 
(Greco et al., 2016). With the increase in evidence showing that existing measures are not 
sufficient to capture such ‘non-health’ benefits (Goebbels et al., 2012; Greco et al., 
2016), NICE guidelines in the UK have recognized that the evaluation of public health 
and social care interventions requires different approaches (further discussion will follow 
in Chapter 4) (NICE, 2012).  
Traditionally, contingent valuation (CV) has been proposed as an alternative 
measurement approach to overcome the narrow evaluative space of the QALY. CV 
methods value outcomes in monetary terms based on individuals’ willingness to pay 
(WTP) within a CBA framework (Gafni, 2006). WTP can be seen as superior to QALYs 
in that it does not impose restrictions on which dimensions of benefits respondents are 
permitted to consider in order to express their preferences (Olsen & Smith, 2001). 
However, this approach has some limitations, since evidence has shown that people’s 
WTP is partly determined by their ability to pay, where the allocation of health care 
resources could be skewed towards the wealthy (Olsen & Smith, 2001). In addition, 
people are in general extremely uncomfortable valuing life and QoL in monetary terms 
and often overstate their real WTP (Coast et al., 2008d). In practice, CBA has not been 
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widely accepted and current policy makers have a preference for CUA based on QALYs 
(Payne & Thompson, 2013).  
Another approach to overcome the narrow focus on HRQoL within the QALY 
framework is to broaden the evaluative space. This approach is the focus of the research 
conducted within this thesis. Recent efforts to overcome the perceived limitations of the 
evaluative space of the QALY have led to the development of alternative preference-
based instruments that are suitable for use in economic evaluation. Three such measures 
have resulted from the Investigating Choice Experiments for the Preferences of Older 
People (ICEPOP) project: namely ICEpop CAPability measure for older adults 
(ICECAP-O) (Coast et al., 2008c), adults (ICECAP-A) (Al-Janabi et al., 2012), and 
individuals at the end of life (ICECAP Supportive Care Measure (ICECAP-SCM)) 
(Sutton & Coast, 2014). In 2016, a fourth instrument became available, which captures 
the benefits to those close to the dying person (ICECAP-Close Person Measure, 
ICECAP-CPM) (Canaway et al., 2016). Outside the ICECAP family of instruments, 
another measure was developed for the social care context, the Adult Social Care 
Outcomes Toolkit (ASCOT), which is a measure of a person’s social care-related QoL 
(Netten et al., 2012). ICECAP and ASCOT measures have only a few or no items directly 
related to physical and mental health, and are more concerned about a person’s 
autonomy, enjoyment, control, or dignity. Table 1.3 provides an overview of the domains 
in the ICECAP-A and ASCOT.  
ICECAP and ASCOT measures do not only have a broader evaluative space, 
these measures are also based on the same theoretical foundation set out by Amartya 
Sen’s capability approach (Sen, 1993). Briefly, Sen’s capability approach distinguishes 
between ‘functionings’ and ‘capabilities’. Functionings are an individual’s set of 
achieved doings and beings, or what a person manages to do or be. Capabilities are an 
individual’s potential to achieve certain functionings, or the various combinations of 
functionings of what a person can do or be (Sen, 1993). Applied to the health care 
context, this approach implies that the evaluation of health care interventions should 
distinguish between ‘observable health achievements’ and the ‘capability to achieve good 
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health’. These issues are discussed further later in the thesis (see Chapters 4-6). The 
ICECAP and ASCOT measures have been validated (although more validation work is 
still warranted) and have been used in a number of countries, including the UK, 
Australia, Canada, and the Netherlands (Coast et al., 2008c; Couzner et al., 2013b; Davis 
et al., 2013; Makai et al., 2014a; Makai et al., 2013; van Leeuwen et al., 2015a; van 
Leeuwen et al., 2015b).   
 
Table 1.3. Overview of the domains in the ICECAP-A and ASCOT a 
Measure Domains 
ICECAP-A Stability 
 Attachment 
 Autonomy 
 Achievement 
 Enjoyment 
ASCOT Control over daily life 
 Personal cleanliness and comfort 
 Food and drink 
 Personal safety 
 Social participation and involvement 
 Occupation 
 Accommodation cleanliness and comfort 
 Dignity 
a The ICECAP-A is used as an example here. Other measures of the ICECAP family 
comprise the ICECAP-O, ICECAP-SCM, and ICECAP-CPM. 
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1.5. Thesis aim and outline 
With the development of outcome measures in economic evaluation that go 
beyond health, understanding the relationships between different approaches is an 
important area of research. The aim of this thesis is to examine methodological 
considerations when using outcome measures in health economic evaluation that extend 
beyond HRQoL and to examine implications for policy and practice when broadening the 
evaluative space of the QALY. The empirical investigations within this thesis focus 
primarily on the relationships between preference-based HRQoL measures and the adult 
(ICECAP-A) and older adult (ICECAP-O) ICECAP instruments. The main objective of 
this thesis is to examine the scope and additional information provided by the ICECAP 
measures when compared with conventional preference-based HRQoL measures. The 
thesis is constructed around three research questions: 
• What are the potential challenges in broadening the evaluative space of the QALY? 
• What is understood by ‘benefits beyond health’?  
• What information is captured by ICECAP measures over and above the information 
garnered by existing preference-based HRQoL measures? 
To achieve these aims, a number of different approaches were undertaken, 
starting with a narrative review, followed by a literature review and three empirical 
analyses. A brief outline of Chapters 2-7 now follows.  
Chapter 2 is a narrative review of challenges associated in broadening the 
evaluative space of the QALY. Theoretical issues associated with the welfarism and 
extra-welfarism approaches are examined, in addition to conceptual and normative 
considerations regarding the extent to which the current maximization principle in health 
care decision-making may be justified. Finally, important methodological and practical 
issues are discussed, including the measurement and valuation of broader benefits, as 
well as the necessity of pragmatism in economic evaluation.  
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Chapter 3 reports a critical interpretive synthesis of articles that discusses the 
notion of benefits beyond health within the context of QALYs. After examining how the 
literature to date has communicated such benefits, non-health benefits are organized into 
a thematic framework. The final output of this chapter is a concept map that displays the 
relationships between non-health benefits.  
Chapter 4 is an empirical analysis of outcome measures within a public health 
context. This chapter reports findings from a study examining the role of the built 
environment and social cohesion for older adults’ QoL, where the ICECAP-O is 
compared with the EQ-5D-5L. This investigation provides evidence in terms of the extent 
to which these instruments are able to capture broader benefits outside the health care 
context. 
Chapter 5 investigates the extent of overlap between the ICECAP-A and five 
preference-based HRQoL measures in an exploratory factor analysis. The ‘added value’ 
of the ICECAP-A instrument in economic evaluation is discussed, along with practical 
implications regarding the use of measures of capability wellbeing. 
Chapter 6 extends the comparative analysis from Chapter 5 through a path 
analysis, providing empirical analysis regarding the relationship between HRQoL, 
capability wellbeing and subjective wellbeing. Using data from individuals living with 
spinal cord injury who suffer from secondary health conditions, this analysis examines 
the effect of secondary health conditions simultaneously on HRQoL, capability 
wellbeing, and subjective wellbeing through direct and mediated pathways. It provides 
further practical considerations and implications for outcome measurement in economic 
evaluation.   
Chapter 7 comprises a discussion of the results of each chapter and their 
implications for health care decision-making. The chapter outlines the degree to which 
previous research gaps have been addressed, as well as the limitations of this work and 
directions for future research. 
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Chapter 2. Challenges associated in broadening the 
evaluative space of the QALY 
2.1. Introduction 
The introduction of QALYs as an integral part of health care decision-making in 
the 1980s came along with criticisms (Harris, 1987; Rawles, 1989), where in particular 
the evaluative space of the QALY framework has been challenged (Mooney, 1989). 
Mooney cast doubt that health services are about health only and, as such, using cost per 
QALY as a decision rule for resource allocation purposes may be inadequate. In his view, 
maximizing QALYs cannot be equated with maximizing utility since there are other non-
health outputs that can be considered as benefits from the health care system (Mooney, 
1989). Chapter 1 provided examples of areas for which non-health outcomes are non-
trivial, such as social care, public health, and other complex interventions. Evidence also 
exists about broader benefits that individuals derive from the actual processes of 
providing care, as opposed to achieving some desired level of health, referred to ‘process 
utility’ (Brennan & Dixon, 2013). Individuals may, for example, prefer easier access to 
certain facilities, or are willing to trade health gain against time spent being counselled. 
Other examples of process-related aspects of health care may also include ‘being treated 
with dignity’ or ‘being treated in a pleasant way’ (Brennan & Dixon, 2013). In particular, 
for end of life treatments, where health production may not be the focus of the care 
provided, process utilities can play an important role (Round, 2012). 
Concerns around the evaluative space of the QALY have not just emerged in 
recent years, as discussions around non-health benefits have existed in the literature since 
the late 1980s (Mooney, 1989; Rawles, 1989). It appears that this topic has faced 
numerous challenges that require further consideration. This chapter outlines the 
theoretical, normative, conceptual, methodological, and practical challenges associated 
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with broadening the evaluative space of the QALY. It explores to what extent challenges 
have been already addressed and highlight existing challenges that require further 
research.  
2.2. Theoretical challenges 
2.2.1. Welfarism versus extra-welfarism 
In standard welfare economics the overall welfare of the society is a function of 
individual utilities, and individual utilities are a function of the goods and services 
consumed by the individuals themselves. It is based on the consumer sovereignty theory 
(Brouwer et al., 2008), which implies that individuals are themselves the best judges of 
what contributes most to their utility and how much that contribution is (Birch & 
Donaldson, 2003). Utilities here can be understood as the value of a function that 
represents an ordering, in particular, a preference ordering of different combinations of 
goods and services consumed (Gafni & Birch, 1995). In other words, utility is a 
numerical representation of a person’s choice behaviour. In welfare economics, a social 
utility function is interpreted as an aggregate of individual utilities and the ultimate goal 
of any resource allocation scheme is to maximize the social utility function (Coast, 2009).   
To determine whether an improvement in social welfare has taken place or not, 
the ‘Pareto principle’ is used. A Pareto improvement would occur if a policy in health 
care makes one or more persons better off (i.e., increases their utility) without making 
another person worse off (i.e., decreases their utility) (Coast, 2009). In practice, however, 
allocation of resources cannot produce only winners but also involves losers (i.e., 
resources devoted to the health care of one person will deny health care to another person 
who might have benefited). A less strict approach, called the ‘potential Pareto principle’ 
(or Kaldor-Hicks criterion (Nicholas, 1939)), allows for the possibility of the winners 
compensating the losers. Under this approach, society as a whole has benefited from a 
particular allocation decision if the winners could, in theory, compensate the losers and 
still remain better off than they were before the decision (Coast, 2009). Important to note 
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is that since individuals can derive utility from different sources, such as from the 
consumption of health services, education or chocolate bars, individuals not receiving 
health can be compensated by enhancing their utility from other sources. Health is, 
therefore, seen as an intermediate stage that contributes to a person’s utility from the 
consumption of health services (Coast, 2009).  
In contrast, the ‘extra-welfarism’ approach, sometimes called the ‘non-welfarist’ 
or ‘decision-maker’ approach, replaces utilities with health as the primary outcome of 
interest for evaluation (Coast et al., 2008d). This approach tries to maximize health as 
opposed to overall welfare. Originally, extra-welfarism was derived from Sen’s capability 
approach (Sen, 1993). Sen rejected the exclusive focus on individual’s utilities and 
suggested to replace it by a broader perspective, considering the quality of utility and 
individual’s capabilities rather than the emotional reaction of individuals to the 
possession of goods and capabilities. Building upon Sen’s capability approach, Culyer 
introduced in the 1980s a theoretical framework around the extra-welfarism approach 
within health economics (Culyer, 1989). It differs from the welfarist perspective in four 
important aspects: i) it permits the use of outcomes other than utility; ii) it permits the use 
of sources of valuation other than the affected individuals; iii) it permits the weighting of 
outcomes (whether utility or other) according to principles that do not need to be 
preference-based; and iv) it permits interpersonal comparisons of wellbeing in a variety 
of dimensions, thus enabling movement beyond welfare economics (Brouwer et al., 
2008). These four important differences are discussed in further detail below.  
While the welfarism approach exclusively focuses on individual utilities, the 
‘extra’ in extra-welfarism is that it broadens the evaluative space to include other non-
utility information. This may include, for example, equity weights and capabilities 
(Brouwer et al., 2008). However, although the extra-welfarism approach allows taking 
measures other than individual utilities into account, Culyer’s expression of extra-
welfarism is limited in that it focuses only on health (Coast et al., 2008d). Given that 
decision makers are mainly interested in health, health has become the primary outcome 
of interest for evaluation (Culyer & Evans, 1996). Whereas in the welfarism approach 
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health is taken into account insofar as it enables utility to be derived from the 
consumption of health care, the extra-welfarism approach suggests that the output of 
health care should not be judged in terms of preferences of health against other goods, but 
rather to its contribution to health. Culyer’s operationalization of the extra-welfarism 
approach aims to maximize health (in terms of QALYs) rather than overall welfare, and 
ignores individuals’ trade-offs between health and other commodities and/or 
characteristics (Birch & Donaldson, 2003). Even though utility theory is used in the 
derivation of QALYs, it is used solely to measure people’s health rather than the utility 
they drive from it (Wagstaff, 1991).  
The second characteristic of the extra-welfarism approach allows judgments to be 
made on behalf of, rather than by, affected individuals. In other words, while decisions in 
the welfarism approach are being made from the individual perspective because an 
individual is the best source of their own health state, the extra-welfarism approach 
allows external judgments that replace or supplement the subjective utility numbers in the 
social welfare function. It is argued that individuals need to be protected from their own 
foolishness, which on the flip side may override their own best interests (Birch & 
Donaldson, 2003). The extra-welfarism approach assumes that a health state has the same 
effect on all individuals. As such, two individuals with the same health states would be 
treated equally according to the extra-welfarism perspective, regardless of whether one of 
them is happier or copes well with their health state. The welfarism approach would, in 
contrast, encapsulate these coping differences (Gyrd-Hansen, 2005). As a result, 
individual preferences might be overlooked within the extra-welfarism approach, as it is 
the aim to maximize the overall health in a society. In the extra-welfarism approach, any 
number of stakeholders can make judgments in regards to the different values for the 
different entities, and how they should to be traded off against one another and compared 
interpersonally (Brouwer et al., 2008). In practice, there is still a debate about the exact 
source of value and the question of whose preferences should count (e.g., patients versus 
public) (Dolan, 1999; Versteegh & Brouwer, 2016). 
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The weighting of outcomes is another key distinction between the two 
approaches, associated with the assignment of priority levels according to principles that 
need not be preference-based. In order to weight benefits, such as health, certain 
characteristics are required. These characteristics may imply that, for example, more 
weight should be attached to health gained by the young, or those with poor levels of 
initial health, or those who stand to lose a large proportion of remaining health. These 
weights can be used to address equity concerns within the extra-welfarism framework. 
Although these weights do not need to be preference-based, extra-welfarists strongly 
advocate the use of preference-based measures (Brouwer et al., 2008). Other authors 
argue that distributional weights are not exclusively for the extra-welfarism approach and 
can be also found in the welfarist theory (Birch & Donaldson, 2003). It is argued that if 
individuals were concerned about distributional issues, either directly or indirectly, this 
would be reflected in their utility function.  
It was previously mentioned that under the extra-welfarism perspective health is 
not treated as an intermediate stage on the way to producing utility but valued on its own 
right. In view of the fact that the allocation of health resources happens simultaneously 
with the production of health, health cannot be transferred from one individual to another 
once produced (Coast, 2009). It follows that the potential Pareto principle no longer 
provide a sufficient theoretical basis for health maximization because the production and 
distribution of health in extra-welfarism is in theory not separable. Therefore, a 
movement beyond welfare economics is acceptable by allowing interpersonal 
comparisons of wellbeing in a variety of dimensions. Interpersonal comparisons refer to 
the ability to compare utility functions of different individuals that are measured on the 
same yardstick. From a welfarist perspective, interpersonal comparisons appear 
impossible or meaningless since neither the Paretian principle, nor the compensation 
(potential Paretian) principle require interpersonal comparison. Under these two 
approaches, what matters is whether at least one person’s utility is increased while no 
other individual’s utility is reduced, or the minimum compensation it would take to make 
sure the loser is no worse off but leaves the gainer better off (Birch & Donaldson, 2003). 
Within the extra-welfarism approach, however, interpersonal comparisons are needed to 
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determine which groups or persons to give priority in allocating health care resources 
(Brouwer & Koopmanschap, 2000). Using health-related outcome measures, such as 
QALYs, enables the comparison of individuals within a health domain. Under this 
approach, it is irrelevant if an individual might be worse-off since the only thing that 
matters are the total QALYs, which are used as a summary measure for the value of an 
intervention and as a basis of comparisons between alternative resource allocations 
(Birch & Donaldson, 2003). 
2.2.2. Incorporation of non-health benefits under the welfarism and extra-
welfarism approach 
The welfarism approach is currently the underlying approach of a CBA based on 
WTP. In welfare economics the measurement of social welfare is the wellbeing of 
individuals as assessed by themselves. This implies that in economic evaluation, benefit 
assessment for a given intervention needs to be based on the extent to which individuals 
are affected and how they value this impact (Brazier et al., 2007). A CBA aims, 
therefore, to assess how people value changes in their own health. In this context, both 
health outcomes and non-health outcomes can be included as long as individuals derive 
utility from it. Here, health is only taken into account insofar as it enables utility to be 
derived from the consumption of health care. 
Even though broader outcomes are considered under the welfarist approach, it 
does not account for process utilities, as from the traditional welfare economic view it is 
assumed that health care has no value in use (Mooney, 2009). Based on Grossman’s 
model of the derived demand for health, individuals pay for health care only because of 
the benefits derived from it, through expected health gains. The welfarism perspective is 
based on ‘consequentialism’, which implies that utility can only be derived from the 
outcomes of behaviour and processes rather than the processes themselves or intentions 
that led to the outcomes (Brouwer et al., 2008). In other words, processes and procedures 
would only be considered if they have utility consequences. However, as Donaldson and 
Shackley have argued, there are other elements in the consumer’s utility function – not 
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only consequences and outcomes (Donaldson & Shackley, 1997). There can be utility in 
the process of health care as well as in its outcome. 
Whereas CBA falls under the welfarist approach, the QALY has no foundation in 
economic welfare theory (Birch & Donaldson, 2003). Firstly, in welfare economics the 
affected group of individuals is the primary source of valuation. This is contrary to the 
QALY concept, which is often not based on an individual’s own valuation of their health 
but rather societal preferences using preference-based HRQoL measures (e.g., EQ-5D-5L 
(Herdman et al., 2011)). Secondly, health is not the single component of utility. Beside 
health, there are other items captured in terms of individual utility, like processes, 
institutions, equity, quality of relationships, and social norms. If health were indeed the 
single component of an individual’s utility function, then the QALY concept would fit 
within the welfarism approach. But if other non-health aspects would also contribute to 
an individual’s wellbeing, this does not hold. It follows that the QALY suits better the 
extra-welfarism approach. In fact, when the QALY was introduced, some health 
economists criticized its fit within the welfarist approach and the extra-welfarism 
approach can be seen as an attempt to justify health maximization and, in turn, QALY 
maximization in the health care objective function (Mooney, 2009). Recent research has 
explored the WTP for a QALY, which can be interpreted as a CBA since the non-
monetary consequences in a CEA can be translated into monetary terms (Gyrd-Hansen, 
2005). Although this approach could be interpreted within the welfare theoretical 
framework, it is not being used to date. 
From an extra-welfarist approach, based on CUA using QALYs, neither process 
utility nor non-health benefits are considered, as can be observed in existing national 
guidelines (CADTH, 2017; NICE, 2013). Given that the objective of publicly-funded 
health care is to improve population health, the extra-welfarism approach focuses on 
health outcomes only and ignores the individual’s potential willingness to trade between 
health and other aspects that may yield wellbeing. Consequently, the current extra-
welfarism approach would only consider non-health outcomes or process utility if they 
contribute to health.  
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Other authors have argued that if decision makers would accept a broader concept 
of wellbeing than that typically adopted within extra-welfarism, process utilities can be 
added into the QALY calculation (Brennan & Dixon, 2013). In fact, there is no 
conceptual reason to exclude process utility and non-health outcomes within the extra-
welfarism approach (Round, 2012). In theory, therefore, non-health outcomes can be 
included within the QALY framework. This reflects also the viewpoint of Brouwer and 
colleagues who have provided another interpretation of the extra-welfarism approach that 
is more aligned with Sen’s capability approach (Brouwer et al., 2008). Although Culyer 
argued that his extra-welfarism framework was based on Sen’s capability approach, the 
extent of Sen’s influence is limited due to three reasons. Firstly, Culyer’s expression of 
extra-welfarism relies purely on health as an outcome, whereas the capability approach is 
multi-dimensional as can be seen in Nussbaum’s list of ten central human capabilities 
(Nussbaum, 2003). Secondly, Sen makes a clear distinction between capabilities and 
functionings, which is not reflected in Culyer’s extra-welfarism approach. Finally, 
whereas Sen’s capability approach moves away from a maximization principle towards 
equity and poverty reduction, Culyer’s expression of extra-welfarism is ultimately to 
maximize health in terms of QALYs (Coast et al., 2008d). Therefore, accepting a broader 
extra-welfarism perspective as proposed by Brouwer et al. compared with the narrow 
explanation introduced by Culyer would allow for the incorporation of benefits beyond 
health (e.g., non-health outcomes and process utility) if a decision maker with authority 
decides to do so (Brouwer et al., 2008).  
Table 2.1 compares the welfarism approach with the two extra-welfarism 
frameworks; one framework that adopts a ‘narrow’ extra-welfarism view based on 
Culyer’s interpretation and one ‘broader’ extra-welfarism view based on Brouwer and 
colleagues. Table 2.1 also summarizes to what extent non-health benefits can be 
incorporated into these theoretical frameworks. 
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Table 2.1. Key characteristics of the welfarism approach compared with two 
extra-welfarism frameworks a 
 
Welfarism 
‘Narrow’ Extra-
welfarism  
(Culyer 1989) 
‘Broad’ Extra-
welfarism 
(Brouwer et al. 
2008) 
Relevant 
outcomes 
• Focus on 
individual utilities  
• Social welfare is a 
function of 
individual 
welfares 
• Consequentialism 
• Focus on health • Focus on outcomes 
other than utility  
• Selection of 
outcomes is 
context-dependent 
Source of 
valuation of 
relevant 
outcomes 
• The affected 
individual 
(individual 
sovereignty) 
• Permits the use 
of sources of 
valuation other 
than the affected 
individual 
• Permits the use of 
sources of valuation 
other than the 
affected individual 
Weighting of 
relevant 
outcomes 
• Weighting of 
outcomes 
reflected in 
individual utilities 
• Permits the 
weighting of 
outcomes 
• Permits the 
weighting of 
outcomes 
Interpersonal 
comparison 
• Individual utilities 
are not 
comparable 
• Permits 
interpersonal 
comparisons 
• Permits 
interpersonal 
comparisons 
Maximization 
rule 
• Maximize social 
welfare 
• Maximize health 
(expressed in 
QALYs) 
• Maximization rule 
is context-
dependent 
Incorporation 
of non-
health 
outcomes 
• Yes, if individuals 
derive utility from 
it (utility can only 
be derived from 
outcomes and not 
from processes) 
• Only if they 
contribute to 
health 
• Yes, if a decision-
maker with 
authority decides to 
include them  
 a Information provided in this Table were partly derived from Brouwer et al. (2008).   
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2.3. Normative challenges 
The extra-welfarism approach is based on the premise that the aim of an 
economic evaluation is to maximize whatever the decision maker wants to maximize. 
The question is then: what should be maximized? This is an important normative 
question because only those benefits that the decision maker considers to be relevant will 
be followed by analysts and included in the primary analysis. Within the context of health 
care, the focus is exclusively on health, as it is argued that individuals prefer more health 
to less health, which is why health is the appropriate maximand to be used in comparing 
resource allocations (Culyer & Evans, 1996). For many years, the emphasis in health 
economics has been almost exclusively on health (Mooney, 2009). Grossman’s work on 
the demand for health in the early 1970s defines health as illness-free days, which 
indicates the ability to work (Grossman, 1972). The healthier a person, the more healthy 
time is available either for work or for leisure activities. Grossman’s model showed that 
individuals do not demand health care for its own sake but because they have a demand 
for health. Thus, the demand for health care is a derived demand (Grossman, 1972). 
Given this emphasis on health, as opposed to health care, it is no surprise that health is 
treated as an end goal. 
The focus on health was further strengthened with the introduction of QALYs, 
which are mainly concerned about a person’s morbidity and mortality (Mooney, 2009). 
Changes in other outcomes, such as patient autonomy, respect, or information are not 
measured. Although many would argue that health is the key consideration for assessing 
the benefits of medical interventions, it is less clear how non-health benefits should be 
dealt with. Particularly, when comparisons are made across a broad range of interventions 
(e.g., drugs and public health services), interventions that result in non-health benefits 
would be disadvantaged in allocation decisions if such broader benefits were not 
captured. Ryan and Shackley provided examples of such benefits, including information, 
autonomy, dignity, the process of treatment, and non-medical reasons for visiting the 
doctor (Ryan & Shackley, 1995).  
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Not taking such evidence into account can potentially lead to misallocation of 
resources because the inclusion of broader outcomes can have significant effects on the 
conclusion of an economic evaluation, as a recent study demonstrated (Makai et al., 
2015). In an economic evaluation of an integrated care model for frail seniors, Makai and 
colleagues found that the intervention had a higher probability of being cost-effective 
when using the ICECAP-O, which is a broader measure of a person’s capability 
wellbeing (see Chapter 4.2.2), when compared with use of the EQ-5D-3L. A second 
example came from a study that evaluated the cost-effectiveness of two psychological 
interventions for drug addictions (Goranitis et al., 2017). This study applied the ICECAP-
A and EQ-5D-5L and concluded that under the health maximization principle based on 
the EQ-5D-5L, the results yielded different treatment recommendations than applying a 
‘sufficient capability’ approach (Mitchell et al., 2015b) using the ICECAP-A. Similar 
implications can be found for process utility within the QALY framework. McNamee and 
Seymour have shown that process values produced a different number of QALYs and 
QALY gains compared with those derived from health outcome values (McNamee & 
Seymour, 2008). As such, the authors argue that the estimation of process utility provides 
additional information to policy makers in judgments over the cost-effectiveness of 
health care interventions and offers a promising alternative to standard cost-per-QALY 
estimation. 
An important question is how far we should go with the evaluative space of 
outcome measurement in economic evaluation. As Donaldson and Shackley discussed in 
regards to process utilities, the possibility of trading non-health attributes for health 
attributes may mean that the provision of television sets in hospital could be 
recommended over some health-enhancing action if the utility gain from the former is 
greater (Donaldson & Shackley, 1997). This concern brings back into question whether 
going beyond health represents ‘good value for money’. Currently, ‘value’ in health care 
can be understood as health outcomes achieved per dollar spent (Porter, 2010). Whether 
this definition is an accurate reflection of societal preferences can be challenged. It is 
likely that citizens demand health care services that might have little or no impact on 
health status. As such, it is important to know what society considers as ‘good value’. For 
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example, as people get richer, there is a change in what they expect from their health care 
services (Kotzian, 2009), meaning that increases in wealth may cause a change in how 
health care is valued. The production of non-health outputs does not necessarily make the 
health care system inefficient. In fact, not considering these preferences can result in a 
misinterpretation of health care systems being inefficient (Kotzian, 2009).  
When it comes to the evaluation of health care systems, there is the need to take 
societal preferences into account. To date, evidence in terms of whether the society is 
willing to give up health gains for non-health benefits remains scarce. A recent study by 
Bansback and colleagues explored which aspects in health care priority setting members 
of the public value most (Bansback et al., 2014). An analytic hierarchy process was 
applied in order to elicit preferences for six different attributes from a representative 
sample in British Columbia, Canada (health benefit, condition severity, prevention, 
fairness, environmental, and non-health benefits). In this study, non-health benefits were 
defined as greater convenience or comfort, as well as increased confidence or autonomy. 
The study showed that study participants valued health benefits most (33%) and non-
health benefits least (7%). While this study provided important empirical evidence, a 
potential limitation concerns framing effects. As participants were asked which attributes 
should be given higher priority in health care, it is maybe not surprising to see that they 
attached a low value to non-health outcomes. The problem here arises also in how we 
label these outcomes, which leads to further conceptual challenges around this topic. 
2.4. Conceptual challenges 
The discussion about health and non-health outcomes for use in economic 
evaluation is difficult due to the lack of a clear definition of such outcomes. The WHO 
defines health “as a state of complete physical, mental and social well-being, and not 
merely the absence of disease” (WHO, 1948). However, in health economics and in the 
development of preference-based HRQoL measures, the WHO definition of health has 
influenced this field only to a limited extent. In a recent paper, de Vries and colleagues 
have argued that existing scales (and corresponding QALYs) may not provide a 
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comprehensive picture of the effectiveness of an intervention for a patient’s health as 
defined by the WHO (de Vries et al., 2016). They argue that while QALYs are currently 
derived from health measures that focus primarily on physical and mental functioning, 
they ignore social wellbeing. 
While the WHO definition of health is still most commonly adopted in practice, 
others have argued that this definition is no longer fit for purpose. Primarily, criticism has 
been focused on the word ‘complete’ in relation to wellbeing. Particularly for chronic 
diseases and disabilities, the WHO definition declares these individuals as ill and 
minimizes the role of the human capacity to cope autonomously with life’s changing 
physical, emotional, and social challenges, and to function with fulfilment and feeling of 
wellbeing. Consequently, Huber et al. define health as “the ability to adapt and to self-
manage” and argue that this is more meaningful for health policy where “health gain in 
survival years may be less relevant than societal participation, and an increase in coping 
capacity may be more relevant and realistic than complete recovery” (Huber et al., 2011, 
p.2). 
Having a clear concept of health would enable a better understanding of non-
health outcomes, but the absence of such a definition means the term ‘non-health 
outcomes’ remains unclear. In a Dutch study that tried to identify important non-health 
outcomes for health promotion, Goebbels et al. used a working definition that categorized 
non-health outcomes as all outcomes not covered by the EQ-5D measure, which contains 
the dimensions mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression (Goebbels et al., 2012). At the same time, the authors acknowledged 
that the dividing line between the non-health and health outcomes was not always a clear-
cut. Conceptual challenges arise also due to the interchangeable use of the terms health, 
HRQoL, and QoL in the economic evaluation literature (Karimi & Brazier, 2016). Given 
that HRQoL is sometimes equated with health status and sometimes with QoL, it appears 
to be impossible to draw a line between health outcomes and non-health outcomes. 
Outside the heath economics literature, more consistent definitions are observed, where 
HRQoL focuses on the measurement of symptoms and functions, whereas QoL is not 
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only influenced by disease and treatment but also by personality, economic status, 
environment, social relationship and culture (Doward & McKenna, 2004).   
There is a general consensus that, in an economic evaluation, health outcomes are 
defined in a narrow sense, i.e., the effects of health care on life years and on functional 
aspects of HRQoL, including aspects related to morbidity and disease, such as mobility, 
disability, pain and distress (Donaldson & Shackley, 1997). While it can be argued that 
this concept might miss important attributes of health care, such as reassurance, dignity 
and information, it has been argued that these attributes can be attributed to health 
because they reflect peoples’ mental health state (Donaldson & Shackley, 1997). Process 
utility can also be construed as health if the process of care were to affect a person’s 
mental health. Some authors have stated that process utility should be measured as part of 
a wider attempt to maximize wellbeing in accordance with the definition of health given 
by WHO (Higgins et al., 2014). However, a further issue with process utility is that is 
remains unknown what aspects of care fall into the process utility category. In a review 
by Opmeer et al., process-related preferences were considered as one type of non-health 
outcomes, including aspects such as discomfort, duration, or health care professional, 
whereas intervention-related outcomes (e.g. invasiveness) and patient-related outcomes 
(e.g. uncertainty or embarrassment) were seen as separate types of non-health outcomes 
(Opmeer et al., 2010).  
The absence of a clear definition of what constitutes an outcome and what is 
regarded as a process is associated with further challenges. In a study by Donaldson and 
Shackley, which examined the existence of process utilities in cholecystectomy patients 
using WTP, process utilities were defined as anything that takes place during surgery and 
while recovering from surgery, including faster recovery, quicker return to work, shorter 
hospital stay, and less pain. Outcomes, on the other hand, were defined as a state in which 
the patient is left after they have recovered (Donaldson & Shackley, 1997). While such 
definitions provide further clarity within the context of an individual study, Ryan & 
Shackley stress that a clear definition is not needed. What matters more is the fact that 
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patients may derive utility (whether called process or outcome) from aspects of health 
care other than health outcome (Ryan & Shackley, 1995).  
While the usefulness of clear definitions of non-health outcomes remains 
debatable, current practice still requires a distinction to be made. For example, the recent 
NICE guidelines state that for some interventions (e.g., interventions with a social care 
focus), the intended outcomes of interventions are broader than improvements in health 
status and, as such, broader preference-based measures of outcome are more appropriate 
(NICE, 2014). The guidelines continue saying that if an intervention is associated with 
both health and non-health-related outcomes, it may be helpful to present these elements 
separately in a CCA. However, in order to justify the use of another type of economic 
evaluation, a better understanding of such benefits is needed. The fact that NICE do not 
specify what constitutes a health and non-health outcome means that further conceptual 
examinations are warranted. 
2.5. Methodological challenges 
Outcome assessment in economic evaluation is divided into three stages: the 
identification stage, the measurement stage, and the valuation stage. The examination of 
methodological challenges associated with broadening the evaluative space of the QALY 
framework, are assessed for each stage separately.   
2.5.1. Identification stage 
Under Culyer’s extra-welfarism approach, having a definition of non-health 
outcomes is inevitable. Given that non-health outcomes are outside the evaluative space, 
such outcomes would need to be excluded unless they contribute to health. In contrast, 
adopting a welfarist perspective does not require a strict definition of health and non-
health outcomes because the goal would be to maximize an individual’s utility, regardless 
whether health outcomes or non-health outcomes enter an individual’s utility function. In 
current practice, where decisions are made on behalf of the affected individual, decision 
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makers determine the appropriate maximand. Given the maximand, a clear scope needs to 
be formulated in terms of what should be measured.  
A crucial role in determining the relevant outcomes is defined by the perspective 
of the economic evaluation (Claxton et al., 2010; Gold et al., 1996). The perspective not 
only determines the evaluative scope (i.e., who is affected by the intervention and who 
should be included in the analysis) but also the evaluative space (i.e., which outcomes 
should be measured). In 1996, the US Panel on Cost-effectiveness in Health and 
Medicine explicitly recommended the societal perspective as the reference case (i.e., the 
set of preferred methods that an analyst should follow when conducting the base case 
analysis in an economic evaluation). The societal perspective implies that all costs and 
benefits should be taken into account, regardless of where these costs and benefits occur 
(Gold et al., 1996). Given the societal perspective, an outcome measure would capture 
everything that matters to society and would need to reflect what decision makers would 
like to accomplish in the public interest. Although the US Panel acknowledges that 
QALYs do not fully reflect this, QALYs still took the role of the main outcome given the 
fact that other important public values cannot be incorporated in a useful way (Gold et 
al., 1996). In an update to the 1996 recommendations, the second Panel on Cost-
effectiveness in Health and Medicine reflected on their initial recommendations and 
stated that since the original publication, many cost-effectiveness analyses have not used 
a societal perspective (Sanders et al., 2016). In addition, the Panel highlighted that a 
number of HTA bodies in Europe, Australia and Canada focus on a health system 
perspective. New recommendations for cost-effectiveness analyses include now two 
reference case analyses: one based on a health care sector perspective and another based 
on a societal perspective (Sanders et al., 2016). 
It can be argued that identifying and measuring all relevant benefits will lead to 
more efficient resource allocation decisions and will enhance the legitimacy and 
acceptability of such decisions. Yet, only a few countries adopt a societal perspective, 
such as the Netherlands or Denmark (Mathes et al., 2013). Given the current focus on the 
health care system in many countries, societal preferences are only taken into account 
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when eliciting preferences for health states. In general, decision makers have little 
information about the preferences of the general public towards other benefits that are 
currently not captured by existing preference-based HRQoL instruments. More research 
is needed to examine what else the general public values in health care besides health. 
2.5.2. Measurement stage 
Once identified, outcomes beyond health need to be measured. It can be assumed 
that using existing preference-based HRQoL will not capture important non-health 
outcomes of health interventions, as they were developed to measure explicitly health-
related aspects of QoL. However, the term ‘health-related’ seems to be vague in this 
context, as some of the existing preference-based measures contain dimensions in their 
descriptive systems that are affected by aspects other than health alone (Brazier et al., 
2007). The SF-6D, for example, asks respondents about their role limitations or social 
activities, which are not only influenced by health (Brazier et al., 2002). Even more such 
dimensions can be found in the AQoL-8D, including a person’s role in the community, 
relationships with family and friends, happiness, or control of one’s life (Richardson et 
al., 2011). Therefore, when measuring non-health outcomes, existing HRQoL 
instruments should be examined more closely in terms of the extent to which they already 
incorporate broader benefits beyond health. This will be examined in more detail in 
subsequent Chapters 5 and 6 of this thesis.  
2.5.2.1. Developing new measures 
When developing new measures of non-health and process utility for use within 
the QALY framework, it is essential to provide evidence that these types of outcomes are 
currently not captured by existing preference-based measures (Brazier & Tsuchiya, 2015; 
Brennan & Dixon, 2013). For example, if a new measure of non-health outcomes will be 
developed that includes social activities as one of the dimensions in its descriptive 
system, double-counting can occur if such a measure will be applied alongside the SF-
6D. On the other hand, it can be argued that double counting is already evident in existing 
preference-based HRQoL measures, since diseases that impact, for example, on pain are 
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likely to impact on multiple dimensions, such as usual activities (Brazier et al., 2007). 
This implies that respondents completing the EQ-5D-5L, which includes pain and usual 
activities in its descriptive system, may be overvaluing the impact of pain on QoL. The 
issue of double counting is particularly important for comprehensive measures like the 
AQoL-8D (see Table 1.2). 
Developing a new instrument that captures non-health benefits from health care 
interventions requires some additional considerations. The selection of domains for the 
descriptive systems of many existing preference-based measures were derived from 
literature reviews and expert judgments with little input from the patients (Stevens, 
2016). Some authors have suggested that in order to improve content validity, it is 
important to ask patients to reflect on what matters to them. This is particularly the case 
when examining non-health outcomes and process attributes, as patients are a better 
source for identifying important dimensions based on their own experiences. Patients 
should, therefore, be involved in the development and testing phase of measures (Coast et 
al., 2008a; Stevens & Palfreyman, 2012). For generic measures, the challenge lies in the 
selection of respondents. If the aim is to develop a generic measure to be applicable 
across a number of patient groups, a purposive sampling of respondents is needed in the 
development of instruments and their evaluation in specific populations groups (Michel 
et al., 2016).  
2.5.2.2. Developing bolt-ons 
The addition or extension of dimensions of existing measures to cover the 
dimensions deemed to be missing from the measure is another way to capture non-health 
benefits. Examples of so called ‘bolt-ons’ have been developed for vision, hearing and 
tiredness (Longworth et al., 2014), cognition (Krabbe et al.), sleep (Yang et al., 2014), 
satisfaction (Dolan et al., 2013), dignity (Dixon et al., 2011), and for patients with 
psoriasis (Swinburn et al., 2013). The key challenge with bolt-ons is that the addition of 
another dimension to an existing measure has consequences for the valuation of health 
states defined by the new instruments, meaning that the use of bolt-ons would require the 
re-valuation of existing measures with the bolt-on. A second challenge is to identify 
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specific dimensions that are ‘missing’ from the respective descriptive system. Existing 
generic instruments also require the addition of generic dimensions. However, Chapter 1 
outlined that benefits beyond health are particularly important for certain conditions and 
disease areas, and also examples described above of previously developed bolt-ons are 
disease-specific. As such, it can be argued that the discussion around the inclusion of 
non-health benefits is not different than the discussion around disease-specific measures. 
The inappropriateness, or rather the limited sensitivity of some generic preference-based 
measures for certain clinical conditions has been highlighted in the literature a number of 
times, including asthma (Flood et al., 2006), diabetes (Sundaram et al., 2010), or epilepsy 
(Mulhern et al., 2012). As a response, many disease-specific preference-based measures 
have been developed for use in economic evaluation (Versteegh et al., 2012), although 
the usefulness of specific measures remains limited with regard to comparisons across 
disease and population groups (Brazier & Tsuchiya, 2010).  
2.5.2.3. Using existing measures that adopt a broader evaluative space 
The final approach to measure broader benefits would be the use of existing 
measures, such as the ICECAP measures (Al-Janabi et al., 2012; Canaway et al., 2016; 
Coast et al., 2008a; Sutton & Coast, 2014) or the ASCOT (Netten et al., 2012). These 
measures were developed with the aim to broaden the evaluative space and to capture 
benefits beyond health. Whereas the ICECAP measures were designed to assess a 
person’s capability wellbeing, the ASCOT measure is designed to capture information 
about an individual’s social care-related quality of life (SCRQoL). The ICECAP 
measures and the ASCOT are based on Sen’s capability approach and the distinction 
between capabilities and functionings is of central importance to the development of both 
measures (Karimi et al., 2016). However, the use of such measures is associated with 
additional challenges, which are outlined below. 
The main challenge in using these instruments relate to the way they measure 
capabilities, which is in tension with Sen’s capability approach. Sen distinguishes 
between functionings, which are the things someone can do and be, and capabilities, 
which are the combinations of functionings available to a person, also referred to a 
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person’s capability set. A common example provided in the capability literature relates to 
the nutritional state of a person. In this context, a person who is fasting has the capability 
and opportunity to eat compared with a person who is starving. As such, capability 
reflects the intrinsic value of having a choice and the opportunity for a better combination 
of functionings. In an attempt to operationalize the capability approach for the purposes 
of economic evaluation, the ICECAP developers phrased the questions in terms of ‘are 
you able to’ or ‘can you’ in order to explicitly shift the focus away from functionings 
(which are concerned with what a person ‘is’ and ‘does’). This operationalization is 
different to the ASCOT measure. The ASCOT measure contains four response options 
(i.e., ideal state, no needs, some needs, high needs) for each domain. While the lower 
three levels of each domain reflect levels of basic functioning (or needs), the highest level 
refers to capabilities. The developers state that “once needs are met, it is also essential to 
identify capabilities: whether or not people are able to achieve their desired situation” 
(Netten et al., 2012, p.x).  
In a recent article, Karimi et al. state that existing capability measures developed 
for use in economic evaluation have two problems: (i) they measure each domain 
independently of other domains and, therefore, ignore the value of choice in the 
capability set, and (ii) they do not provide an accurate description of an individual’s 
entire capability set (Karimi et al., 2016). Although Sen advocated that interpersonal 
comparisons could be made in the space of capabilities, Sen avoided the provision of a 
list of capabilities because a person’s capability set may vary. The list of capabilities is 
context-dependent, in terms of both the geographical area to which it applies as well as 
the sort of evaluation that is done (Sen, 1993). It is likely that Sen would argue that 
reducing people’s capability achievements to a number of attributes to measure capability 
wellbeing, as done by existing measures, is inappropriate as these vary across individuals 
in quality and quantities. Three other problems with existing capability measures relate 
to: (i) collapsing multidimensional capabilities information into a single index score 
using preference-based valuation techniques; (ii) measuring perceived capabilities rather 
than objective capabilities, where problems with adaptation might occur (i.e., individuals 
may not recognise their own lack of capability because they have adapted to their 
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situation); and (iii) ignoring a person’s agency goals, which refers to goals other than 
one’s wellbeing (e.g., wellbeing of others or commitments outside the person). Before 
using existing measures to capture broader benefits of health care interventions, these 
challenges for the capability approach need to be resolved.  
2.5.3. Valuation stage 
The valuation of non-health outcomes or process attributes faces additional 
challenges. There are contradictory views about the use of conventional valuation 
techniques, such as TTO, SG or VAS for the valuation of non-health outcomes. On the 
one side, it was argued that given the amount of risk one would accept or the idea of 
giving up life-years for attributes such as the provision of information or other process-
related aspects may appear unrealistic and could involve respondents dealing in very 
small risks or amounts of time (Donaldson & Shackley, 1997). Nevertheless, these 
techniques and others were used to measure process utility in previous studies (Brennan 
& Dixon, 2013). Opmeer and colleagues identified nine other preference-elicitation 
methods that were used in the literature to value non-health outcomes, such as ranking, 
recommendation to someone else, or WTP (Opmeer et al., 2010). Also Donaldson and 
Shackley suggested using WTP as a measure to estimate such benefits (Donaldson & 
Shackley, 1997), whereas Ryan has proposed the use of conjoint analysis to take account 
of factors beyond health outcomes (Ryan, 1999). Conjoint analysis is based on the 
premise that any good or service can be described by its characteristics, also referred to as 
attributes, and the extent to which an individual values a good or service depends on the 
levels of these characteristics (Lancaster, 1966). Types on conjoint analysis include 
ranking, rating, and discrete-choice experiments (DCEs). In particular, DCEs are gaining 
attention in the health economics literature. While initially designed to measure non-
health outcomes (Ryan, 1999), DCEs are now being used in the valuation of health 
outcomes. Examples can be found in a number of countries, where DCEs were used to 
produce QALY weights for the EQ-5D-5L, such as Australia (Viney et al., 2014) and 
Canada (Bansback et al., 2012). However, the use of DCEs within the QALY framework 
is only possible if a ‘life year’ attribute is added to the DCE task (Bansback et al., 2012), 
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which would provide values anchored on the dead-full health utility scale. Another 
anchoring approach was proposed in a study by Brazier et al., which included using the 
state ‘dead’ in the DCE to rescale regression coefficients (Brazier et al., 2012). Rowen 
and colleagues compared a number of other methods for converting DCE values onto the 
dead-full health QALY scale (Rowen et al., 2015). Although some issues for 
consideration remain in using DCEs to estimate utility values (Flynn, 2010a), the DCE 
can be considered as a promising technique to value non-health outcomes within the 
QALY framework.  
Some have argued that the DCE tasks are less cognitively challenging than the 
conventional elicitation techniques (Bansback et al., 2012), although it can be still 
complex for certain population groups (Ratcliffe et al., 2011). Best-worst scaling (BWS) 
has been proposed as an alternative to DCE tasks (Flynn et al., 2007). Rather than 
making choices between states, this method asks participants to choose the best and the 
worst attribute (dimension) defining the (health) state (Coast et al., 2008b). Different 
types of BWS exist (Flynn, 2010b), which have recently been applied to measure 
process-related utility of treatments for Parkinson disease (Weernink et al., 2016). BWS 
techniques are particularly useful if there is an interest in knowing the absolute impact 
(utilities) of attributes, such as testing the hypotheses that ‘waiting time is more important 
than continuity of care’ (Flynn et al., 2007).  
When using traditional techniques such as SG or TTO, the valuation of broader 
benefits requires additional consideration of the duration of the health state in the 
valuation task. Whereas, usually, valuation measures were used to value chronic health 
states, within the context of non-health outcomes, health states are temporarily and not 
chronic. Although Torrance originally developed a temporary health state approach based 
on TTO (Torrance, 1986), others have argued that this method is not useable in a study of 
process utility, for which outcomes may be in terms of hours or days (Swan et al., 2003). 
A review of methods for measuring temporary health states for cost-utility analyses 
identified numerous other methods (Wright et al., 2009). A temporary health state was 
defined as a transient health state lasting < 1 year that may impact some discomfort or 
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temporary reduction in QoL. The methods identified by the study included: TTO with 
specified duration of the health state, TTO with a lifespan modification, waiting trade-off, 
chained approaches for TTO and SG, and sleep trade-off. Wright and colleagues 
concluded that advantages and disadvantages vary by method and that no gold standard 
method merged from their analysis.  
Besides the different techniques that can be applied to value important non-health 
outcomes and process attributes, one important question still remains in terms whose 
values should be considered in the valuation process – those of the general population, 
health professionals, or patients. The ongoing discussion within health outcomes research 
is not different to non-health outcomes. It appears that as long as national HTA 
guidelines favour societal values in economic evaluation, it is more appropriate to 
consider the general population the primary source of values in this process. 
  Finally, the valuation of a new measure of broader benefits could also be 
conducted using statistical mapping techniques. Mapping has been proposed as a 
technique to transfer a non-preference based measure into utility data, where an algorithm 
is estimated between the non-preference based measure and a target measure that 
provides utility, such as the EQ-5D-5L (Chuang & Whitehead, 2012). However, since the 
mapping function relies on statistical association, mapping would not be appropriate if 
the two measures have no conceptual overlap (Brazier & Tsuchiya, 2015), which is likely 
to be the case between a health measure and a non-health measure.  
2.6. Practical challenges 
The HTA process contains two stages, the assessment stage and the appraisal 
stage. In the assessment stage, clinical and cost-effectiveness evidence is gathered based 
on expert evaluation of the quality and meaning of scientific evidence submitted by 
manufacturers or other means, such as a systematic review of literature and advice from 
clinical experts. The appraisal stage derives recommendations about which 
intervention(s) ought to be recommended, for whom, and under what circumstance 
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(Morgan et al., 2006). Although the focus of this thesis is on the incorporation of non-
health outcomes within the assessment stage, outcomes beyond health can also be 
explored separately in the appraisal stage of health care decision making (Goebbels et al., 
2012). Where decisions need to be made that are based on more than one criterion, the 
concept of multi-criteria decision analysis (MCDA) has been introduced, which refers to 
a set of methods and approaches to aid decision-making. MCDA provides a systematic 
process for clarifying what is being taken into account (criteria), how each of these 
criteria is to be measured, and how much importance (weight) to put on each criterion 
(Devlin & Sussex, 2011). Rather than incorporating non-health outcomes into economic 
evaluation, non-health outcomes could be added to a MCDA exercise, which would 
provide decision makers with important additional information in the appraisal stage.  
The extent to which the information on non-health outcomes would enter the 
decision-making process under the MCDA framework is unclear. Additional criteria for 
the appraisal stage already exist but have been used infrequently. Within the UK context, 
the ‘social value judgments’ proposed by NICE describe that for an incremental cost-
effectiveness ratio (ICER) > £20,000 per QALY gained, other criteria will be considered, 
such as (i) the degree of certainty around the ICER, (ii) whether the assessment of the 
change in QoL has been adequately captured, and (iii) whether the intervention is an 
innovation (NICE, 2008). The need for accurate information of QoL benefits is an 
indication that broader benefits, which are not necessarily captured by existing measures, 
are already taken into account during the appraisal stage – yet, empirical evidence 
indicates the opposite. As one assessment of the impact of NICE’s criteria on its 
decision-making practice has shown, cost-effectiveness is the principle determinant of 
most NICE decisions, predicting 82% of decisions, and the probability of rejection 
increases significantly with an increasing ICER (Dakin et al., 2013). It follows that the 
provision of such additional criteria in the appraisal stage is useful but the process to 
weight them against each other requires further consideration.  
It seems that the incorporation of non-health benefits in the assessment stage will 
find a greater role in health care decision-making than in the appraisal stage, although 
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decision makers may find it challenging to compare different health-based QALYs and 
non-health based QALYs. With the introduction of the ASCOT instrument, NICE social 
care guidance now refer to the social-care QALY (NICE, 2016), but there is also the 
possibility of a capability-QALY (Cookson, 2005b), a process-adjusted QALY, or a 
‘Super QALY’ (Buxton, 2008). In addition, Brazier and Tsuchiya have recently 
introduced the concept of wellbeing-adjusted life years (WELBYs) (Brazier & Tsuchiya, 
2015). As the name suggests, a WELBY is similar to a QALY in that it combines 
quantity and QoL into a single measure but the descriptive system used to derive 
WELBYs focuses on wellbeing rather than health alone. Given these many different 
ways of weighting time spent in varying QoL states, the original idea of the QALY as a 
comparable measure across all clinical areas is unlikely to hold (i.e., one WELBY ≠ one 
QALY ≠ one Super QALY etc.). Also, while countries currently use implicit or explicit 
threshold values for a cost per QALY gain (Cleemput et al., 2011), new threshold values 
would need to be determined for the different outcomes described above.  
It is already known that different preference-based HRQoL measures produce 
different health state valuations (Brazier et al., 2004; McDonough & Tosteson, 2007; 
Whitehurst & Bryan, 2011; Whitehurst et al., 2014a). The introduction of additional non-
health measures to generate QALYs will increase the complexity of health-care decision-
making. The fact that NICE guidance requires the use of the EQ-5D instrument, as the 
measurement of outcomes for economic evaluation, provides an important example for 
this discussion (NICE, 2013). It follows that in health care decision-making simplicity 
and consistency seem to play an important role. Pragmatism is a further central feature in 
health care decision-making, as can be seen by the current use of QALYs. Despite 
criticism of the QALY, its strengths have led to its widespread adoption. It is often 
argued that because of the lack of a better measure as an alternative, the QALY is an 
indispensable tool (Johnson, 2009) and should be used as a reference method in order to 
make comparisons across diseases and interventions (Drummond et al., 2009). Although 
some improvements to QALY measurement have been proposed, these ideas resulted 
only in journal publications and were not implemented by decision makers (Johnson, 
2009). Evidence also indicates that decision makers already find the current concepts 
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behind QALYs difficult to understand and show limited knowledge about formal 
methodology (Coast, 2004). It can be assumed that the consideration of non-health 
benefits in economic evaluation will add another layer of complexity that may face 
decision makers’ rejection. Nevertheless, as shown by a recent qualitative study with 22 
experts in the field of health economics and/or public health, the importance of non-
health outcomes and the need to measure them are widely accepted (van Mastrigt et al., 
2015). While different methods are applied across countries, including the use of 
different perspectives, countries that adopt a narrow health care sector perspective may 
encounter more challenges in going beyond health than countries that already adopt a 
societal perspective.  
2.7. Conclusion 
This chapter provided an overview of theoretical, normative, conceptual, 
methodological, and practical challenges in broadening the evaluative space of the QALY 
in economic evaluation. It can be concluded that from a theoretical point of view, non-
health outcomes can be incorporated into the QALY framework if a broader extra-
welfarist view is adopted. There are also strong arguments for including such broader 
benefits, as this approach may provide a better representation of what constitutes ‘value’ 
from the deployment of scarce health care resources. A number of different approaches 
have been proposed for the measurement and valuation of broader benefits, and with the 
development of the ICECAP and ASCOT instruments, this topic has gained attention 
among decision makers. Although certain practical challenges remain, the fact that some 
HTA bodies (e.g., NICE and College van Zorgverzekeringen (CVZ)) now embed the 
ICECAP and ASCOT in their guidelines is a big step forward (NICE, 2013; Zorginstituut 
Nederland, 2016). A major challenge remains on the conceptual level. Given the existing 
inconsistencies in the literature in terms of what constitutes a health outcome, a non-
health outcome, or a process, more clarification is needed. The next chapter will focus on 
this issue and will conceptualize benefits beyond the health-related QALY.  
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Chapter 3. Conceptualizing benefits beyond the health-
related QALY – a critical interpretive synthesis 
3.1. Introduction 
Chapter 2 showed that one of the main challenges for the topic of interest remains 
at the conceptual level (i.e., what is understood as a non-health benefit). To shed more 
light on benefits beyond the health-related QALY, understanding the underlying idea of 
the ‘QALY approach’ or the ‘QALY framework’ in the health economics literature is 
crucial. It is noticeable that there are at least three interpretations of the QALY: (i) the 
QALY as a measure of utility that captures preferences over health states multiplied by a 
person’s life expectancy; (ii) the QALY as a measure of health functionings over length 
of life, using measures such as the EQ-5D-3L; and (iii) the QALY that adjusts length of 
life by indices of QoL, referring to the ‘Q’ in the QALY. Although QoL is so broad that it 
could, in principle, incorporate a range of outcomes, the QALY currently has a strong 
focus on health, which implies that the assessment of benefits of health care interventions 
is either judged in terms of changes in health status or extension of life.  
The terms used to describe the Q in the QALY can be vague in the sense that 
QoL, HRQoL and health have been used interchangeably in the health economics 
literature. Karimi and Brazier recently provided an overview of these terms (Karimi & 
Brazier, 2016). The authors state that while it is easiest to distinguish between health and 
QoL, the term HRQoL is more complex. The definitions of HRQoL identified by Karimi 
and Brazier resemble either health status or QoL and included: (i) HRQoL as functioning 
(an individual’s ability to carry out activities) and wellbeing (an individual’s subjective 
feelings); (ii) HRQoL as the health aspect of QoL, where non-health aspects such as 
economic circumstances are not included in HRQoL; (iii) HRQoL referring to aspects of 
QoL that can be affected by health (i.e., aspects affected by the presence of disease and 
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treatment); and (iv) HRQoL referring to the value of health and the corresponding values 
assigned to different health states (Karimi & Brazier, 2016). These varied definitions and 
their interchangeable use, have, to some degree, led to the different interpretations of the 
QALY framework. 
Given that many interpretations of the QALY currently exist, it can be also 
expected that many diverse understandings will be identified of so-called ‘non-health 
benefits’, ‘broader benefits’, ‘benefits beyond health’, or any other nomenclature. While 
some descriptions of non-health benefits may have resulted from a misinterpretation of 
the QALY framework in the first instance, it is crucial to understand which broader 
benefits are thought to be outside the QALY. To gain a better understanding of such non-
health benefits, an examination of how previous literature has described such broader 
benefits is warranted. While recent discussions have contributed to a better understanding 
of what is included in the QALY, benefits that are currently not captured by the QALY 
have received less attention. In light of recent calls to go beyond the health-related 
QALY (Brazier & Tsuchiya, 2015; Payne & Thompson, 2013), a comprehensive 
overview of benefits that currently do not fit within the QALY framework is warranted. 
The objectives of this chapter are to critically review and synthesize existing literature 
regarding benefits beyond health within the context of QALYs, and to develop a concept 
map that shows the relationship between different aspects of non-health benefits. 
3.2. Methods 
3.2.1. Critical Interpretive Synthesis 
A critical interpretive synthesis (CIS) was undertaken. CIS is similar to meta-
ethnography (i.e., systematic analysis and synthesis of qualitative research), with the 
difference that the synthesis is not of qualitative studies but of methodologically diverse 
literature (Dixon-Woods et al., 2006). CIS builds interpretation by, firstly, identifying 
interpretations offered by the original studies and, secondly, enabling the development of 
new interpretations that go beyond those offered in primary studies (Campbell et al., 
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2011). Dixon-Woods et al. also described these interpretations as synthetic constructs 
(i.e., broad theoretical categories), which are the result of a transformation of the 
underlying evidence into a new conceptual form (Dixon-Woods et al., 2006). Table 3.1 
provides a comparison of key characteristics of a systematic review and CIS. The term 
‘critical’ in CIS relates to the fact that judgments need to be made about how the 
evidence contributes to the development of the new concept. CIS is distinguished from 
critical appraisal in that CIS treats literature as an object of inquiry. This critical scrutiny 
of the literature applies to the entire process (i.e., sampling, selection of publications, and 
data synthesis). The final output of a CIS is the synthesizing argument, which integrates 
the evidence from across the studies into a coherent thematic framework. It can consist of 
synthetic constructs but also original interpretations reported in the literature. The process 
of CIS is characterized by its iterative, interactive, dynamic, and recursive nature, where 
often searching, sampling, critique and analysis go hand in hand.  
3.2.2. Literature Search 
The literature search was undertaken in Web of Science in October 2015, using 
the ‘citation pearl growing’ method (Hartley et al., 1990). Firstly, key ‘pearls’ or key 
papers were identified that were relevant for the topic of interest. These key papers, 
which were known to the doctoral candidate and supervisory committee, were used to 
search for papers that cited the key papers in order to retrieve the first ‘wave of pearls’. 
After screening these new papers for eligibility (see section 3.2.3), papers that were 
included were used to generate the second wave of pearls, i.e., identifying papers that 
have cited the wave one inclusions. These steps were repeated and after each wave of 
pearls a test of saturation was applied that determined the point at which to stop searching 
for new literature. The saturation point was determined by answering after each wave of 
searching whether the literature retrieved adds anything new to the understanding, and 
whether further searching is likely to add new knowledge (further details are provided in 
the next section). The final step comprised a reference list search of included papers. The 
process of the citation pearl growing method is illustrated in Figure 3.1.  
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Table 3.1. Comparison of key characteristics of a systematic review and CIS a 
 Systematic review b Critical interpretive synthesis 
Purpose • To systematically summarize 
data 
• To develop an understanding of 
topics, concepts and theories 
grounded in evidence  
Process • Structured process of 
searching, appraising, and 
synthesizing findings 
• Iterative, interactive, dynamic and 
recursive 
• Searching, sampling, and critique 
happen concurrently 
• There is a need for constant 
reflexivity  
Research 
question 
• Defined a priori and does not 
change 
• Developed at the outset but can be 
refined 
Searching • Explicit and exhaustive 
search strategies in 
bibliographic databases  
• Can include bibliographic searches 
but also purposive selection of 
relevant literature from various 
sources 
• Sampling until theoretical 
saturation is reached 
Selection • A priori defined inclusion 
and exclusion criteria aiming 
for comprehensive 
identification and inclusion of 
all relevant literature 
• Selective, purposive and informed 
by the emerging theoretical 
framework 
Quality 
appraisal 
• Quality checklists applied to 
all articles included 
• Quality judged in terms of 
relevance and rigour 
Synthesis • Data are extracted in a 
systematic way and 
synthesized quantitatively 
(e.g., meta-analysis) or 
qualitatively based on 
findings from studies 
included 
• Data extraction useful but not 
essential; the aim is to develop a 
synthesizing argument, linking 
existing constructs from the 
findings to synthetic constructs 
(new constructs developed during 
synthesis) 
Reproducibility • Results need to be 
reproducible 
• Authorial voice is noticeable and 
results may not be reproducible 
a This table is a summary of previous comparisons (Dixon-Woods et al., 2006; Entwistle et al., 2012; 
Wilson et al., 2014). 
b Most but not necessary all points typically apply to a systematic review. 
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Figure 3.1. Graphical illustration of the citation pearl growing method  
 
The idea of applying a citation pearl growing method is to find papers similar to 
the key set of papers. Compared with a conventional database search, a citation search 
can identify publications that would not be found via standard database searches because 
there is no constraint by the vocabulary of a search strategy. After each wave, full-texts 
of all identified articles were screened to determine eligibility given that titles and 
abstracts were not sufficient to make this judgment. Full-texts were appraised in a 
systematic way by the doctoral candidate only. In a first step, the paragraph was reviewed 
where the reference that identified the paper was cited. In a second step, a search was 
undertaken for keywords, such as ‘non-health’, ‘broader’, ‘beyond’, ‘QALY’, ‘cost-
utility’, and ‘utility’. The selection of papers was driven a by a list of pre-specified 
selection criteria. 
3.2.3. Selection criteria 
The selection process in a CIS can be generally described as subjective and is 
typically informed by the emerging theoretical framework (Dixon-Woods et al., 2006). In 
order to be included in the analysis, papers had to be journal articles written in English. 
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An additional inclusion criterion was the explicit demonstration of a link between the 
non-health benefit and the QALY framework. This included papers that used different 
terminology, such as ‘non-health outcomes’, or discussed any kinds of benefits that 
currently lie outside the QALY framework (according to the author(s) of the respective 
study). Given that QALY weights are often derived from standardized preference-based 
measures that have been found to lack sensitivity for certain disease areas or population 
groups (Brazier & Tsuchiya, 2010), papers that focused on the development of a specific 
preference-based instrument (e.g., the development of an asthma-specific measure) were 
excluded. The rationale for this was the focus on generic measures and the identification 
of broad constructs of non-health benefits that are outside the QALY framework. Given 
that the aim of a CIS is not to identify all relevant references but literature that 
contributes something new to the topic of study, papers were also excluded if they did not 
provide further understanding beyond the general critique, or if they cited already 
included studies. For example, if a paper discussed a previously identified non-health 
benefit without providing a new/alternative definition, or further descriptive attributes 
that would offer more clarity, it did not contribute to a better knowledge of the topic of 
study and was not included. There were no constraints on publication dates.  
Different types of evidence were eligible to be included in the CIS (empirical, 
qualitative, commentaries, etc.). Papers were not judged by their quality in view of the 
fact that methodologically weak papers may still prove conceptually insightful. It was 
more important to judge quality in terms of relevance and rigor in how the paper 
subsequently informed the test of saturation. Relevance indicates whether the paper 
addresses the concept of interest, while rigor refers to whether the paper has sufficient 
weight to make a contribution. Quality judgement in terms of relevance and rigor has 
been generally suggested for qualitative reviews (Pawson et al., 2005). The selection 
process was conducted with the support using EndNote X6. 
3.2.4. Data extraction and synthesis 
Multiple approaches were used for the data extraction process. Firstly, key 
characteristics of the included papers were extracted in a standardized table (see 
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Appendix 3.1). Furthermore, a second table documented all non-health benefits offered 
by the original studies. While non-health benefits were being added to this table 
throughout the identification phase, a thematic analysis was applied at the same time, 
identifying constructs of similar non-health benefits. This analytic step generated the 
synthetic constructs, which is the result of a transformation of the underlying evidence 
into a new conceptual form. Constructs were not defined a priori but were specified in an 
iterative approach, i.e., they were modified in response to search results and findings 
from retrieved studies. Initial constructs were developed by the doctoral candidate and 
verified by the senior supervisor (DGTW). These constructs were then organized into 
higher-level themes, capturing the broad phenomena described. 
In a last step, a synthesis argument was developed that integrated evidence from 
studies and synthetic constructs into a coherent and explanatory framework. In this way, 
contradictions in the evidence when producing the synthesis argument were considered. 
Since the synthesis argument describes the complete phenomenon under review, while 
considering the synthetic constructs as well as the relationships between them, this step 
subsequently informed the organization of the concept map. The concept map displays 
the relationships between concepts and the potential overlap between concepts. A concept 
map does not provide causal relationships but rather a better understanding of a 
phenomenon (i.e., interpretative approach). In the following section, the results of the 
CIS are presented by themes derived from the thematic framework analysis. Constructs 
within a theme are then discussed and presented in a concept map. Attributes, derived 
from existing literature, that describe each constructs are presented in Appendix 3.2 and 
purposively reported in the results section (an appropriate method of the CIS). 
3.3. Results 
The CIS of the literature was based on 109 papers. Figure 3.2 shows the flow 
diagram of the literature search. Firstly, 21 core references were identified from the 
authors’ own collections and were included in the review (see Appendix 3.1). The first 
wave of searching that cited these 21 core references retrieved 274 unique references and 
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47 references were included after full-text screening. These 47 references were cited by 
523 additional unique references, of which 31 were included. Although these 31 papers 
were relevant and were included in the review, they did not yield new constructs but 
rather provided further understanding of existing constructs. Since it was not anticipated 
that further searching is likely to add new knowledge, the rule of saturation was applied 
after the 2nd wave of search.  
 
 
Figure 3.2. Flow diagram of the literature search 
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In the final step, the reference list search of 99 papers retrieved additional 10 
references that were included in the analysis. These 10 additional references were 
identified through a process of title and abstract screening, followed by a full-text review. 
Characteristics of all included studies are provided in Appendix 3.1. 
The synthetic constructs were based around four themes: (i) benefits affecting 
wellbeing (subjective wellbeing, psychological wellbeing, capability wellbeing, and 
empowerment); (ii) benefits derived from the process of health care delivery (process 
utility); (iii) benefits beyond the affected individual (e.g., spillover effects, externalities, 
option value, and distributional benefits); and (iv) benefits outside the health care sector. 
Table 3.2 provides an overview of the main constructs as well as the higher-level themes. 
Additionally, Appendix 3.2 provides a list of all benefits beyond the health-related 
QALY identified from the literature and applied to the thematic framework. What 
follows is a detailed discussion of the results by theme. 
 
Table 3.2. Thematic framework analysis of benefits beyond the health-related 
QALY 
Theme Construct 
Wellbeing Subjective wellbeing 
 Psychological wellbeing 
 Capability (wellbeing) 
 Empowerment 
Process utility Intervention characteristics 
 Provider characteristics 
 Structural characteristics 
 Process characteristics 
Benefits beyond the affected individual Spillover effects 
 Externalities 
 Option value 
 Distributional benefits (equity & need) 
Benefits outside the health care sector Other sectors 
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3.3.1. Benefits affecting wellbeing 
Benefits that extend beyond the narrowly defined health-related evaluative space 
of the QALY were often linked to the concept of wellbeing or a general definition of 
QoL. Makai and colleagues proposed two concepts of wellbeing (Figure 3.3) (Makai et 
al., 2014b). Firstly, wellbeing can be interpreted as an inherently subjective concept, 
which implies that it does not contain health dimensions. The overarching concept of 
QoL then constitutes functional HRQoL dimensions and subjective wellbeing. This is 
illustrated in Figure 3.3 in the left part, labeled ‘A’. The second concept of wellbeing (see 
Figure 3.3, labeled ‘B’) treats wellbeing as representing individuals’ welfare, which is 
dependent on individuals’ functioning, thus encompassing HRQoL dimensions.  
While Makai and colleagues have offered diverse interpretations of the concept of 
wellbeing, the thematic analysis retrieved four general categories of benefits that affect a 
person’s wellbeing: (i) subjective wellbeing, (ii) psychological wellbeing, (iii) capability 
wellbeing, and (iv) empowerment (see Table 3.2).  
 
          A          B 
Figure 3.3. Two concepts of wellbeing based on Makai et al. (2014b) 
 
Subjective wellbeing is associated with positive affects or negative affects (i.e., 
basic experiences of the ongoing events in people’s lives), satisfaction with life, and 
domain satisfaction. For example, Van Mastrigt et al. identified emotions (i.e., a sense of 
satisfaction or enjoyment) as a non-health outcome relevant for economic evaluations of 
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public health interventions (van Mastrigt et al., 2015). Negative feelings were also 
considered in the literature, such as regret or disappointment (Salkeld, 1998; Salkeld et 
al., 2004), and burden (i.e., not feeling oneself to be a burden on others) (Coast, 2014; 
Coast et al., 2008a). The second component of subjective wellbeing identified from the 
literature referred to (life) satisfaction, which can be understood as the global judgment 
about the quality of a person’s life (Schulz et al., 2014; Stanczyk et al., 2014). This was 
usually discussed within the broader concept of QoL, general wellbeing, and view of life 
(Benning et al., 2015; Davis et al., 2015; Gandjour, 2001; Hoefman et al., 2013; Thorn et 
al., 2014). Lastly, domain satisfaction reflects a person’s evaluation of the specific 
domains in his or her life, such as satisfaction with leisure and work activity (Connell et 
al., 2014; Cookson, 2005b), usual or outside activities (Al-Janabi et al., 2011; Davis et 
al., 2013), and creativity and play (Benning et al., 2015; Makai et al., 2014b). Activities 
relating to family (Cookson, 2005b; van Mastrigt et al., 2015) and social 
interactions/relationships formed two other domains in the literature (Al-Janabi et al., 
2011; Chisholm et al., 1997; Coast et al., 2008a; Davis et al., 2013; Goebbels et al., 
2012; Hausman, 2012; Lorgelly et al., 2010; Makai et al., 2014b; Netten et al., 2012; van 
Mastrigt et al., 2015). These activities were closely related to the concept of (social) 
support (i.e., feeling supported) (Benning et al., 2015). A number of other domains were 
discussed, including security and safety (Ali & Ronaldson, 2012; Makai et al., 2014b), 
environment/community/neighbourhood (Makai et al., 2014b; Ong et al., 2009; van 
Mastrigt et al., 2015), and activities relating to religion or spirituality (Coast, 2014; Coast 
et al., 2008a; Cookson, 2005b; Ong et al., 2009; Round, 2012). Further examples for the 
concept of subjective wellbeing can be obtained from Appendix 3.2. 
While subjective wellbeing refers to hedonic wellbeing in terms of pleasure, 
enjoyment and satisfaction, a second concept of wellbeing was identified, referring to 
psychological wellbeing. Psychological wellbeing, or eudaimonic wellbeing, includes 
aspects of flourishing, where wellbeing increases when an individual more closely fulfills 
their nature as a human being (i.e., he or she flourishes). Psychological wellbeing 
includes benefits such as autonomy (i.e., having one’s autonomy respected) (Mooney, 
1998; Ryan & Shackley, 1995), freedom (Makai et al., 2014b), independence (Chisholm 
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et al., 1997; Makai et al., 2014b; Makai et al., 2013), and control (i.e., perceived life 
control, and the ability to keep things in perspective) (Benning et al., 2015; van Mastrigt 
et al., 2015). Self-perception, such as self-confidence (Benning et al., 2015; Borghi & 
Jan, 2008; van Mastrigt et al., 2015), self-esteem (Borghi & Jan, 2008; Cookson, 2005b; 
Hausman, 2012), self-efficacy (Borghi & Jan, 2008), and self-respect (Coast et al., 
2008a) were also discussed in the literature, which all relate to psychological wellbeing. 
Other examples categorized under psychological wellbeing included goals (i.e., to set 
more and realistic goals) (Goebbels et al., 2012), hope (i.e., having goals and aspirations, 
and being involved in activities that were fulfilling and had meaning and purpose) 
(Connell et al., 2014; Salkeld, 1998), and the ability to cope (Payne & Thompson, 2013).  
Another construct of wellbeing refers to individuals’ capabilities. The capability 
approach was introduced by Amartya Sen who argued that capabilities (things that people 
are free to do or be) should be included in the overall assessment of a person’s wellbeing 
and not only outcomes (functional utilities) (Simon et al., 2013). Here, the focus is on 
choice and control, and to measure what people can do, rather than what they actually do 
(Netten et al., 2012). Capabilities may be seen as a conceptualization of wellbeing in a 
broader sense, where capability wellbeing captures a variety of health and non-health 
outcomes (Al-Janabi et al., 2012; Makai et al., 2013). While some of the identified 
studies referred to the capability approach in general (Buchanan & Wordsworth, 2015; 
Crosignani et al., 2015; Lorgelly et al., 2015; Thorn et al., 2014), others have identified 
specific capabilities and developed instruments to measure them. Examples include the 
Oxford CAPabilities questionnaire-Mental Health (OxCAP-MH), for use in mental health 
(Simon et al., 2013), and the OCAP-18, which was developed for public health (Lorgelly 
et al., 2015). Both instruments consist of similar capabilities, which were modified to 
improve the application for the respective field of study. Another set of capability 
measures was developed by the ICECAP group, which consists of the ICECAP-A 
(dimensions: stability, attachment, autonomy, achievement, and enjoyment) (Al-Janabi et 
al., 2012; Al-Janabi et al., 2013b), ICECAP-O (dimensions: attachment, security, role, 
enjoyment, and control) (Coast et al., 2008a), and ICECAP-SCM (dimensions: choice, 
love & affection, physical & emotional suffering, dignity, being supported, and 
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preparation) (Sutton & Coast, 2014). Similar capabilities were included in the capability 
measure for those who experience chronic pain, developed by Kinghorn et al., although 
this is not part of the ICECAP family (Kinghorn et al., 2015). Most of the instruments 
mentioned above use particular wording to measure a person’s capabilities, such as what 
a person ‘can do’ or ‘is able to do’. A slightly different approach to measuring 
capabilities was provided by Netten et al. with the development of the Adult Social Care 
Outcomes Toolkit (ASCOT). The ASCOT approach combines both functionings and 
capabilities concerning food and drink, personal care, safety, social participation and 
involvement, control over daily living, accommodation, cleanliness and comfort, 
occupation and dignity. Each attribute contains four response options. While the lower 
three options of each attribute reflect levels of basic functioning or needs, the highest 
level refers to capabilities. The authors state that “once needs are met, it is also essential 
to identify capabilities: whether or not people are able to achieve their desired situation” 
(Netten et al., 2012, p.x).       
The final construct of wellbeing identified by the thematic analysis is the concept 
of empowerment (McAllister et al., 2012). The definition of empowerment provided by 
McAllister describes patients as “self-determining agents with some control over their 
own health and healthcare, rather than as passive recipients of healthcare” (McAllister 
et al., 2012, p.2). Using a case study of clinical genetics, McAllister and colleagues 
developed a model that conceptualized empowerment as a multi-dimensional construct 
including: cognitive control, decisional control, behavioural control, emotional 
regulation, and hope for the future. Empowerment was also discussed by others (Alayli-
Goebbels et al., 2013; Coulter et al., 2013; Lorgelly, 2015; Lorgelly et al., 2010; Payne et 
al., 2013; Schulz et al., 2014) in relation to consciousness, self-esteem, and life skills, 
such as health literacy, problems solving and communication skills, stress management, 
and skills to cope with emotions (Alayli-Goebbels et al., 2013). Closely related is the 
concept of decision-making (i.e., being able to make informed decisions) (Goebbels et 
al., 2012; Payne et al., 2013; Ryan et al., 2014), where control (i.e., control over 
decision-making) (Goebbels et al., 2012; Petrou & Wolstenholme, 2000), provision of 
information and knowledge sharing (Benning et al., 2015; Borghi & Jan, 2008; Dowie, 
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2001; Grosse et al., 2008; Mooney, 1998; Payne et al., 2013; Ryan, 1999; Ryan & 
Shackley, 1995; Salkeld et al., 2004), and health literacy (Benning et al., 2015) play an 
important role. Finally, behavioural change (Essink-Bot et al., 2003; Lorgelly, 2015; van 
Mastrigt et al., 2015) was discussed as a non-health outcome that can be categorized 
under the umbrella term of empowerment. Behavioural change can be linked to 
awareness of health risks and overcoming addictions (Goebbels et al., 2012), self-
management capacities (Benning et al., 2015), and effort to change lifestyle behaviour 
(Goebbels et al., 2012).  
3.3.2. Benefits derived from the process 
This concept of benefits denotes that the focus should not only be of what is 
achieved in a health care system but how it is achieved. The narrow consequentialist view 
of the QALY only considers consequences and outcomes but others have argued that 
there are other elements in the consumer’s utility function (Donaldson & Shackley, 
1997). Therefore, when consuming health care services individuals may have preferences 
over not only health consequences but also the circumstances associated with those 
consequences (Birch & Donaldson, 2003). This utility or disutility derived from the 
actual processes can be labeled under the umbrella term ‘process utility’.  
It has been argued that ignoring process utility in the overall valuation of utility 
from health care could lead to a sub-optimal provision of health care (Higgins et al., 
2014), which is particularly important when treatment alternatives produce similar health 
outcomes but differ in terms of process-of-care factors (McNamee & Seymour, 2008). 
Others have noted that process utility is a term used as a synonym for ‘patient 
experiences’ and ‘satisfaction’ from the process (Annemans et al., 2013; Buchanan & 
Wordsworth, 2015; Mooney, 1998; Payne et al., 2013; Ryan et al., 2014; Swan et al., 
2016; Tinelli et al., 2013), which can be linked to the quality of care provided. Dirksen 
discussed the role of ‘patient preferences’ that reflect patient’s evaluation of the process 
of health care (Dirksen, 2014). Given that the QALY framework is based on the mean 
public or patient values, the treatment recommended to an individual patient (e.g., 
through the process of shared decision making) may differ from what is being 
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recommended at a system-wide level. Such mean preferences can potentially override 
preferences of the patient or affected individual. In view of the fact that individuals’ 
preferences are influenced by factors relating to the health care process, it is argued that 
incorporating patient preferences into the QALY framework will lead to improved 
satisfaction with the process of care and better health outcomes (Brazier et al., 2009). 
Opmeer and colleagues previously discussed non-health outcomes of health care 
interventions related to process utility, and distinguished between features of the 
intervention, features of the health care process, or subjective/perceived impact on 
patients (Opmeer et al., 2010). Similar concepts were also used in the thematic analyses 
of this CIS to summarize aspects of process utility, which comprise: (i) intervention 
characteristics, (ii) provider characteristics, (iii) structural characteristics, and (iv) process 
characteristics. These concepts are reported in Appendix 3.2 and summarized below.   
 Several papers identified non-health benefits that can be derived from certain 
features of the health care intervention itself. Such features include, for example, the 
accuracy of a test (Payne et al., 2013), mode and frequency of administration (Ali & 
Ronaldson, 2012; Brouwer, 2008), invasiveness (intensity) of the intervention (Alayli-
Goebbels et al., 2013; Opmeer et al., 2010), and complications or morbidity related to the 
invasiveness, such as the pain of testing or postoperative bleeding (Swan et al., 2016; 
Swan et al., 2003; Swan et al., 2010). The extent to which the intervention is tailored to 
the individual, group, or family has also been associated with non-health benefits (Alayli-
Goebbels et al., 2013; Grosse et al., 2008). 
Numerous structural characteristics that refer to attributes of the setting in which 
care is provided were discussed. Access to health care was described within the context 
of the location of care and distance to the health facility (including travel time) (Ali & 
Ronaldson, 2012; Benning et al., 2015; Birch et al., 2003; Dowie, 2001; Grosse et al., 
2008; Payne et al., 2013; Petrou & Wolstenholme, 2000; Ryan, 1999; Ryan et al., 2014; 
Shackley et al., 2001; Swan et al., 2016; Swan et al., 2010). Furthermore, the 
coordination of services (Swan et al., 2016), availability of non-health related services 
(Ali & Ronaldson, 2012), and the type of care delivery including follow-up care 
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(continuity of care) (Ryan, 1999; Shackley et al., 2001) have been considered as 
characteristics of the structure that provide utility. Lastly, the treatment environment 
itself, such as continuity of staff (Shackley et al., 2001), comfortable accommodation 
(Kotzian, 2009), and cleanliness of facilities (Ali & Ronaldson, 2012; Swan et al., 2016) 
were stated as important characteristics that can lead to utility gain.  
Provider characteristics, which include the attitude of the health care staff (Ryan, 
1999) and the relationship to the health care provider (Coulter et al., 2013), were 
discussed as additional aspects of process utility. This contains the quality of the 
relationship (Payne et al., 2013), as well as the extent of physicians’ involvement during 
the process (Alayli-Goebbels et al., 2013). The nature of the consultation formed an 
important component of process utility, which refers to prompt and clear communication, 
and time to talk (Grosse et al., 2008). In this context, individuals may derive benefits 
during the process if the provider acts in a respectful manner, demonstrates competency 
(Swan et al., 2016), and is able to provide recommendations or advice in terms of the 
treatment options (Annemans et al., 2013). Ryan also stated that there might be non-
medical reasons to see the doctor (Ryan & Shackley, 1995), which closely relates to 
Borghi and Jan’s argument that the demand for some health care interventions may be a 
derived demand not for health but, for example, for information (Borghi & Jan, 2008).  
The provision of information and the ‘value of knowing’ were discussed as key 
characteristics of the process of health care delivery (Donaldson & Shackley, 1997; Ryan 
& Shackley, 1995; Towse & Garrison, 2013). This goes beyond the ‘value of 
information’ for decision-making and includes the value of information even when the 
information does not affect treatment (Neumann et al., 2012). Specifically, the 
information produced by health care intervention was discussed (Birch et al., 2003), often 
within the context of genetic testing (Bajaj & Veenstra, 2013; Buchanan et al., 2013; 
Eden et al., 2013; Grosse et al., 2009; Lu & Cohen, 2015). Bajaj et al. listed some 
consequences of knowing, such as anxiety (or anxiety relief) or the implications of test 
results for other family members (Bajaj & Veenstra, 2013). Grosse suggested that the 
utility of genomic information could be considered from three perspectives: the public 
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health perspective (i.e., health improvements), the clinical perspective (i.e., diagnostic 
thinking and therapeutic choice), and the personal perspective, where information can 
have a value per se (Grosse et al., 2009). Veenstra and colleagues used the term ‘health-
related utility’ that combines the attributes of clinical utility and social utility that are 
associated with influences on clinical outcomes or QoL (Veenstra et al., 2010). Buchanan 
et al., however, distinguished between ‘personal utility’ and ‘clinical utility’, where the 
value of personal genetic information may not be captured by clinical utility but by 
personal utility, which describes benefits and harms that are manifested outside of 
medical contexts (Buchanan et al., 2013). This could include, for example, improved 
certainty of knowing and, hence, individuals’ sense of control, self-identity and autonomy 
(Buchanan et al., 2013). Several studies stated that information is important for the 
reassurance it can provide (Buchanan et al., 2013; Cookson, 2005b; Donaldson & 
Shackley, 1997; Grosse et al., 2008; Howard et al., 2008; Ryan, 1999; Ryan & Shackley, 
1995; Salkeld et al., 2004; Swan et al., 2003).  
The concept of process utility was also used as a collective term for all activities 
that occur during health care delivery (Dirksen, 2014). This includes whether or not a 
patient is treated with dignity (Al-Janabi et al., 2011; Ali & Ronaldson, 2012; Coast, 
2014; Coast et al., 2008a; Coast et al., 2008d; Cookson, 2005b; Donaldson & Shackley, 
1997; Makai et al., 2014b; Makai et al., 2013; Mooney, 1998; Ryan, 1999; Ryan & 
Shackley, 1995; Schlander et al., 2014; Torgerson & Raftery, 1999), experiences 
fear/anxiety or uncertainty (Borghi & Jan, 2008; Opmeer et al., 2010; Salkeld, 1998; 
Swan et al., 2010), comfort/discomfort (Al-Janabi et al., 2012; Cookson, 2005b; Makai et 
al., 2014b; Makai et al., 2013; Opmeer et al., 2010), stress or convenience/inconvenience 
(Ding et al., 2011; Higgins et al., 2014), being treated in a pleasant/unpleasant way 
(Brennan & Dixon, 2013; Brouwer et al., 2008; Donaldson & Shackley, 1997), and 
embarrassment or cosmetic issues (Borghi & Jan, 2008; Opmeer et al., 2010; Swan et al., 
2016). Privacy (Ryan et al., 2014), duration of treatment, and other time-related aspects 
of the process of care (e.g., time to talk, waiting time, time to complete a test and 
knowing the results, length of stay, and convenience of appointment times) were also 
associated with additional benefits (Dowie, 2001; Grosse et al., 2008; Opmeer et al., 
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2010; Payne et al., 2013; Ryan, 1999; Ryan et al., 2014; Shackley et al., 2001; Swan et 
al., 2016; Swan et al., 2010). The importance of choice (e.g., choice of medical staff, 
service level, and type of provider) and the act of choosing may also lead to an additional 
effect on utility (Ali & Ronaldson, 2012; Kotzian, 2009; Ryan & Shackley, 1995). 
Brouwer et al. discussed the choice of becoming a carer within the context of informal 
care and the associated burden of care (Brouwer et al., 2005). In general, care (i.e., being 
cared for, receiving care, and providing care) was mentioned as an important 
characteristic of the process from which individuals may derive utility (Brouwer et al., 
2005; Davidson & Levin, 2010; Mooney, 1998). Finally, end-of-life aspects, such as 
being prepared for death and the quality of dying (i.e., emotional and physical suffering) 
were highlighted as important process characteristics (van Mastrigt et al., 2015).  
3.3.3. Benefits beyond the affected individual 
A number of benefits were discussed in the literature that occur beyond the 
affected individual, which refers to the ‘evaluative scope’ of the QALY (i.e., who is 
affected by the intervention and who should be included in the analysis). The current 
evaluative scope of the QALY contains only patient QALYs and ignores QALY gains in 
significant others (Al-Janabi et al., 2011). Significant others may include family members 
and friends (Ali & Ronaldson, 2012; Brouwer et al., 2006; Coast, 2014) or informal 
caregivers (Al-Janabi et al., 2011; Hoefman et al., 2013). Such spillover effects refer 
either to the ‘family effect’, where family members may experience health changes 
because someone in their social environment is ill (effects of caring about other people) 
or ‘caregiver effect’, which is the effect on health induced by the burden of informal care 
(effects of caring for someone who is ill) (Bobinac et al., 2010; Bobinac et al., 2011; 
Brouwer, 2008). Providing informal care is, however, not necessarily associated with 
negative effects, as there are also positive effects, such as feelings of being appreciated 
by the cared-for patient or spending time together (Davidson & Levin, 2010). Brouwer 
and colleagues referred to this as the process utility from providing informal care 
(Brouwer et al., 2005). A few studies noted that the benefits and harms of genetic testing 
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include not just the impact on the individual being tested but the health effects for family 
members (Eden et al., 2013; Grosse et al., 2008; Rogowski et al., 2014).  
Spillover effects can be seen as a form of externalities, where a general distinction 
can be made between: (i) caring externalities, which refer to the utility people derive 
from the knowledge that other people are receiving health care, or (ii) selfish externalities 
where an individual cares about others’ consumption of health care because this 
consumption affects their own health (Donaldson & Shackley, 1997; Labelle & Hurley, 
1992; Olsen & Smith, 2001; Ryan & Shackley, 1995). The former is sometimes described 
as altruism (Jacobsson et al., 2005), which is a type of non-use value (Olsen & Smith, 
2001; Sach et al., 2007). Another type of non-use value refers to the concept of ‘option 
value’, which derives from uncertainty regarding future need (Labelle & Hurley, 1992). 
Here, option value describes the utility obtained from having the option to use health care 
services at some point in the future (Donaldson & Shackley, 1997; Eden et al., 2013; 
Olsen & Smith, 2001; Ryan & Shackley, 1995). Since not only users of the services 
derive utility but also current non-users, who may or may not use the service in the future 
(Ryan & Shackley, 1995), it represents a benefit that extends beyond the affected 
individual. Similarly, Borghi & Jan referred to ‘passive use value’ within the context of 
health promotion programs, which refers to the indirect learning from others or 
reassurance from knowing that others have learned (Borghi & Jan, 2008). Although it has 
been previously acknowledged that benefits of a program can accrue to the broader 
community, such externalities lie outside QALY framework, which could lead to a non-
optimal allocation of resources (Labelle & Hurley, 1992). 
Generally, the three concepts described above (spillover effects, externalities and 
option value) refer to non-health benefits outside the affected individual. A fourth non-
health benefit that is not directly relevant for the affected individual but the society 
overall relates to distributional benefits, such as equity and need. A number of papers 
noted that applying the QALY maximization rule leads to sub-optimal allocation of 
resources because distributional issues are ignored (Baker et al., 2010; Schlander et al., 
2014). Under the QALY framework, the overall health benefits of an intervention are 
 61 
calculated by aggregating the QALY gains accruing to individuals using a simple, 
unweighted summation, which is known as the ‘QALY maximization’ rule. Since 
concerns about how benefits are distributed across individuals are ignored (distributive 
neutrality), all QALYs are of equal social value regardless to whom they accrue and the 
context in which they are enjoyed (‘QALY egalitarianism’). In other words, a ‘QALY is 
a QALY is a QALY’ under all circumstances and regardless of the characteristics of 
recipients (Singer et al., 1995; Williams, 1997). Although a theoretical basis for equity 
weighting is provided by the extra-welfarism approach, until today no such weights are 
used in practice. Different approaches have been put forward to incorporate equity 
considerations into the QALY framework, such as distributional weights based on age, 
severity, lifestyle, socioeconomic status, and having dependents, etc. (Baker et al., 2010). 
Herlitz & Horan emphasize the importance of health ‘needs’ (i.e., the severity of pre-
treatment health states) that can be seen as an independent objective for allocation 
decisions, which is different but not mutually exclusive to health maximization or equity 
concerns (Herlitz & Horan, 2016). Allocation based on a need-based prioritization 
framework was also discussed for genetic tests (Rogowski & Schleidgen, 2015). 
3.3.4. Benefits outside the health care sector 
A number of papers discussed that the allocation of resources in health care will 
affect other sectors, such as education, criminal justice, environment, housing, and labour 
(Ali & Ronaldson, 2012; Bayoumi, 2004; Beale et al., 2012; Benning et al., 2015; Coast 
et al., 2008d; Edwards et al., 2015; Edwards et al., 2013; Gandjour, 2001; Hausman, 
2012; Laxminarayan et al., 2014; Lorgelly et al., 2010; Lu & Cohen, 2015; van Mastrigt 
et al., 2015). At the same time, it has been cautioned that the inclusion of such benefits 
on the effect side can lead to double counting if the effect is already captured by the cost 
side of an economic evaluation (which has been the typical approach to capture such 
broader impacts) (Bayoumi, 2004). Yet, controversial views still exist around this topic in 
the literature. For example, decreased criminal activity may be associated with QoL 
effects. Therefore, treating such outcomes only as costs runs the risk of undervaluing the 
associated QoL benefits (Bayoumi, 2004). Particularly within the context of health 
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promotion, Benning and colleagues have highlighted the importance of reductions in 
criminal behaviour, as well as better educational achievements, increased labour 
participation and work productivity (Benning et al., 2015).  
With regard to labour and productivity gains, the Washington Panel’s 1996 
guidelines for economic evaluation of health care interventions initially proposed that 
productivity costs should be incorporated as health effects in the denominator of the cost-
effectiveness ration (rather than in numerator) (Brouwer et al., 1997). The rationale for 
this was based on the definition of productivity cost by the Washington Panel, which also 
accounted for the lost or impaired ability to engage in leisure activities. However, 
although lost or impaired ability to engage in leisure activities should be reflected in 
QALYs, it has been highlighted that current preference-based HRQoL instruments used 
to calculate QALYs do not include such benefits of survivor consumption and leisure 
forgone (Liljas, 2011; Nyman, 2011). Besides the lost or impaired ability to engage in 
leisure activities that affect QoL, it can also be argued that lost or impaired ability to 
work can also influence an individual’s QoL. As such, particularly within a cost-utility 
framework, it has been cautioned to include productivity loss in the denominator of the 
ICER because the QALY also reflects the influence of work loss, which may lead to 
double counting (i.e., productivity loss being included in both the numerator and 
denominator of the ICER).  
Despite these controversies, the Second Panel on Cost-Effectiveness in Health 
and Medicine now recommends that productivity loss should be considered in the cost 
side in an economic evaluation (Sanders et al., 2016). Currently, there is no clear 
approach as to how to incorporate other benefits outside the health care sector, such as 
reductions in criminal behaviour. An alternative method was suggested to incorporate a 
multi-sectorial approach, or an inter-sectoral compensation test, where inter-sectoral costs 
and benefits are simultaneously captured and adjusted for budgets and resources that are 
allocated by different ministries (van Mastrigt et al., 2015). However, there are no simple 
ways of integrating costs and benefits in other sectors within existing decision rules and 
the proposed methods are still at a theoretical stage of development.  
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3.3.5. Concept map  
The concept map shown in Figure 3.4 displays the relationships between different 
non-health benefits identified by the CIS. The four higher-order themes discussed above 
were further broken down into two groups that are indicators of whether benefits accrued 
within or outside the affected individual. Benefits outside the affected individual 
comprise (i) benefits beyond the affected individual and (ii) benefits outside the health 
care sector. Benefits affecting wellbeing and benefits derived from the process form a 
second group that is concerned with the affected individual. While a distinction has been 
made between process and outcome, it needs to be noted that it was not always possible 
to make a clear cut between what constitutes an outcome and what is process-related. 
This is illustrated by the dashed line in the concept map.  
With regard to wellbeing, the four concepts described above overlap conceptually, 
which is also reflected in the concept map. For example, positive relationships can be 
considered as a domain of psychological wellbeing, but social interactions and being 
satisfied with social relationships is also an important component of subjective wellbeing. 
Likewise, certain capabilities such as enjoyment or autonomy conceptually overlap with 
psychological and subjective wellbeing. The concept of empowerment was previously 
described as another conceptualization of Sen’s capability approach (McAllister et al., 
2012; Payne et al., 2013) and, in addition, is closely related to psychological wellbeing. 
Moreover, since empowerment can be seen as a process by which individuals gain 
control over their lives, it can be also linked to the concept of process utility.
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Figure 3.4.  Concept map of benefits outside the health-related QALY based on literature identified through the CIS 
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3.4. Discussion 
The identification of benefits of health care interventions and their consideration 
in health economic evaluation remains a challenging task. While QALYs have been most 
frequently used in the assessment of health interventions, there are increasing concerns 
that the QALY framework does not capture all benefits of health care interventions. The 
aim of this chapter was to provide a better understanding of benefits beyond the health-
related QALY. This work critically reviewed existing evidence and identified four broad 
types of non-health benefits that are currently considered outside the QALY framework, 
which include: (i) benefits affecting wellbeing; (ii) benefits derived from the process of 
health care delivery; (iii) benefits beyond the affected individual; and (iv) benefits outside 
the health care sector. Given these findings, the future course of action concerning such 
non-health benefits remains unclear. Possible choices include ignoring non-health 
benefits, abandoning the QALY for something else, or incorporating non-health benefits 
into the QALY framework. These three options are discussed in the next sections. 
3.4.1. Ignoring non-health benefits within the QALY framework 
Given that non-health benefits have played a minor role in health care resource 
allocation decisions to date, it can be argued that they should be ignored within the 
QALY framework. However, countries that currently base their reimbursement decisions 
on QALY gains are recognizing the potential importance of non-health benefits in 
economic evaluation, as reflected in recent guidelines. With the introduction of the 
ASCOT and ICECAP measures in the NICE guidelines, broader measures of wellbeing 
are gaining significant attention in health care decision-making (NICE, 2014). In 
addition, NICE now also allows consideration of evidence on the ‘process characteristics’ 
of health care technologies that have a value to people independently of any direct effect 
on health, such as improving convenience in delivery and administration of care, and the 
level of information provided to patients (NICE, 2013). A similar development can be 
also observed in Canada, where recent guidelines proposed the incorporation of non-
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health effects using a CCA to complement the health effects captured in a CUA 
(CADTH, 2017). An important statement made in the CADTH guidelines is that the 
value of non-health effects should be based on being traded-off against health. In this 
context, the guidelines refer to societal values that should be reflected in the values of 
non-health benefits. As such, to answer the question whether or not non-health benefits 
should be ignored, more studies are needed to explore whether society is willing to 
sacrifice health gains in order to achieve a range of distributional, wellbeing, and process-
related objectives.  
Williams noted that if, besides health, priority should be given to aspects related 
to ‘access to health care’, it is important to understand that this would imply that health 
care resources could be taken away from improving people’s health and to devote them to 
reinforcing people’s sense of security about care being available to them when they need 
it (Williams, 1996). Whether this is a reflection of what society wants from the health 
care system is unclear. One ethical objection to incorporating non-health benefits is if 
someone who is in medical need will be not treated because health care resources were 
spent for non-health benefits (Broome, 2002). Getting more views from citizens would 
help to inform this debate and enable policy makers to identify an appropriate maximand.  
In search of a maximand, there is, however, possibly a tension between what 
patients want versus what the society and the decision maker regards as relevant. It was 
previously argued that non-health benefits are particularly valued by patients, whereas 
decision makers or tax-payers might value a more limited, health-focused set of attributes 
(Bryan & Dolan, 2004). Similar views have been provided by others, suggesting that 
compared with patients, citizens may be reluctant to fund health care that provides non-
health benefits but does not affect health status (Clark & Olsen, 1994). While health is 
considered unique in the sense that it enables people to ‘flourish’, process utility does not 
have necessarily this feature and, thus, it has been argued that individuals will not feel an 
obligation to subsidize their fellow citizens’ use of health care resources that are not 
health enhancing (Clark & Olsen, 1994). A contrary view was offered by Mooney, who 
questioned the role of decision makers to define what is important for a patient’s utility 
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function, especially the legitimacy of non-health outcomes (Mooney, 1994). In view of 
the fact that patients may derive utility from aspects of health care other than health 
outcome, ignoring such broader benefits seems to be an incorrect approach to proceed 
with. The problem appears to be in the limited ability of the QALY to incorporate non-
health benefits. As such, a better solution could be the identification of another approach 
that allows the incorporation of non-health benefits and to abandon the QALY for 
something else. 
3.4.2. Abandoning the QALY 
Alan Williams once said about the QALY: “there is quite a lot I don’t like about 
it, but it’s not so bad when you consider the alternative” (Williams, 1996, p.1803). The 
list of alternative approaches of resource allocation decisions in the health economics 
literature is long and comprises, for example, CBA, CCA, or MCDA. A recent qualitative 
study has offered some other alternatives that were proposed by experts, such as the use 
of the Happiness Index, Wellbeing Index, capability indices, a CUA using a broader 
QALY concept, or CUA/CEA using the multi-sectorial approach (van Mastrigt et al., 
2015). Nevertheless, these alternatives are also not free of problems as the authors 
underscore. Drawbacks of CBA include the use of individual preferences, the difficulty to 
express benefits in monetary terms, the lack of standardised methods, and the need for a 
tailored CBA for every specific intervention. The main limitation of the CCA, on the 
other hand, is the difficulty to determine the overall impact of the intervention, where 
different outcomes under consideration could potentially indicate a different course of 
action. Due to the lack of a standardized approach for MCDA and for the multi-sectorial 
approach, these two alternatives can also not be considered as superior to the QALY. 
Questionable is also the use of bolt-ons to derive a ‘broader QALY’. Finally, given the 
difficulty to measure capabilities and the uncertainty about the society’s acceptance of 
wellbeing as a metric to inform policy decisions, these alternatives need to be explored 
further before their application in practice.  
Whether the QALY should be abandoned for something else needs also to be 
examined in light of the role of the QALY in the decision-making process. QALYs were 
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introduced as a tool to inform decision makers as explicitly as possible about the 
interpersonal comparisons of utility (Mooney, 1989). Importantly, QALYs do not inform 
decision makers what is the ‘best’ option in terms of overall social value. This is because 
apart from improving health outcomes, decision-makers usually consider other criteria in 
resource allocation decisions (Shah et al., 2012). A frequent problem is that most 
decision-making agencies lack explicit and transparent frameworks for incorporating the 
multiple criteria considered when prioritising health technologies (Hansen, 2012). Given 
the absence of the relative importance of additional criteria, and a clear maximand for 
resource allocation decision-making, it appears that the exclusion of benefits beyond 
health does not appear to be problematic for the QALY metric per se but rather a wider 
issue for the decision-making. 
In addition, while the QALY can be seen as a framework that informs resource 
allocation decisions in health care, the instruments used to derive QALYs play an 
important role in determining the evaluative space of the QALY. As such, it was not 
surprising to see that authors of identified papers discussed the limitation of the 
evaluative space of the QALY with a particular linkage to an instrument – in particular, 
the most frequently used instrument, the EQ-5D-3L. Two Dutch studies, for example, 
have studied the importance of non-health outcomes and defined such broader outcomes 
as “all outcomes not incorporated in EQ-5D based QALYs” (Goebbels et al., 2012, 
p.180; van Mastrigt et al., 2015). While such working definitions most likely stem from 
the fact that the EQ-5D is also the preferred instrument by some national HTA agencies, 
such as NICE in the UK (NICE, 2013) or CVZ in the Netherlands (Zorginstituut 
Nederland, 2016), it raises the question as to what extent this particular preference for an 
instrument is the cause of the problem itself i.e., driving the discussions around broader 
non-health benefits. 
Brazier and colleagues noted that the key criticism of most generic preference-
based HRQoL measures is that researchers have designed them with little or no input 
from people with relevant health problems (Brazier et al., 2014). The development of 
broader instruments (e.g., ICECAP and ASCOT), on the other hand, was shaped by 
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findings from qualitative interviews with affected population groups. Given that, it 
remains unclear whether existing preference-based HRQoL measures deviate 
fundamentally from broader instruments or whether important aspects of the impact of 
impairments on people’s lives have been missed due to the failure to include end users in 
the development phase. From a theoretical point of view, the QALY measure can 
embrace any HRQoL characteristics that are important to people (Williams, 1996). As 
Chapter 2 outlined, under the extra-welfarism approach there are no theoretical reasons to 
limit the QALY to health outcomes only. Yet, in practice, it seems that QALYs are 
currently defined by what is measured rather than the conceptual origin. It follows that 
although non-health benefits have been largely ignored when estimating QALYs, one 
should not dismiss the QALY framework but rather develop appropriate instruments that 
capture such broader benefits (Round, 2012). Besides this focus on instruments to 
broaden the evaluative space of the QALY, a number of methodological advances have 
been proposed in the literature that would allow the incorporation of non-health benefits 
into the QALY framework.   
3.4.3. Incorporating non-health benefits into the QALY framework 
The CIS identified four broader types on non-health benefits: (i) benefits affecting 
wellbeing; (ii) benefits derived from the process of health care delivery; (iii) benefits 
beyond the affected individual; and (iv) benefits outside the health care sector. This 
section challenges whether these constructs truly represent non-health benefits and 
discusses the extent to which they are already considered within the QALY framework or 
can be incorporated into the QALY framework 
A number of benefits affecting wellbeing were identified, such as subjective 
wellbeing, psychological wellbeing, capability wellbeing, and empowerment. It has been 
argued that existing preference-based HRQoL measures that are used to generate QALYs 
do not account for wellbeing, which has resulted in the development of broader outcome 
measures, such as the ASCOT and the ICECAP instruments. However, it needs to be 
noted that several wellbeing attributes identified through the CIS can be found in existing 
preference-based HRQoL measures. For example, ‘happiness’ in the HUI or ‘control’, 
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‘pleasure’, and ‘coping’ in the AQoL-8D. This indicates that concepts of wellbeing are 
not excluded from the QALY framework per se. Instead, the absence of such attributes is 
largely a reflection of the dimensions that are included in the descriptive systems of 
preference-based HRQoL measures. Accordingly, there is the need for further 
investigation in terms of the extent to which aspects of wellbeing are currently captured 
by existing preference-based HRQoL measures. This research question is the focus of 
Chapter 5. It is also important to note that even if newly developed measures provide 
additional information beyond that of existing preference-based HRQoL measures, their 
use within the QALY framework is not straightforward. While the ASCOT can be used 
to derive ‘social-care QALYs’ as it is anchored on a scale of 0 ‘being dead’ to 1 ‘ideal 
SCRQoL state’ (Netten et al., 2012), the ICECAP instruments do not have QALY 
properties, given that they were anchored on a ‘full capability’ to ‘no capability’ scale 
(Flynn et al., 2015). This means that only the ASCOT can be used to calculate QALYs, 
while ICECAP measures just provide sets of preference-weighted index values. Other 
capability measures identified in this chapter (e.g., OxCAP-MH) are also not suitable for 
the use within the QALY context, and some researchers abstain from collapsing 
multidimensional capabilities information into a single index score because it is in 
tension with the original capability approach (Simon et al., 2013).  
Although process attributes are not directly included in existing preference-based 
HRQoL measures, there are still similar concerns with regard to double counting. 
Brennan and Dixon highlight that the extent to which process utility is not captured by 
existing preference-based HRQoL measures is currently unknown (Brennan & Dixon, 
2013). In order to avoid double counting, this information is required before any separate 
estimates of process utility are added into cost-effectiveness analyses. Ryan and Shackley 
provided an example on this issue within the context of screening programmes (Ryan & 
Shackley, 1995). Here, double counting could occur because screening programmes 
provide the opportunity for reassurance but may provoke anxiety in patients, where 
anxiety is already included in many preference-based HRQoL measures (Ryan & 
Shackley, 1995). While further research is needed to explore the extent to which process-
related aspects are captured by existing preference-based HRQoL measures, newly 
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developed preference-based measures already pay close attention to process-related 
aspects, which can be observed in the inclusion of a dignity question (i.e., the impact of 
the care process on the person’s sense of self-worth) in the ASCOT instrument or a 
question regarding choice (i.e., having a say in the decision-making) in the ICECAP-
SCM.  
Brennan and Dixon mention that there is currently no sound methodological 
framework for the incorporation of ‘process’ into QALY frameworks and suggest the 
exploration of alternative methodologies, such as the use of psychometric approaches or 
the use of a process-related ‘bolt-on’ (Brennan & Dixon, 2013). However, the use of bolt-
ons is again not straightforward, given that new valuation studies would be required in 
order to capture the relative impact of the added dimension on heath state valuations. An 
attempt to incorporate process preferences directly within the QALY framework was 
demonstrated by McNamee and Seymour through the use of TTO and SG tasks 
(McNamee & Seymour, 2008). Alternatively, Swan and colleagues have developed a 
MAUI to capture the effects of testing and screening on QoL, called the Temporary 
Utility Index (TUI) (Swan et al., 2010). It is also possible to complement QALYs with a 
patient-reported experience measure (PREM) that accounts for patient satisfaction with 
the treatment (Olsen, 2017). Although no perfect methods exist to capture process utility 
within the QALY framework, these studies have demonstrated that the incorporation of 
process utility within the QALY framework is not impossible. 
With regard to benefits beyond the affected individual, recent efforts showed that 
it is feasible to include family spillovers in economic evaluations within the extra-
welfarism framework (Al-Janabi et al., 2015; Al-Janabi et al., 2016). Al-Janabi and 
colleagues have developed a framework that adapts the conventional cost-effectiveness 
decision rule to include two multiplier effects – one specified for the health benefit 
generated, and one for the health benefit displaced by funding the intervention (Al-Janabi 
et al., 2015). This allows for consideration of health spillovers, as these multiplier effects 
express the ratio of total health effects (for patients and their family networks) to patient 
health effects. However, the authors highlight that accounting for health spillovers (or 
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health externalities) in resources allocation decisions may result in greater funding for 
services for people with dependents, at the expense of those without (Al-Janabi et al., 
2015). Inevitably, the ethical implications of such evaluations will require further 
consideration.  
While other equity issues were identified in this chapter around the QALY 
framework, Mooney urged caution that QALYs per se do not create any ethical problems 
but they may if health is assumed the only output of health services. He stressed that, in 
practice, equity problems can be addressed by attaching empirical weights (Mooney, 
1989). A theoretical basis for equity weighting is also provided by the extra-welfarism 
approach, which in fact does no longer separate between equity and efficiency concerns 
that would usually allow economist to take on a neutral position towards the 
distributional issues (Coast, 2009). However, the main problem is to identify such 
weightings. An important step to incorporate equity concerns for priority setting in health 
care has been made in the Netherlands, with the introduction of the concept of 
proportional shortfall (van de Wetering et al., 2013). This concept combines elements of 
fair innings and severity-of-illness, where priority is given to those patients who lose the 
greatest proportion of their remaining health expectancy due to illness if this illness 
remains untreated. In other words, proportional shortfall looks at the fraction of QALYs 
that people lose relative to their remaining life expectancy (Stolk et al., 2004). The 
proportional shortfall is measured on a scale from 0 (no health loss) to 1 (complete loss of 
remaining health) (van de Wetering et al., 2013). The advantage of this approach is that 
equity concerns can be addressed in an explicit and transparent way. However, others 
provided a contrary view and argued that incorporating equity aspects into the QALY 
framework is not straightforward (Wailoo et al., 2009), which could potentially overload 
the framework and it becomes even more difficult to understand the key concepts behind 
it (Nord et al., 2009).  
Finally, benefits outside the health care sector have also gained attention in recent 
years. Brazier and Tsuchiya have provided ten possible approaches for extending the 
health-related QALY using wellbeing and monetary-based methods (Brazier & Tsuchiya, 
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2015). In particular, the proposal of a WELBY is noteworthy. The WELBY is the same 
as a QALY, except that the descriptive system of a standardized instrument would be 
concerned with wellbeing rather than HRQoL. Whether the WELBY is the answer for 
improving cross-sector comparisons remains unknown. Other ‘minor adjustments’ to the 
QALY that would allow for the comparison of outcomes across sectors is the use of 
mapping, bolt-ons, or the valuation of measures on a common scale using preferences. 
However, the authors conclude that any choice between these approaches involves 
political decisions about what counts in measuring benefits of interventions (Brazier & 
Tsuchiya, 2015). Additionally, there is a risk of double counting given that outcomes 
across sectors are not unrelated. Here, double counting relates to the fact that the 
dimensions in one measure may be captured to some extent by dimensions in the other 
measure. As such, cross-sector comparisons require an overall measure of benefit whilst 
avoiding double counting. Another form of double counting that requires further research 
relates to the issue whether benefits outside the health care sector should be captured in 
the denominator or the numerator of the ICER. This is particularly an issue for reduction 
in criminal behaviour, better educational achievements, as well as increased labour 
participation and work productivity.  
It can be concluded that non-health benefits identified are to some extent already 
included in the QALY framework or methods have been developed to incorporate those. 
Generally, part of the discussion and the way these broader benefits have been labeled is 
largely driven by the theoretical foundation of the QALY. The QALY was introduced as 
a measure of health outcome and as such the focus moved away from focusing on 
individuals’ utility. Accounting for utility associated with process of care, as well as 
wider effects on SWB is considered outside the QALY. Also the incorporation of 
spillover effects falls under the utilitarian idea of aggregating all utility impact in all 
affected individuals and not only the individual. However, even if the QALY as a 
measure of health outcome appears to be a simple metric, health is complex and 
identifying, measuring and valuing different types of health improvements is challenging. 
For that reasons, adapting a broader extra-welfarism approach proposed by Brouwer and 
colleagues is a move towards a more precise QALY measure that is more of significance 
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to the decision maker involved or the public served by the decision-making authority 
(Brouwer et al., 2008). Therefore, if a decision maker with authority decided that such 
broader benefits are of relevance for the allocation of health care resources (which can be 
observed in countries like the UK, where the focus on wellbeing and process-attributes is 
growing), it is an acknowledgment that these benefits are associated with health 
improvements and as such should not be labelled as ‘non-health benefits’.         
3.4.4. Strengths and limitations 
A number of strengths and limitations of this work are worth noting. With regard 
to the chosen method, the conduct of a CIS using a citation pearl growing methods was 
considered as a strength of this work, which allowed for the identification of papers in 
this research area, and a more appropriate synthesis of the findings. For example, the lack 
of consistent indexing and terminology across papers would make it difficult to develop a 
search strategy for bibliographic databases, as it is usually done in conventional 
systematic reviews. It was also expected that discussions around benefits beyond health 
are not always included in the abstracts, meaning that relevant papers could be missed by 
a bibliographic database search. The citation pearl growing method has been previously 
applied within the context of health economics (Dolan et al., 2005; Mitchell et al., 2017a) 
and recommended for searching within the social sciences literature (Papaioannou et al., 
2010). A second strength of the CIS can be seen in the way evidence was appraised and 
synthesized. While conventional systematic reviews aim to summarize data and require a 
basic of comparability between concepts, this work involved different forms of evidence 
(with incompatible aims) and concepts could not be well specified a priori. The use of 
more qualitative approaches to synthesize evidence that allowed for the development of 
own interpretations can be seen as another strength of this work.  
With regard to limitations, it needs to be acknowledged that not all relevant 
papers on this topic were included in the analyses. Firstly, the search did not consider 
grey literature and, secondly, with regard to the selection criteria, papers that cited 
already included papers were excluded, as it was assumed that such papers would not 
identify any new concepts that provide a deeper understanding of the topic. However, it is 
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worth highlighting that it was not the aim of this chapter to generate an exhaustive list of 
papers that discuss broader benefits within the QALY framework but rather to provide a 
better understanding of the concepts describing non-health benefits, which is in line with 
the CIS approach. Finally, in contrast to conventional systematic review methodology, 
the findings produced by the CIS may not be reproducible due to approaches applied for 
the literature search and synthesis. With regard to the literature search, it is possible that a 
different researcher would have used a different core set of papers, which could have 
resulted in the inclusion of different papers. However, this is not to say that a different 
thematic framework would have emerged. While the production of the synthetic 
constructs and the synthesizing argument is an interpretive process that allows for going 
beyond interpretations provided by the original studies, deviations are more expected in 
the classification of different non-health attributes (i.e., referring to the list in Appendix 
3.2), rather than the synthetic constructs or the broader themes identified.   
3.5. Conclusion 
This chapter has synthesised existing literature of broader benefits that are 
currently outside the QALY framework. While different alternatives were discussed in 
terms of dealing with non-health benefits in future, it can be concluded more effort is 
needed to incorporate non-health benefits into the QALY framework. It appears that the 
QALY framework does not exclude such broader benefits per se but rather the narrow 
focus of preference-based instruments used to derive QALYs and the absence of a clear 
maximand for resource allocation decision-making. With a range of methods introduced 
to extend the health-related QALY, these approaches need to be tested empirically and 
explored further in practice to rule out double counting.  
Whether or not the evaluative space of the QALY is limited to health alone will 
be explored further in the following chapters. This will be done through the direct 
comparisons of preference-based HRQoL measures that are used to derive QALY 
weights with outcome measures that adopt a broader evaluative space, particularly 
wellbeing measures that relate to the concept of capability and subjective wellbeing. The 
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next chapter reports findings from a study that applied the EQ-5D-5L and the ICECAP-
O, a measure of capability wellbeing for older adults, within the context of public health. 
Results of this work aim to inform the current research gap in terms of the extent to 
which both instruments are able to capture broader benefits outside the health care 
context. The subsequent chapters will then explore the extent of double counting, and 
further relationships between wellbeing measures and other preference-based HRQoL 
measures.  
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Chapter 4. Complementarity of the ICECAP-O and 
EQ-5D-5L in the context of public health 
4.1. Introduction 
Methods for economic evaluation of clinical interventions have become well 
established and the use of CUA has become the dominant form (CADTH, 2017). 
However, as highlighted in the previous chapter, the application of conventional health 
economic evaluation methods to public health interventions faces some methodological 
challenges. Public health interventions comprise a wide range, from screening and 
immunizations through to the promotion of healthy eating, physical activity and 
wellbeing (Drummond et al., 2007). Public health interventions are often considered as 
‘complex’ (Craig et al., 2008) because they not only combine educational, social and 
political strategies but also because the benefits of the interventions are often occurring 
outside the affected individual and outside the health care sector (Greco et al., 2016). 
Drummond et al. have identified four main challenges in conducting an economic 
evaluation of public health interventions: (i) attributing outcomes to interventions, (ii) 
measuring and valuing outcomes, (iii) incorporating equity considerations, and (iv) and 
identifying intersectoral costs and consequences (Drummond et al., 2007). Chalkidou et 
al. identified four further challenges that concern (i) the analytical perspective, (ii) the 
extrapolation of results to the appropriate time horizon, (iii) the quality of evidence, and 
(iv) the cost-effectiveness threshold (Chalkidou et al., 2008).  
Given that one of the methodological challenges for public health is the 
measurement and valuation of benefits, the exploration of the field of public health is of 
particular relevance to the topic of this thesis. It was previously reported by Lorgelly and 
colleagues that benefits of public health interventions impact broader aspects of QoL and 
not just health, which is why using QALYs as the measure of outcome may result in 
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underestimation of the relative benefits (Lorgelly et al., 2010). The evaluation of public 
health interventions requires instead multiple or broader outcome measures (Greco et al., 
2016). Although public health guidance by NICE now places more emphasis on CCA and 
CBA, CUA is still required because it provides a single yardstick or currency for 
measuring the impact of interventions on health (NICE, 2012). Likewise, the Canadian 
guidelines state that a CCA may be helpful to present results for interventions involving 
public health (CADTH, 2017). Despite the proposal of other methods that could be 
employed to measure and value a broader set of benefits generated by public health 
interventions (Banke-Thomas et al., 2015; Claxton et al., 2007; Greco et al., 2016; Huter 
et al., 2016; Trueman & Anokye, 2013), the use of the capability approach is gaining 
particularly attention in the public health field (Lorgelly, 2015; Marsh et al., 2012; van 
Mastrigt et al., 2015). Under the capability approach, the evaluation of public health 
interventions would then be based on their impact on a person’s capability to function in 
a particular way. At this current stage, little is known about the application of the 
capability approach to outcome measurement in public health, more specifically, how 
well capability measures perform when compared with preference-based HRQoL 
measures. The aim of this chapter is to investigate the complementarity of a capability 
measure, the ICECAP-O, and a preference-based HRQoL measure, the EQ-5D-5L, in a 
public health context. Looking at a specific population group consisting of older adults, 
this chapter will provide further evidence about the extent to which these two measures 
are able to pick up benefits of different ‘characteristics of the environment’ that play an 
important role in public health research.  
4.1.1. The role of the environment in older age 
Characteristics of the environment can be broken down into two components: 
social and physical characteristics. The latter refers to the natural environment (e.g., 
plants, water, earth, air quality, climate) and the built environment. Features of the built 
environment comprise the urban design (the design of the city and the elements within 
it), land-use (the distribution of activities across space), and the transportation system 
(including the physical infrastructure of roads, sidewalks, bike paths, railroad tracks, 
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bridges and services provided) (Handy et al., 2002). The social environment, on the other 
hand, encompasses interpersonal relationships (e.g., social support and social networks), 
social inequalities (e.g., socioeconomic position and income inequality, racial 
discrimination etc.), and neighbourhood and community characteristics (e.g., social 
cohesion and social capital, and neighbourhood factors) (McNeill et al., 2006a). The 
social environment comprises broader factors that could affect large groups or entire 
communities such as culture, norms, indicators of social disorder, and is associated with 
place attachment that can be understood as a sense of belonging to the neighbourhood 
(Barnett & Casper, 2001; Rowles, 1983; Sallis, 2009). 
The built environment and social environment are of particular importance for 
older adults. The extent to which older adults engage with their environments is different 
compared with most other people, mainly because as individuals age, their environment 
tends to shrink to the locale of their home or immediate neighbourhood (King, 2008). The 
environmental press theory by Lawton suggests that the environment places a certain 
degree of ‘press’ or stress on individuals (Lawton, 1977). How well individuals function 
in their environment is a reflection of the degree to which individuals’ competence meets 
the press imposed by the environment (Lawton, 1977). As physical health declines, older 
adults are less able to function within their surroundings and, therefore, are more 
vulnerable to the forces within their environment (Noreau & Boschen, 2010). 
Environmental challenges include, for example, uneven sidewalks, high curbs, increased 
traffic, or short timing for crosswalks. A combination of physical impairments and lower 
neighbourhood walkability presents challenges to moving about, which may lead to loss 
of independence, social isolation, and the inability to remain in a familiar social 
environment (Hanson et al., 2013). Social isolation, in turn, can lead to depression and 
other adverse mental health outcomes (Rosso et al., 2011). A supportive environment 
with fewer barriers, on the other hand, can promote physical activity (Morris et al., 2008) 
as well as social interaction (Day, 2008), and is associated with better perceived QoL 
(Rantakokko et al., 2010).  
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Although previous conceptual frameworks have emphasized the importance of 
environmental characteristics on QoL (Ferrans et al., 2005; WHO, 2002b; Wilson & 
Cleary, 1995), a recent review has identified only ten studies that explored this 
association in an older adult population (Garin et al., 2014). It was shown that 
accessibility, residential satisfaction, home size, housing type, heavy traffic, higher 
usability, exterior environment, interior environment, street noise, and safety from traffic 
were associated with QoL (Garin et al., 2014). However, the authors stress the difficulty 
to hypothesize on the nature of relationships due to the different use of environmental 
variables that may have resulted in conflicting findings.  
With regard to the social environment, an increase in social cohesion has the 
potential to positively influence older adults’ QoL. Social cohesion can be understood as 
the extent of connectedness and solidarity among groups in society (Kawachi & 
Berkman, 2000). Previous literature indicated that neighbourhood cohesion was 
predictive of good health, wellbeing and QoL (Elliott et al., 2014; Friedman et al., 2012; 
Gale et al., 2011). However, none of this research has examined these relationships using 
preference-based measures of HRQoL or capability wellbeing and further investigation of 
the association between the built environment and social cohesion with older adults’ QoL 
is required. In consideration of this existing research gap, the objectives of this chapter 
are to explore the association between the built environment and social cohesion with 
older adults’ perceived HRQoL and capability wellbeing, and to shed more light on the 
extent to which the EQ-5D-5L and ICECAP-O are influenced by characteristics of the 
environment. 
4.2. Methods 
4.2.1. Data source    
The data used for this secondary analysis are from the ‘Walk the Talk (WTT): 
Transforming the Built Environment to Enhance Mobility in Seniors’ project. This study 
was approved by the University of British Columbia’s Clinical Research Ethics Board 
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(certificate: H10-02913) and detailed information on study design and methods have been 
published elsewhere (Chudyk et al., 2014). Briefly, this cross-sectional study consists of 
qualitative and quantitative components that investigate the impact of the built 
environment on the mobility and health of older adults living on low income in 
Vancouver, Canada.  
Study participants were older adults that were in receipt of a Shelter Aid for 
Elderly Renters (SAFER) rental subsidy from BC Housing (BC Housing, n.d.). The rental 
subsidy is available to residents of British Columbia aged ≥ 60 years who pay more than 
30% of their gross monthly household income towards the rent of their residence. This, 
however, does not imply that SAFER recipients necessarily reside in low-income 
neighbourhoods. Individuals were eligible if (i) they were current SAFER recipients aged 
≥ 65 years (according to WHO’s definition of an older or elderly person (WHO, 2002a)), 
(ii) resided in one of eight select cities within Metro Vancouver, (iii) self-reported that 
they were able to participate in a mobility assessment that involved a 4-meter walk, (iv) 
were able to walk ≥ 10 meters with or without mobility aid, (v) had left their home to go 
into the community at least once in a typical week, (vi) had not been diagnosed with 
dementia, and (vii) spoke and understood the English language. In total, 5806 households 
in eight select cities within Metro Vancouver were sampled using a stratified design. 
Following this, 200 households were randomly selected from within each decile of Walk 
Score® (n=2,000) to ensure diversity across the built environment. Five households were 
excluded because they were contacted prior for participation in the pilot study. Out of 
1995 mailed invitations, 161 participants agreed to participate in the WTT study. 
Participants took part in a two-hour measurement session where they completed 
questionnaires about their neighbourhood built environment, social cohesion, health 
(including QoL) and physical activity, and underwent performance-based measures of 
cognition and lower-extremity function.  
4.2.2. Outcome variables 
The two primary outcome measures for QoL were the EQ-5D-5L and the 
ICECAP-O. While the EQ-5D-5L is considered a measure of an individual’s HRQoL, the 
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ICECAP-O is a measure of person’s capability wellbeing, which accounts for the fact that 
a person’s capabilities (what a person can do) may differ from their functionings (what a 
person actually does) (Al-Janabi et al., 2012). The ICECAP-O is considered to go beyond 
health-related aspects of QoL and into a broader measure of a person’s capability 
wellbeing, and was specifically designed for older adults (Grewal et al., 2006). It covers 
five attributes – attachment, security, role, enjoyment, and control – with scores ranging 
from zero (no capability) to 1 (full capability). The UK tariff was used to calculate the 
ICECAP-O index scores (Coast et al., 2008b), as no value set is available yet for the 
Canadian population. To ensure comparability, the crosswalk value set for the EQ-5D-5L 
that reflected the values of the UK population was also used (van Hout et al., 2012). The 
psychometric properties of the EQ-5D-5L are well established across many countries and 
population groups (Alvarado-Bolanos et al., 2015; Feng et al., 2015; Golicki et al., 2015; 
Herdman et al., 2011). Also the ICECAP-O has been validated in a number of studies (in 
the UK (Coast et al., 2008c), Germany (Makai et al., 2014a), Australia (Couzner et al., 
2013a) and the Netherlands (Makai et al., 2013)) and has consistently been found to be a 
valid instrument to measure capability wellbeing. 
4.2.3. Explanatory variables 
The perceived built environment was measured using the Neighbourhood 
Environment Walkability Scale – Abbreviated (NEWS-A) (Cerin et al., 2006). This 
instrument contains twelve subscales (A-L) and describes individuals’ perceptions of 
their neighbourhood built environment features (for reference, labels A-L are used later 
in the chapter). Subscales are scored such that higher scores indicate higher walkability, 
except for subscale G, H, K, and L where higher scores indicate lower walkability. Scores 
for ten subscales range from 1-4, while subscale A is anchored on a 173-865 scale 
(residential density items were weighted relative to the average density) and subscale B 
on a 1-5 scale. For the WTT study, the NEWS-A was modified (items were dropped or 
added) in order to make it more suitable for older adults. As a result of these changes, 
subscale E (infrastructure and safety) could not be calculated for this dataset because of a 
dropped item. Items that were added to the NEWS-A were not used in the analyses. The 
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validity of the unmodified NEWS-A was previously established in older adults residing 
in the United States (Starnes et al., 2014).  
Next, the perceived social cohesion was measured using Sampson’s 5-item 
measure of collective efficacy (SC-5PT) (Sampson et al., 1997). This measure asks 
respondents to indicate the extent to which they agree or disagree (on a 5-point scale) that 
‘this is a close-knit neighbourhood’, ‘people around here are willing to help’, ‘people in 
this neighbourhood can be trusted’, ‘people in this neighbourhood generally do not get 
along with other’, and ‘people in this neighbourhood do not share the same values’. After 
reversing the coding for the last two statements, items are averaged to reflect levels of 
perceived social cohesion (average scores ranging from 1 to 5, where higher scores 
indicate higher collective efficacy). The SC-5PT showed being a reliable and valid 
measure in previous literature (Lochner et al., 1999; Sampson et al., 1997).  
Finally, the Street Smart Walk Score ® (SSWS) was used as an objective measure 
of the built environment. Previous evidence has shown differences between objective and 
perceived measures of the environment (Gebel et al., 2011; Leslie et al., 2005; McGinn et 
al., 2007), which suggest that these measurement types are likely capturing different 
constructs and both should be considered (Rosso et al., 2011). The SSWS is based on the 
Walk Score® (www.walkscore.com), which is a publicly available index that measures 
the walkability of an address based on distances to nearby destinations (e.g., grocery 
stores, restaurant, shops). Road connectivity characteristics, such as intersection density 
and block length, are included in the score. Walk Score® uses data from Google, 
Education.com, Open Street Map, Localeze, and places added by the Walk Score user 
community. The SSWS uses an updated methodology that better reflects the pedestrian-
walking experience (Frank, 2013), with scores ranging from zero to 100, where higher 
scores denote higher walkability. 
4.2.4. Covariates  
Previous literature has identified a number of covariates relevant for studying the 
relation of interest, including sociodemographic characteristics, health status, personality 
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traits, emotional stability, and social support (Elliott et al., 2014; Friedman et al., 2012; 
Gale et al., 2011). For the analyses in this work, age, sex, living arrangements, physical 
function (number of comorbidities and gait speed), and psychosocial measures 
(loneliness and self-efficacy for walking) were included as precision variables and 
potential confounders - although no distinction is being made between these two in the 
statistical model. A self-report questionnaire was used to gather participants’ 
sociodemographic information. Number of comorbidities was measured with the 
Functional Comorbidity Index, a self-report measure of the presence of eighteen 
comorbid diseases (Groll et al., 2005). Gait speed (usual pace) was assessed as part of the 
4-meter walk component of the Short Physical Performance Battery (Guralnik et al., 
1994). Loneliness was measured with 11 items drawn from the Revised UCLA 
Loneliness Scale (R-UCLA) (Russell et al., 1980) – a measure of social isolation, 
loneliness, and dissatisfaction with one’s social interactions. Finally, self-efficacy for 
walking was evaluated with the Ambulatory Self Confidence Questionnaire, which 
assesses perceived self-efficacy to walk in twenty-two different environment situations 
(Asano et al., 2007). 
4.2.5. Statistical analyses 
Pearson’s correlation analyses were conducted for environmental features and 
outcome measures; correlations were interpreted as weak (0.10 to 0.30), moderate (0.30 
to 0.50), or strong (greater than 0.50) (Cohen, 1988). To examine the associations 
between the built environment and social cohesion with QoL while adjusting for 
covariates, separate stepwise backward Tobit regression models for the EQ-5D-5L and 
ICECAP-O index scores were used. The Tobit model is the recommended model for QoL 
measures that are subject to upper censoring (Austin et al., 2000). Some have argued that 
the use of the Tobit model or the censored least absolute deviations (CLAD) model, 
which both treat the distribution of index scores as censored at 1, are not appropriate 
within the context of QALYs (Pullenayegum et al., 2010). Pullenayegum and colleagues 
have argued that in an economic evaluation the outcome of interest should be utility 
(anchored on a 0-1 QALY scale) rather than HRQoL (which is a broader, more abstract 
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construct). Sullivan has taken a contrary view and argues that utilities are not bounded at 
1.0 because regardless how ‘full health’ is defined by descriptive systems, there will be 
individuals who exceed the definition (Sullivan, 2011). As such, the basic characteristics 
of utilities require that scores exceed 1.0. This viewpoint finds further support with the 
development of the new Canadian tariff for the EQ-5D-5L, where the upper anchor was 
set at 0.949 rather than 1, which challenged the idea that no problems in the five 
dimensions of the EQ-5D-5L can be equated to full health (i.e., a health state =1) (Xie et 
al., 2016). As such, analyses by Pullenayegum and colleagues showing that the Tobit and 
CLAD models lead to bias when the utility was bounded at 1 may not provide reasonable 
proof against the use of such alternative models.        
All covariates (sex, age, living arrangement, number of comorbidities, gait speed, 
loneliness, and self-efficacy for walking), NEWS-A subscales, SC-5PT, and SSWS were 
entered into the model. Backward stepwise elimination was used to remove variables 
relating to the built environment and social cohesion (i.e., exploratory variables); a p-
value of greater than 0.1 was the criterion for removal. Covariates were not eligible for 
removal to explicitly control for them when exploring the associations. To examine the 
associations with each environmental feature separately, while controlling for covariates, 
another set of Tobit models for the EQ-5D-5L and ICECAP-O index scores was fitted. 
Prior to running the regression models, missing value analysis was carried out to explore 
the patterns of missing data and to determine whether data were missing at random. 
Missing data were imputed using multiple imputation by chained equations (MICE) and 
combined estimates and variances were obtained using Rubin’s rule (Rubin, 2004). 
Backward stepwise Tobit regression analyses were also repeated within a ‘complete case’ 
sample and compared with the results from a backward stepwise OLS regression. 
Appropriate tests for multicollinearity (VIF and tolerance test), homoscedasticity 
(White’s test), and normality (Shapiro-Wilk test) indicated that assumptions were not 
violated. Descriptive statistics are presented as mean (SD), number (%), median, and 
interquartile range (IQR). All statistical tests performed were two-sided with p ≤ 0.05 
considered to be statistically significant. STATA version 10 (StataCorp, 2007) was used 
for all analyses and Microsoft Excel for Mac 2011 for graphical presentations. 
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4.3. Results 
Characteristics of the study population are reported in Table 4.1. In total, 160 
individuals (women n=102) aged ≥ 65 years were included in this study. Participants 
were mostly white, Canadian-born and lived alone. Although this population is of low 
socioeconomic status as measured by household income, the percentage of those 
individuals who completed some high school or less was only 12.5%, i.e., the majority 
was well educated. Table 4.1 also presents the characteristics of the study population 
used for the complete case analysis when applying the EQ-5D-5L and ICECAP-A. 
 
Table 4.1. Characteristics of the study population (values are numbers 
(percentages) unless states otherwise) 
 Total (n=160) Complete case     
EQ-5D-5L 
(n=137) a 
Complete case 
ICECAP-O 
(n=135) a 
Mean Age (SD) 74.3 (6.3) 73.8 (6.1) 73.8 (6.1) 
Gender    
Females 102 (63.8) 87 (63.5) 87 (64.4) 
City of residence    
Vancouver 58 (36.3) 50 (36.5) 49 (36.3) 
Surrey 38 (23.8) 31 (22.6) 31 (23.0) 
West Vancouver 14 (8.8) 12 (8.8) 12 (8.9) 
Burnaby 14 (8.8) 10 (7.3) 10 (7.4) 
Richmond 12 (7.5) 11 (8.0) 10 (7.4) 
North Vancouver 10 (6.3) 9 (6.6) 9 (6.7) 
New Westminster 9 (5.6) 9 (6.6) 9 (6.7) 
White Rock 5 (3.1) 5 (3.6) 5 (3.7) 
Born in Canada    
Yes 87 (54.4) 80 (58.4) 79 (58.5) 
Mean (SD) years in Canada 43.9 (15.7) 44.4 (15.9) 44.0 (15.8) 
Ethnicity    
White 125 (78.1) 110 (80.3) 109 (80.7) 
Other 16 (10.0) 13 (9.5) 13 (9.6) 
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SD=standard deviation. 
a Complete case refers to the number of cases with complete data on the outcome 
variables, explanatory variables and covariates.  
 
Chinese 7 (4.4) 6 (4.4) 5 (3.7) 
South Asian 3 (1.9) 2 (1.5) 2 (1.5) 
Black 2 (1.3) 1 (0.7) 1 (0.7) 
Latin American 2 (1.3) 2 (1.5) 2 (1.5) 
Southeast Asian 2 (1.3) 1 (0.7) 1 (0.7) 
Japanese 2 (1.3) 2 (1.5) 2 (1.5) 
Filipino 1 (0.6) 0 (0) 0 (0) 
Marital Status    
Divorced 60 (37.5) 55 (40.1) 55 (40.7) 
Widowed 50 (31.3) 40 (29.2) 39 (28.9) 
Single (never married) 25 (15.6) 21 (15.3) 20 (14.8) 
Married (or common law) 14 (8.8) 11 (8.0) 11 (8.1) 
Separated 11 (6.9) 10 (7.3) 10 (7.4) 
Education Level    
University 55 (34.4) 47 (34.3) 46 (34.1) 
Trade/ College diploma 53 (33.1) 46 (33.6) 46 (34.1) 
High School 32 (20.0) 29 (21.2) 28 (20.7) 
Some High School or less 20 (12.5) 15 (10.9) 15 (11.1) 
Mean (SD) years lived in 
current residence 
9.4 (9.5) 9.6 (9.8) 9.6 (9.9) 
Living Arrangements    
Alone 130 (81.3) 111 (81.0) 110 (81.5) 
With a spouse or partner 16 (10.0) 13 (9.5) 13 (9.6) 
With another family 
member 
10 (6.3) 9 (6.6) 8 (5.9) 
With a friend or 
roommate 
3 (1.9) 3 (2.2) 3 (2.2) 
Other 1 (0.6) 1 (0.7) 1 (0.7) 
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Histograms of the EQ-5D-5L and ICECAP-O index scores, presented in 
Appendices 4.1 and 4.2, demonstrate that both measures show a certain degree of ceiling 
effects; such findings confirmed the appropriateness of the Tobit model. Appendices 4.3 
and 4.4 indicate some strong correlations between environmental features, while no or 
only weak correlations were found between environmental features and the two outcome 
measures. Based on the missing value analysis, one participant was excluded from further 
analyses due to language barriers that resulted in missing data (i.e., this formed a total 
sample size of 160 individuals). The missing data analysis also showed a high degree of 
missing values (17%) for the NEWS-A subscale I (parking) for the total sample. Eighty-
two percent of individuals who did not respond to this question reported that they had no 
vehicle at their disposal in the past seven days. This indicated that the subscale was not 
applicable for this study population and was dropped from further analyses. Missing 
values for the remaining variables ranged from 0-5% (see Appendix 4.3). Each variable 
was imputed using a regression model conditional on all other variables used for the 
analyses. In total, 15 datasets were generated that reflected the percentage of missing 
values considering all variables (16% overall) and combined estimates and variances 
were calculated. Descriptive statistics for selected instruments are reported in Table 4.2. 
Mean (SD) scores for the EQ-5D-5L and the ICECAP-O were 0.794 (0.15) and 0.843 
(0.11), respectively.  
Figure 4.1 and Figure 4.2 show the percentage of responses at each level across 
all dimensions for the EQ-5D-5L and ICECAP-O. None of the participants reported the 
lowest level (extreme problems) on any of the EQ-5D-5L dimensions. Furthermore, with 
the exception of the ‘pain or discomfort’ dimension, the majority of this study population 
reported ‘no problems’ on all EQ-5D-5L dimensions. For the ICECAP-O, Figure 4.2 
indicates that this study population was very independent, with 62% reporting the highest 
level (i.e., greatest capability).  
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Table 4.2. Descriptive statistics for instruments under consideration 
 N Mean SD Median IQR Min Max 
Environmental Instruments        
NEWS-Aa        
Scale A: Residential density 157 331.27 158.35 265 247 173 792 
Scale B: Land use mix-
diversity 
158 2.81 0.87 2.75 1.33 1.18 4.82 
Scale C: Land use mix-
access 
158 3.39 0.76 3.67 1.00 1.00 4.00 
Scale D: Street connectivity 156 3.07 0.77 3.00 1.00 1.00 4.00 
Scale F: Aesthetics 160 3.16 0.72 3.25 1.00 1.25 4.00 
Scale G: Traffic hazards b 155 2.57 0.57 2.67 1.00 1.00 4.00 
Scale H: Crime b 152 1.69 0.69 1.67 1.00 1.00 4.00 
Scale J: Lack of cul-de-sacs 159 2.98 1.02 3.00 2.00 1.00 4.00 
Scale K: Hilliness b 159 2.02 1.05 2.00 2.00 1.00 4.00 
Scale L: Physical barriers b 159 1.42 0.82 1.00 0 1.00 4.00 
SC-5PT 156 3.45 0.70 3.60 1.00 1.80 5.00 
Street Smart Walk Score 160 72.04 24.94 81.00 37.00 0.00 100 
Quality of Life Instruments        
EQ-5D-5L 160 0.79 0.15 0.80 0.17 0.23 1.00 
ICECAP-O 158 0.84 0.11 0.87 0.14 0.48 1.00 
Other Instruments        
Functional comorbidity 
Index 
158 2.90 2.12 3.00 3.00 0 9.00 
Loneliness questionnaire 160 1.56 0.43 1.45 0.73 1.00 3.00 
Gait Speed 160 1.00 0.26 0.98 0.31 0.45 1.91 
Ambulatory questionnaire 160 8.36 1.67 8.91 2.29 3.27 10.00 
SD=standard deviation, IQR= interquartile range, Min=minimum, Max=maximum, NEWS-A= 
Neighbourhood Environment Walkability Scale – Abbreviated, SC-5PT= Sampson’s 5-item measure of 
collective efficacy.  
a NEWS-A Scale E (Infrastructure and Safety) cannot be calculated because of a dropped item; NEWS-A 
Scale I (Parking) removed due to missing values.   
b Reverse coding, where higher score indicate ‘less pedestrian friendly’. 
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Figure 4.1. Percentage of responses at each level across all EQ-5D-5L dimensions 
(n=160) 
 
  
 
Figure 4.2. Percentage of responses at each level across all ICECAP-O 
dimensions (n=158) 
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Table 4.3 (showing the results of the backward stepwise Tobit regression 
analysis) and Table 4.4 (showing the results examining each environmental feature 
separately) indicate that no statistically significant variables were found for older adults’ 
HRQoL using the EQ-5D-5L. However, when measuring QoL using the ICECAP-O, 
better social cohesion (SC-5PT) was associated with higher ICECAP-O index scores. In 
addition, a negative association between NEWS-A subscale D (street connectivity) and 
ICECAP-O was found, i.e., short distances between intersections and many alternative 
routes were associated with lower capability wellbeing. Overall, associations were small; 
an increase in street connectivity by one unit decreased ICECAP-O index scores by 0.028 
(0.024 when built environment features were analyzed separately; Table 4.4). For social 
cohesion, a 0.029 (0.024 when analyzed separately) increase in ICECAP-O index scores 
was found when social cohesion was increased by one unit. 
Results for the complete case analyses are provided in Appendix 4.6 and 4.7. 
Backward stepwise OLS and Tobit regression analysis yielded similar results and showed 
that after controlling for covariates, the EQ-5D-5L was associated with land-use (access), 
aesthetics, and cul-de-sacs, while the ICECAP-O was associated with aesthetics and 
social cohesion. However, BIC, AIC and LR chi2 indicated a better model fit for the 
Tobit model when compared with simple OLS, which supports the use of the Tobit model 
in the main analyses. 
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Table 4.3. Backward stepwise Tobit regression analysis 
 EQ-5D-5L (n=160)  ICECAP-O (n=160) 
 β (SE) 95% CI p  β (SE) 95% CI p 
Constant 0.219 (0.189) (-0.151, 0.590) 0.248  0.829 (0.119) (0.596, 1.062) <0.001 
Covariates       
Sex (ref. Female) -0.040 (0.026) (-0.091, 0.010) 0.119 0.008 (0.016) (-0.023, 0.039) 0.622 
Age 0.005 (0.002) (0.002, 0.010) 0.006 0.000 (0.001) (-0.002, 0.003) 0.680 
Living with someone (ref. Yes) 0.033 (0.031) (-0.027, 0.092) 0.288 0.032 (0.019) (-0.005, 0.068) 0.089 
Functional Comorbidity Index 0.027 (0.006) (-0.038, -0.016) <0.001 <0.001 (0.003) (-0.006, 0.008) 0.792 
Loneliness  -0.057 (0.027) (-0.110, -0.003) 0.039 -0.143 (0.017) (-0.177, -0.108) <0.001 
Gait Speed -0.019 (0.054) (-0.124, 0.086) 0.728 0.037 (0.033) (-0.027, 0.102) 0.253 
Ambulatory self-efficacy 0.048 (0.008) (0.032, 0.064) <0.001 0.016 (0.005) (0.006, 0.026) 0.003 
Perceived built environment (NEWS-A)     
A: Residential density - - - - - - 
B: Land-use mix (diversity) - - - - - - 
C: Land-use (access) - - - - - - 
D: Street connectivity - - - -0.028 (0.010) (-0.047, -0.008) 0.006 
F: Aesthetics - - - - - - 
G: Traffic hazards b - - - - - - 
H: Crime b - - - - - - 
J: Lack of cul-de-sacs - - - - - - 
K: Hilliness b - - - - - - 
L: Physical barriers b - - - - - - 
Social cohesion       
SC-5PT - - - 0.029 (0.011) (0.007, 0.052) 0.011 
Objective built environment       
Street Smart Walk Score - - - - - - 
β=beta coefficient, SE=standard error, CI=confidence interval, p=two-sided p-value, NEWS-A= Neighbourhood Environment Walkability Scale – Abbreviated, 
SC-5PT= Sampson’s 5-item measure of collective efficacy.  
a Backward stepwise elimination was used to remove variables relating to the built and social environments; p > 0.1 was the criterion for removal. Covariates 
were not eligible for removal.  
b Reverse coding, where higher score indicate ‘less pedestrian friendly’. 
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Table 4.4. Tobit regression analysis exploring each environmental feature separately, after adjusting for covariates 
  EQ-5D-5L (n=160)                             ICECAP-O (n=160)  
β (SE) 95% CI p β (SE) 95% CI p 
Perceived built environment (NEWS-A) adjusted for covariates (examined separately)    
A: Residential density  <0.001 (<0.001) (-<0.001, <0.001) 0.464 <0.001 (<0.001) (-<0.001, <0.001) 0.158 
B: Land-use mix (diversity)  0.004 (0.013) (-0.023, 0.032) 0.749 -0.011 (0.009) (-0.028, 0.006) 0.207 
C: Land-use (access)  0.018 (0.015) (-0.011, 0.048) 0.235 -0.014 (0.010) (-0.033, 0.004) 0.123 
D: Street connectivity  -0.002 (0.002) (-0.032, 0.028) 0.886 -0.024 (0.010) (-0.043, -0.004) 0.019 
F: Aesthetics  -0.023 (0.017) (-0.056, 0.010) 0.171 -0.018 (0.011) (-0.039, 0.003) 0.089 
G: Traffic hazards b  -0.022 (0.020) (-0.061, 0.017) 0.276 0.008 (0.012) (-0.017, 0.033) 0.560 
H: Crime b  -0.020 (0.017) (-0.054, 0.013) 0.245 0.011 (0.011) (-0.010, 0.032) 0.299 
J: Lack of cul-de-sacs  -0.016 (0.001) (-0.039, 0.006) 0.158 -0.004 (0.007) (-0.018, 0.010) 0.591 
K: Hilliness b  -0.006 (0.012) (-0.028, 0.017) 0.632 0.010 (0.007) (-0.004, 0.024) 0.157 
L: Physical barriers b  <-0.001 (0.015) (-0.029, 0.028) 0.976 0.010 (0.009) (-0.008, 0.028) 0.261 
Social cohesion adjusted for covariates     
SC-5PT  -0.011 (0.018) (-0.046, 0.023) 0.520 0.024 (0.011) (0.001, 0.047) 0.040 
Objective built environment adjusted for covariates     
Street Smart Walk Score  <0.001 (<0.001) (-0.001, 0.001) 0.853 -<0.001 (<0.001) (-<0.001, <0.001) 0.227 
β=beta coefficient, SE=standard error, CI=confidence interval, p=two-sided p-value, NEWS-A= Neighbourhood Environment Walkability Scale – Abbreviated, 
SC-5PT= Sampson’s 5-item measure of collective efficacy. 
a Covariates included in this model: sex; age; living arrangement; functional comorbidity index; loneliness; gait speed; and ambulatory self-efficacy. 
b Reverse coding, where higher scores indicates ‘less pedestrian friendly’. 
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4.4. Discussion 
This chapter contributes to a limited body of literature that examines the 
association between environmental features and older adults’ QoL. The findings suggest 
that street connectivity and social cohesion were associated with older adults’ capability 
wellbeing. When considering health-related aspects of QoL only, using the EQ-5D-5L, 
the associations between the built environment and social cohesion with older adults’ 
HRQoL were small and not statistically significant. Such findings suggest that the EQ-
5D-5L appears to be too narrow to capture benefits of the environment and could 
potentially underestimate the impact of environmental interventions. The ICECAP-O 
appears to be more influenced by characteristics of the environment, meaning that it is 
more likely to pick up benefits of environmental changes, particularly regarding the 
social environment.  
In the analyses performed in this chapter, only street connectivity emerged as an 
important built environment feature where greater street connectivity, defined as shorter 
distances between intersections and many alternative routes, was associated with lower 
capability wellbeing. Previous literature has shown that better street connectivity 
facilitates walking in the neighbourhood (Frank et al., 2005; Handy et al., 2002; Rosso et 
al., 2011; Saelens et al., 2003) and includes other benefits, such as shorter travel trips, 
increased travel by public transport, and more interactions among neighbourhood 
residents (Turrell, 2010). Therefore, the finding of a negative association between street 
connectivity and ICECAP-O scores was unexpected. These findings can possibly be 
explained within the context of older adults. Although a more walkable neighbourhood 
supports walking, it may be also associated with more traffic (Villanueva et al., 2013). 
This exposure to traffic might be negatively associated with older adults’ QoL simply 
because potential reductions in vision, hearing and/or physical robustness could increase 
the risk of injury (Villanueva et al., 2013). The proposition that lower QoL is attributable 
to higher exposure to traffic was not supported by other results in this work, where the 
‘traffic hazard’ subscale of the NEWS-A (which contains three items concerning the 
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amount and speed of traffic in the neighbourhood) was not significant. Other literature 
links better street connectivity with traffic calming since a large number of intersecting 
streets tends to slow traffic (Turrell, 2010). More important, however, is the perceived 
safety by older adults in relation to street connectivity (Yen et al., 2014). While subscale 
G of the NEWS-A ‘traffic hazard’, does not refer to safety, subscale E, ‘infrastructure 
and safety for walking’, would have provided more insights. Since this subscale could not 
be generated in the dataset, additional associations between QoL and the presence of 
sidewalks and pedestrian signals that help walkers to cross busy streets could not be 
explored in this work.  
Interestingly, although eleven perceived and objective built environment features 
were considered in this chapter, only one association was apparent between the ICECAP-
O and the built environment. Other built environment characteristics did not seem to be 
associated with older adults’ QoL and the role of social cohesion appeared to be stronger. 
Similar results were found in the study by Friedman and colleagues, which examined the 
impact of three neighbourhood-level factors on QoL among older adults attending New 
York senior centers. The authors found that social cohesion was a significant correlate of 
QoL (as was safety), while walkability was not (Friedman et al., 2012). The qualitative 
component of the WTT study previously published also provided evidence that social 
needs can often shape individuals’ behaviour regardless of whether they live in a highly 
walkable neighbourhood with amenities in close proximity (Franke et al., 2013). For 
example, in the qualitative WTT study a participant reported that he prefers to use small 
alleyways rather than main streets because of the greater likelihood of meeting others 
(Franke et al., 2013). Further to this, others have shown that, for older adults, features of 
the built environment might be secondary to attributes of the social environment in 
promoting physical activity (King, 2008). Although the study by King was concerned 
with physical activity and not QoL, such findings may explain why an association was 
found for one built environment feature only. On the contrary, while the social 
environment, such as social cohesion, is particularly important within the context of older 
adults, it is important to understand that the social environment often involves 
interactions that take place within the built environment. It is within the neighbourhood 
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space where older adults have opportunities to interact with others, access opportunities 
for socialization, and perform their activities of daily living. The built environment can, 
therefore, be seen as a facilitator or barrier for the social environment.  
4.4.1. Implications for the public health agenda 
The potential of the ICECAP-O to be used in public health interventions can be 
supported by findings of this work. As the results suggest, individuals who live in a less-
favourable environment are more likely to experience a negative impact on their 
capability wellbeing. Such observations open new opportunities for future policy 
interventions to reconsider the approaches for the evaluation of public health care 
interventions, i.e., potentially moving away from functionings towards capabilities. It was 
previously recognized in the literature that healthy aging should not only focus on 
individual achievement but also consider broader circumstances (Stephens et al., 2015). 
Stephens and colleagues further highlighted that many public health intervention models 
focus too much on the delay of illness, disease, disability and mortality. They suggest that 
rather than placing responsibility on individuals for engaging in exercise, diet, and social 
engagement prescriptions to produce good health, successful aging should focus on what 
people can achieve, with support, despite the limitations of physical health changes. As 
the authors were able to demonstrate in their qualitative study, older people were not 
simply excluded from achieving valued functionings because of physical limitations but 
by having to make choices or simply by a lack of money or appropriate transport 
(Stephens et al., 2015).  
Environmental factors play a particularly important role in the capability 
approach, as can be illustrated using the example of a mobility-impaired person in a 
wheelchair. In order to convert ‘commodity characteristics’ into capability (e.g., from the 
mobility and transportation properties of the wheelchair into the ability to move around, 
or the ability to transport oneself), one needs to consider personal factors (e.g., severity of 
an individual’s impairment affecting his/her manoeuvre the wheelchair) as well as 
environmental factors (e.g., type of terrain or street conditions to facilitate or prevent 
wheelchair movement such as flat, paved roads or dirt roads with bumps) (Welch 
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Saleeby, 2006). In this context, the consideration of the individual’s environment is 
important since it provides a more realistic assessment of what an individual can really do 
or his/her real potential to achieve certain functionings within the context of his/her real-
life settings factoring in environmental barriers and/or facilitators. In the capability 
literature, there are three groups of ‘conversion factors’ that refer to the factors that 
determine how resources are converted to functionings. While disability is a personal 
conversion factor in the sense that it is harder for a disabled person to convert the 
characteristics of the commodity into a functioning, social factors (e.g., social norms), 
and environmental conversion factors (e.g., the built environment) need also to be 
considered (Robeyns, 2005). For example, even if a mobility-impaired person has the 
same income (i.e., personal conversion factor) as an able-bodied person, she/he will not 
be able to travel on public transport if there are no ramps on the buses (i.e., 
environmental conversion factor) (Trani et al., 2011). While the application of the 
capability approach to health is still at an early stage (Kinghorn, 2015; Mitchell et al., 
2017a), it is gaining more attention, especially within the context of public health 
(Lorgelly et al., 2015), and has the potential to play an important role in future studies.   
4.4.2. Strengths, limitations and directions for further research  
A major strength of the current work relates to the opportunity to explore social 
cohesion and built environment factors together when assessing the association with 
older adults’ QoL. The application of a broad concept of QoL (i.e., HRQoL and 
capability wellbeing) provided a better understanding of the associations with the built 
environment and social cohesion. Another strength of this work can be seen in the 
reduced likelihood of the occurrence of self-selection, a concept which can be understood 
as the tendency of people to choose locations based on their travel activities, needs and 
preferences (Mokhtarian & Cao, 2008). There is evidence that individuals whose QoL is 
higher are likely to be more active and, therefore, these individuals may have chosen to 
live in a more activity-friendly neighbourhood (Sugiyama & Ward Thompson, 2007). 
Consequently, all features of the neighbourhood that are potentially related to health and 
wellbeing may be determined by the characteristics of individuals who reside there. In 
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this work, self-selection was less of an issue because of individuals’ enrolment in the 
SAFER rental subsidy program. Compared with other individuals, this study population 
may have fewer opportunities to move to a different residence that better suits their 
current needs and preferences as a result of their low income. This also implies that the 
generalizability of the findings to older adults of higher socioeconomic status should to 
be made with care. Older adults on low income may rely more on their local 
neighbourhood and amenities that are reachable by walking, as owning a car or taking 
public transportation may be unaffordable for them.  
Another note on the generalizability of this work is that the characteristics of the 
study population are different compared with other older adults of low income. Typically, 
individuals of low income attain lower levels of education (i.e., both are characteristics of 
a low socioeconomic position (McNeill et al., 2006a)); the majority (87.5%) of 
participants in this work obtained a high school diploma or higher degrees. Previous 
literature has highlighted that older adults living on a low income may be at increased 
risk of morbidity and poor physical function (Nilsson et al., 2010). The number of self-
reported comorbidities in this population is similar to Canadian population norms of older 
adults (Wister et al., 2015). With respect to the QoL, the index scores and distribution of 
responses across the dimensions of the EQ-5D-5L and ICECAP-O are similar to 
population norms available for older adults aged 65 and older in Canada, UK, and 
Australia (Couzner et al., 2013a; Flynn et al., 2011; Health Quality Council of Alberta, 
2014). Collectively, results suggest that the study population is different compared with 
other older adults of low income but similar to older adults in general. Since no 
information is available in the dataset about a person’s socioeconomic history, low 
income could represent either a recent or a lifelong circumstance. Additionally, the low 
response rate of the WTT study is another consideration for the generalizability of this 
work.      
The primary limitations of this work are the small sample size, which may have 
resulted in the failure to detect associations, and the cross-sectional design, from which 
the establishment of causal links cannot be made. The lack of a priori information about 
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which features of the environment may affect QoL, especially for the NEWS-A 
subscales, is a further limitation. The advantage of using a backward elimination 
procedure is to reduce the number of variables in the final model to yield a parsimonious 
model. However, such automated selection procedures are problematic as they may lead 
to bias in parameter estimates, inconsistencies among model selection algorithms, the 
inappropriate focus or reliance on a single best model, and an inherent problem of 
multiple hypothesis testing (Whittingham et al., 2006). Multiple hypothesis testing could 
lead to a Type 1 error, where certain associations may be found when in reality such 
associations do not exist. In particular, results from the complete case analysis need to be 
interpreted with caution because significant predictors may have resulted by chance 
alone. However, the application of different models in this work has provided more 
confidence in the results. Particularly, the comparison between the Tobit model and a 
simple OLS in this Chapter, where similar results were obtained when running a 
backward stepwise regression, provided further confidence in the results. 
Another limitation of the analyses is that neighbourhood was not taken into 
account. Individuals living in the same neighbourhood could have correlated 
observations, thus reducing the effective sample size (Maas & Hox, 2005). Multilevel 
models that account for the fact that individuals are nested within neighbourhoods are 
needed in future research. It should also be acknowledged that there is a potential risk 
that some variables that were considered as confounders in the analyses have, in fact, 
mediated the relation between the built environment and social cohesion and QoL. For 
example, a previous study provided evidence that self-efficacy mediated the relation 
between social and physical environments and physical activity (McNeill et al., 2006b). 
More longitudinal studies are necessary to understand the dynamic changes in QoL 
among older adults living across diverse built and social environments. Particular focus is 
required to explore how built and social environments impact a person’s functionings and 
capabilities. Given that this work looked at associations only, the ability of the EQ-5D-5L 
and the ICECAP-O to capture the benefits of environmental interventions in a 
longitudinal setting remains unknown. Generally, evidence on the responsiveness (i.e., 
the ability of an instrument to measure change) of these measures in an older adult 
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population remains scare. Recent evidence has indicated that the EQ-5D-3L is more 
responsive than the ICECAP-O in individuals at risk of mobility impairment (Davis et 
al., 2016). On a final note, future studies should also explore these relationships in 
samples of low HRQoL and capability levels. Given the distribution of the ICECAP-O 
and the EQ-5D-5L in this work, none of the participants reported the lowest level 
(‘extreme problems’) on the EQ-5D-5L and only a few reported ‘no capability’ on the 
ICECAP-O, which could have influenced the findings. 
4.5. Conclusion 
In conclusion, this chapter has found that street connectivity and social cohesion 
might be important for older adults’ capability wellbeing. The association between 
capability wellbeing and other NEWS-A subscales, as well as HRQoL and environmental 
factors could not be confirmed and need to be examined further. The findings should be 
interpreted with caution and be considered as hypothesis-generating. Larger studies are 
required to explain the effect of the various features of the built and social environments 
on older adult’s QoL.  
This chapter has also shown that there are differences between the EQ-5D-5L and 
the ICECAP-O in the ability to identity environmental benefits. At this stage, it remains 
unknown why differences were found between these two measures. Further analyses of 
the complementarity of the EQ-5D-5L and the ICECAP-O are warranted to explore 
similarities and differences between these measures. Given the availability of numerous 
preference-based HRQoL measures, such analyses should be extended beyond the EQ-
5D-5L to fully explore the additional information provided by the ICECAP measures. 
This type of analysis will be the focus of the next chapter.   
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Chapter 5. Overlap between the ICECAP-A and five 
preference-based health-related quality of life measures – 
explanatory factor analyses 
5.1. Introduction 
Chapter 3 identified capability wellbeing as one form of wellbeing that is 
currently not captured by the QALY framework, while the previous chapter has shown 
that the use of the capabilities approach has the potential to provide additional 
information to health care decision-making. Generally, there is a growing interest in 
Sen’s capability approach within health economics, and for outcome measurement in 
economic evaluation in particular (Lorgelly, 2015). With the development of new 
capability measures, including the ICECAP family (i.e., ICECAP-A, ICECAP-O etc.) 
changes in guidelines for HTA have recognized the potential importance of broader 
benefits in economic evaluation and have made provision for the measurement of 
capability wellbeing. For example, NICE in the UK has recommended the use of 
capability measures in social care economic evaluations for interventions that are 
associated with non-health benefits (NICE, 2014). Yet, little guidance has been provided 
in terms of what constitutes a health benefit or a non-health benefit, and which decision 
rules should be applied if using ICECAP instruments alongside other preference-based 
HRQoL instruments. Dutch guidelines also advocate for the use of ICECAP instruments 
in long-term care, where the focus of interventions might be more on improving a 
person’s wellbeing rather than their health (Zorginstituut Nederland, 2016). Since 
ICECAP instruments do not have ‘QALY properties’ (i.e., current values are not 
anchored onto the ‘full health’ to ‘dead’ scale but on a ‘full capability’ to ‘no capability’ 
scale (Flynn et al., 2015)), the reference cases described in the UK and Dutch guidelines 
recommend supplementing CUA (using the EQ-5D (-3L or -5L) (Brooks, 1996; Herdman 
et al., 2011)) with cost-consequences analysis or cost-effectiveness analysis using an 
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ICECAP instrument. The underlying intention is to capture explicitly broader aspects of 
capability wellbeing alongside health benefits. 
In practice, decision makers may find it difficult to interpret and reconcile 
findings from such primary and supplementary analyses without further information 
describing the extent of overlap between measures of HRQoL and capability wellbeing or 
any additional non-HRQoL measure. The extent of overlap between the ICECAP 
instruments and the EQ-5D-3L has been examined in two previous studies. Davis and 
colleagues performed an exploratory factor analysis (EFA) comparing the ICECAP-O 
with the EQ-5D-3L in seniors enrolled in a falls prevention clinic (Davis et al., 2013), 
showing that the two instruments tapped into distinct and complementary factors. These 
results were confirmed by a second EFA, which compared the ICECAP-A with the EQ-
5D-3L in an adult population of patients with knee pain (Keeley et al., 2016). 
Further research is needed to explore whether similar relationships hold in other 
clinical and non-clinical settings, as well as for other preference-based HRQoL 
instruments. It is well established that preference-based HRQoL instruments differ 
greatly in their coverage of physical, mental and social health domains (Karimi & 
Brazier, 2016; Richardson et al., 2015b; Richardson et al., 2014a; Whitehurst et al., 
2014a). These issues raise the potential for different degrees of overlap between 
preference-based HRQoL instruments (i.e., preference-based instruments that define 
health states) and the potential for different degrees of overlap when comparing HRQoL 
measures with measures of capability wellbeing. Such investigations are particularly 
important in order to avoid double counting when using HRQoL and capability wellbeing 
instruments simultaneously in health economic evaluation. In this context, double 
counting – where the same underlying concept of benefit is measured twice – could occur 
explicitly (i.e., summing health and non-health benefits into a single metric) or implicitly 
(e.g., misguided interpretation of outcomes data from a cost-consequences analysis). The 
objectives of this chapter are to investigate the extent to which five preference-based 
HRQoL instruments capture aspects of capability wellbeing, as measured by the 
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ICECAP-A, and to consider the implications of the findings within the context of other 
literature regarding capability wellbeing and economic evaluation. 
5.2. Methods 
5.2.1. Data Source 
Data were obtained from the Multi Instrument Comparison (MIC) project, a 
multinational survey funded by Australia’s National Health and Medical Research 
Council. Comprehensive details regarding the background, rationale and administration 
of the MIC survey have been reported elsewhere (Richardson et al., 2012). Briefly, the 
aim of the MIC project was to compare several QoL and wellbeing instruments across 
seven disease areas (in addition to a ‘disease free’ population defined as reporting 70 on a 
0-100 VAS) in six countries: Australia, Canada, Germany, Norway, UK, and USA. The 
MIC survey was administered online between February 2012 and May 2012 by a global 
survey company, CINT Pty Ltd, which sent the link to the survey to people on their 
database until predetermined quotas of patients and demographically representative 
public respondents were achieved. Data collection was approved by the Monash 
University Human Research Ethics Committee (CF11/3192-2011001748). 
5.2.2. Instruments 
The MIC survey contained a comprehensive set of questions and standardized 
instruments (Richardson et al., 2012). In addition to questions about demographics, self-
reported illnesses and subjective wellbeing, all participants were asked to complete the 
ICECAP-A (with the exception of participants in Norway) and seven preference-based 
HRQoL instruments: 15D (Sintonen, 2001), Assessment of Quality of Life 4-dimension 
(AQoL-4D) (Hawthorne et al., 1999), Assessment of Quality of Life 8-dimension 
(AQoL-8D) (Richardson et al., 2009), EQ-5D-5L (Herdman et al., 2011), Health Utilities 
Index Mark 3 (HUI-3) (Feeny et al., 2002), Quality of Well-Being Scale Self-
Administered (QWB-SA) (Seiber et al., 2008), and SF-6D (Brazier et al., 2002) (based 
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on the 36-item Short Form health survey version 2 (SF-36v2) (Ware et al., 2008)). 
Instruments were administered in a randomized order to account for order-effect bias 
(Perreault, 1976). 
For the analyses reported in this chapter, a decision was made to focus on the 35-
item AQoL-8D (rather than the 12-item AQoL-4D) because of the more comprehensive 
descriptive system and the greater potential for overlap with the ICECAP-A. The QWB-
SA was also excluded because the measurement scale used for many items provides 
nominal data. These data would require transformation in order to meet the requirements 
for the statistical analysis performed, and such transformations effectively render the 
analysis meaningless because the descriptive system has been modified. An overview of 
the dimensions and items contained within the preference-based HRQoL instruments 
included in this analysis (15D, AQoL-8D, EQ-5D-5L, HUI-3, and SF-6D) is provided in 
Appendix 5.1, with more comprehensive details available elsewhere (Richardson et al., 
2014a). The ICECAP-A comprises five dimensions (lay descriptions used by the 
instrument developers are included in brackets): stability (an ability to feel settled and 
secure), attachment (an ability to have love, friendship and support), autonomy (an ability 
to be independent), achievement (an ability to achieve and progress in life), and 
enjoyment (an ability to experience enjoyment and pleasure). Each dimension comprises 
one question with four levels of response, ranging from full capability to no capability 
(Al-Janabi et al., 2012). 
5.2.3. Statistical analysis 
Exploratory factor analyses (EFA) were conducted in Mplus 7.4 (Muthén & 
Muthén, 1998-2015). The purpose of EFA is to explore the underlying structure for a set 
of measures and to ascertain the number of distinct constructs that account for the pattern 
among the measures. These constructs are called factors or common factors, reflecting 
the fact that they are common to more than one measured variable (Fabrigar & Wegener, 
2012). Since these constructs are unobserved, they represent latent variables. The 
observed scores in the dataset are called measured variables and refer to a set of variables 
that can be directly measured. Figure 5.1 is a graphical illustration of a hypothetical 
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common factor model, consisting of six measured variables (MV) (squares) that are 
influenced by a single unique factor (U). Latent variables (common factors and unique 
factors) are presented as circles. The model shows the existence of two common factors, 
with the first common factor strongly influenced by the first three measured variables and 
the second by the last three measured variables. The strength and direction of association 
between each item and each of the common factors is reflected by factor loadings. Higher 
factor loadings indicate that more of the variance in the observed variables is attributable 
to the latent variable (i.e., the common factor) (Fabrigar & Wegener, 2012). Single-
headed arrows depict the causal effects and indicate the direction of the influence. 
Double-headed arrows represent a non-directional association (correlation). A non-
directional association of a variable with itself represents the variance in the variable, 
which is usually assumed to be 1.0 with a mean of zero. 
    
Figure 5.1. Graphical illustration of a hypothetical common factor model 
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Figure 5.1 also shows that each measured variable is influenced by a single 
unique factor, with the value of 1 indicating that an increase of one unit in the unique 
factor corresponds to an increase of one unit in the measured variable. These unique 
factors represent that portion of the score on a measured variable that is not explained by 
the common factor. Therefore, the variance of each measured variable can be 
decomposed into a common variance (communality) and unique variance (uniqueness). In 
this figure, the unique factors are independent of each another (i.e., no paths among the 
unique factors). It is also assumed that the two common factors are related (i.e., oblique 
design), which is illustrated by the double-headed arrow between the common factors. 
Orthogonal designs, on the other hand, would assume independency between common 
factors. Compared with a confirmatory factor analysis (CFA), where explicit assumptions 
are made regarding the number of factors based on priori theory, an EFA does not have 
expectations about the underlying structure. Therefore, while CFA is considered as an 
approach to test a proposed theory, a EFA is used to generate a theory (Williams et al., 
2010).  
Applied to this work, EFA was used to explore the underlying structure for a set 
of measures and to determine whether or not the ICECAP-A instrument measures 
something unique, i.e., a construct or constructs not captured by current preference-based 
HRQoL instruments. In all pairwise comparisons (i.e., item-level responses for the 
ICECAP-A compared with item-level responses for each of the other instruments, namely 
15D, AQoL-8D, EQ-5D-5L, HUI-3, and SF-6D), the numbers of unique underlying 
latent factors were ascertained that were associated with the items covered by the 
respective preference-based HRQoL instrument and the ICECAP-A. The axes of the 
initial factor analysis were rotated using the geomin oblique rotation. As explained above, 
oblique rotation permits correlations between common factors, which is to be expected 
when all items measure aspects of a person’s quality of life. Pearson correlation 
coefficients were used to examine the extent of the relationship between factors (factors 
are considered as continuous variables); correlations were interpreted as weak (0.10 to 
0.30), moderate (0.30 to 0.50), or strong (greater than 0.50) (Cohen, 1988). Weighted 
 107 
least square means and variance adjusted (WLSMV) model estimation was applied to 
account for the ordinal nature of the item-level data. 
The factor model and the number of common factors for each pairwise analysis 
were selected using the following procedure. The first step comprised an examination of 
eigenvalues. Eigenvalues are numerical values that correspond to the variance in the 
items accounted for by each of the common factors (Fabrigar & Wegener, 2012). More 
specifically, an eigenvalue is the sum of the squared factor loadings for a given factor. 
Model selection based on eigenvalues typically entails comparison of eigenvalues against 
the Kaiser criterion, where the number of factors with eigenvalues greater than one gives 
the number of common factors to be specified in the model (Fabrigar & Wegener, 2012). 
Evaluation against the Kaiser criterion was supplemented with inspection of scree plots, 
which are graphical representations of the eigenvalues plotted in a descending order. 
Model selection based on scree plots typically involves identification of the last 
substantial drop in the magnitude of the eigenvalues and retention of common factors 
prior to this drop (Fabrigar et al., 1999). 
Scree plots also guided the identification of increases (decreases) in the number of 
factors suggested by the Kaiser criterion that return large gains (small losses) in the 
variance explained. Three model fit indices were used to further quantify such gains 
(losses). The root mean square error of approximation (RMSEA) estimates goodness of 
fit as the discrepancy between the model and the data per degree of freedom for the 
model (Fabrigar et al., 1999); RMSEA values were interpreted as indicating a good (less 
than 0.05), acceptable (0.05 to 0.08), marginal (0.081 to 0.1), or poor (greater than 0.1) fit 
(Fabrigar & Wegener, 2012). The Tucker-Lewis Index (TLI) and Comparative Fit Index 
(CFI) were also used. These goodness of fit estimates indicate how much better a model 
fits the data compared with a baseline model that assumes no relationship exists between 
any of the variables (Geiser, 2013). For both the TLI and CFI, values greater than 0.9 
indicate a ‘good’ model fit (Hu & Bentler, 1999). 
Using more than one criterion to guide the selection of the number of factors 
raises the possibility of seemingly conflicting results (e.g., a situation where the Kaiser 
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criterion suggests a two-factor model, whereas model fit statistics suggest a three-factor 
model). Within EFA, it is important to recognize that the objective is not to arrive at the 
‘true’ or ‘correct’ number of factors but to estimate the patterns of correlations among 
observed variables and to simplify the data so that these patterns of correlations can be 
more easily interpreted (Fabrigar & Wegener, 2012). Where selection based on the Kaiser 
criterion, scree plot and model fit did not yield a ‘clean’ factor structure, models with an 
increased number of factors were explored to see whether this improved the interpretation 
of the model (i.e., the interpretability of each set of items in the respective factors). A 
clean factor structure is given when item loadings are all greater than 0.3 on at least one 
factor, and there are no or few cross-factor loadings (i.e., items that load greater than 0.3 
on more than one factor) (Costello & Osborne, 2005). Where expansion of the number of 
factors failed to remove cross-loadings, the parsimonious model with fewer factors 
suggested by the Kaiser criterion, scree plot, and model fit statistics was selected as the 
preferred model. 
Once a preferred factor model was identified for each pairwise comparison, using 
the procedure described above, overlap between the ICECAP-A and the respective 
HRQoL instrument was examined using the following criteria: (i) the number of common 
factors shared by both instruments, and (ii) the extent to which items from each 
instrument correlate with each shared common factor based on factor loadings. While the 
former refers to items of the ICECAP-A and the respective HRQoL instrument that 
contribute to the same underlying latent factor, the latter describes the strength of this 
contribution. The correlation among common factors was also examined to explore the 
extent to which the instruments in each pairwise comparison measure separate but 
correlated factors. The robustness of results was examined by comparing the overlap in 
the preferred factor model against the overlap in alternative factor models for each 
pairwise comparison. In addition, supplementary analyses were carried out within each of 
the seven disease groups, as a previous study has reported that major diseases are 
associated with relatively different impacts on health and capability (Mitchell et al., 
2015a). 
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5.3. Results 
Data from 6,756 individuals were used in the analyses. Edit procedures were 
performed by the principal investigators of the MIC study, based upon a comparison of 
duplicated or similar questions, as well as completion time and can be found elsewhere 
(Richardson et al., 2012). Such editing procedures resulted in the removal of 17% of the 
total sample. Given that the online program did not permit respondents to proceed until 
questions were completed, there were no missing data and only 14 individuals did not 
complete the final question (Richardson et al., 2015a). Table 5.1 provides the 
characteristics of the study population for the combined sample and by country. Quota 
sampling was used in the MIC study and, therefore, the distributions of age, gender and 
education level were similar across the countries. The presence of a chronic disease was 
self-reported by the majority (78%) of the study population.  
5.3.1. ‘Preferred’ factor models 
Scree plots and the Kaiser criterion suggested a two-factor model for the EQ-5D-
5L; a three-factor model for the 15D, HUI-3 and SF-6D; and a five-factor model for the 
AQoL-8D (see Appendices 5.2 – 5.11). In an attempt to improve model fit and 
interpretability, expansion of the number of factors was explored for all models. For the 
EQ-5D-5L and 15D this resulted in an improvement in the model fit and factor structure 
with fewer cross-factor loadings, supporting the superiority of a three- and four-factor 
model, respectively. For the HUI-3, moving to a four-factor model improved model fit 
but resulted in a poorer factor structure and the three-factor model was retained as the 
preferred model. With regard to the SF-6D, a four-factor model was preferred because of 
a better model fit and a cleaner factor structure. A six-factor model was explored for the 
AQoL-8D but this did not improve interpretability of the factor structure and the five-
factor model was retained. Results for each pairwise EFA are provided in Tables 5.2 – 
5.6.
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Table 5.1.  Characteristics of the study population (values are numbers (percentages) unless stated otherwise) a 
 Australia 
(N=1,341) 
Canada 
(N=1,330) 
Germany 
(N=1,269) 
UK 
(N=1,356) USA (N=1,460) 
Total 
(N=6,756) 
Age (mean (SD)) 53.9 (14.9) 48.7 (15.4) 49.2 (13.7) 51.6 (16.2) 52.0 (14.9) 51.1 (15.2) 
Gender 
(Female) 686 (48.8) 826 (62.1) 591 (46.6) 670 (49.4) 900 (61.6) 3,707 (54.2) 
Education b       
High school 472 (35.2) 388 (29.2) 249 (19.6) 517 (38.1) 527 (36.1) 2,193 (32.0) 
Diploma or 
certificate or 
trade 
469 (35.0) 633 (47.6) 698 (55.0) 409 (30.2) 428 (29.3) 2,670 (39.0) 
University 400 (29.8) 309 (23.2) 322 (25.2) 430 (31.7) 505 (34.6) 1,982 (29.0) 
Self-reported health condition     
Disease-free 265 (19.8) 328 (24.7) 260 (20.5) 298 (22.0) 321 (22.0) 1,472 (21.5) 
Asthma  141 (10.5) 138 (10.4) 147 (11.6) 150 (11.1) 150 (10.3) 726 (10.6) 
Cancer 154 (11.5) 138 (10.4) 115 (9.1) 137 (10.1) 148 (10.1) 692 (10.1) 
Depression 146 (10.9) 145 (10.9) 160 (12.6) 158 (11.7) 168 (11.5) 777 (11.4) 
Diabetes 168 (12.5) 144 (10.8) 140 (11.0) 161 (11.9) 168 (11.5) 781 (11.4) 
Hearing 
problems 
155 (11.6) 144 (10.8) 136 (10.7) 126 (9.3) 156 (10.7) 717 (10.5) 
Arthritis 163 (12.2) 139 (10.5) 159 (12.5) 159 (11.7) 179 (12.3) 799 (11.7) 
Heart 149 (11.1) 154 (11.6) 152 (12.0) 167 (12.3) 170 (11.6) 792 (11.6) 
a Data from Norway is not used in this analysis because the ICECAP-A was not administered. SD=standard deviation. 
b Categories refer to the ‘highest level’ of education. 
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5.3.2. Overlap with the ICECAP-A 
Results suggest some degree of overlap between the ICECAP-A and the HRQoL 
instruments, although the extent of overlap varied across instruments. For the 15D EFA, 
two common factors were shared (Factors 2 and 4) (see Table 5.2). In each case, 
ICECAP-A dimensions did not load strongly onto the respective shared factor (autonomy 
(0.337) on Factor 2 and stability (0.307) on Factor 4) and the shared factor mostly 
explained variance in the 15D items. All five ICECAP-A dimensions loaded strongly 
onto Factor 1 – a factor that was not shared by any 15D items. However, Factor 1 was 
strongly correlated (r = 0.714) with Factor 4, which included the 15D items depression 
(0.841), distress (0.870), vitality (0.491), mental function (0.309), and sleeping (0.439). 
 
Table 5.2. EFA comparing the ICECAP-A with the 15D (4-factor model) a 
 Rotated item loadings 
 Factor 1 Factor 2 Factor 3 Factor 4 
ICECAP-A     
Stability 0.601 0.029 -0.021 0.307 
Attachment 0.742 -0.165 0.061 0.090 
Autonomy 0.497 0.337 0.064 -0.078 
Achievement 0.762 0.224 -0.034 0.006 
Enjoyment 0.802 0.019 0.010 0.109 
15D     
Mobility 0.060 0.902 0.039 -0.167 
Vision 0.042 0.147 0.468 -0.006 
Hearing -0.028 0.012 0.654 -0.121 
Breathing -0.030 0.563 0.064 0.145 
Sleeping -0.010 0.374 0.010 0.438 
Eating -0.003 0.280 0.648 -0.024 
Speech 0.024 -0.091 0.815 0.094 
Elimination -0.112 0.371 0.277 0.172 
Usual activities 0.152 0.812 -0.001 0.029 
Mental function 0.085 0.085 0.474 0.309 
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Discomfort and symptoms -0.088 0.763 -0.034 0.197 
Depression 0.126 0.014 0.009 0.841 
Distress 0.028 -0.016 0.056 0.870 
Vitality 0.086 0.472 -0.002 0.491 
Sexual activity 0.096 0.467 0.057 0.240 
  Correlations among factors 
             Factor 1 1.000    
             Factor 2 0.463* 1.000   
             Factor 3 0.422* 0.562* 1.000  
             Factor 4 0.714* 0.428* 0.396* 1.000 
RMSEA 0.042 [90% CI: 0.040 to 0.044] 
CFI 0.991 
TLI 0.985 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative Fit Index, 
TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is underlined.  
* Significant at 5% level. 
 
The degree of overlap was much larger when comparing the ICECAP-A with the 
AQoL-8D. Three common factors (Factors 1-3) were shared by ICECAP-A and AQoL-
8D items (see Table 5.3). Four ICECAP-A dimensions (stability (0.782), autonomy 
(0.345), achievement (0.634), and enjoyment (0.553)) and eighteen AQoL-8D items 
loaded onto Factor 1. Factor 2 was shared by ICECAP-A autonomy (0.415) and fourteen 
AQoL-8D items. Factor 3 included ICECAP-A attachment (0.682) as well as enjoyment 
(0.338) and six items of the AQoL-8D (social exclusion (0.307), close relationships 
(0.782), enjoying close relationships (0.842), pleasure (0.365), social isolation (0.338), 
and intimacy (0.581)). Strong correlations were observed between Factors 1 and 3 (r = 
0.643), and Factors 1 and 4 (r = 0.641). Despite the strong correlation with Factor 1, 
Factor 4 was not a shared factor. Factor 4 comprised AQoL-8D items only, with the 
largest factor loadings being social exclusion (0.679) and social isolation (0.653). 
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Table 5.3. EFA comparing the ICECAP-A with the AQoL-8D (5-factor model) a 
 Rotated item loadings 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 
ICECAP-A      
Stability 0.782 0.033 0.084 -0.045 -0.156 
Attachment 0.161 -0.045 0.682 0.107 -0.070 
Autonomy 0.345 0.415 -0.098 0.080 -0.231 
Achievement 0.634 0.245 0.081 -0.080 -0.264 
Enjoyment 0.553 0.117 0.338 -0.044 -0.140 
AQoL-8D      
Energy level 0.544 0.390 0.020 -0.049 0.034 
Social exclusion 0.060 0.043 0.307 0.679 -0.004 
Getting around 0.073 0.781 0.033 0.107 -0.037 
Community role -0.035 0.701 0.046 0.348 0.005 
Sadness 0.742 -0.041 0.012 0.234 0.176 
Frequency of pain 0.017 0.883 -0.001 -0.020 0.523 
Confidence 0.721 -0.054 0.021 0.132 -0.132 
Calm 0.765 0.010 -0.044 0.026 0.130 
Family role 0.042 0.587 0.110 0.346 0.013 
Close relationships -0.002 0.002 0.782 0.228 0.054 
Communication 0.002 0.201 0.218 0.301 -0.097 
Sleep 0.392 0.348 0.007 0.015 0.196 
Feeling worthless 0.653 -0.003 0.055 0.275 0.024 
Anger 0.600 -0.074 0.038 0.072 0.185 
Mobility -0.079 0.937 -0.005 -0.005 0.004 
Self-harm 0.488 -0.004 0.071 0.268 0.039 
Enthusiasm 0.700 0.068 0.177 -0.056 -0.055 
Worry 0.824 -0.036 -0.133 0.127 0.102 
Self-care 0.018 0.796 0.018 0.124 -0.062 
Happiness 0.735 -0.027 0.287 -0.032 0.039 
Coping 0.775 0.072 -0.019 0.070 -0.121 
Degree of pain -0.009 0.920 -0.001 -0.065 0.555 
Enjoy close relationships 0.018 -0.053 0.842 0.101 0.021 
Pain interference 0.026 0.894 0.008 0.020 0.395 
Pleasure 0.550 0.034 0.365 -0.035 0.011 
 114 
Feeling burden 0.367 0.333 -0.085 0.339 -0.075 
Contentment 0.723 0.043 0.235 -0.021 -0.045 
Vision 0.004 0.389 0.170 -0.046 0.013 
Control 0.809 0.013 0.019 0.045 -0.144 
Household tasks 0.026 0.868 -0.068 0.056 -0.036 
Social isolation 0.092 0.045 0.338 0.653 -0.031 
Hearing -0.133 0.359 0.210 0.014 -0.006 
Depression 0.781 -0.019 0.011 0.189 0.174 
Intimacy 0.199 0.085 0.581 0.034 0.043 
Despair 0.733 0.019 -0.035 0.214 0.124 
  Correlations among factors 
        Factor 1 1.000     
        Factor 2 0.494* 1.000    
        Factor 3 0.643* 0.354* 1.000   
        Factor 4 0.641* 0.301* 0.336* 1.000  
        Factor 5 0.000 -0.222* -0.081* -0.048* 1.000 
RMSEA 0.061 [90% CI: 0.061 to 0.062] 
CFI 0.974 
TLI 0.965 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative Fit Index, 
TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is underlined.  
* Significant at 5% level. 
 
The EQ-5D-5L shared two common factors with the ICECAP-A (Factors 1 and 3) 
(see Table 5.4). Four ICECAP-A dimensions (stability (0.803), attachment (0.798), 
achievement (0.658) and enjoyment (0.826)) and EQ-5D-5L anxiety/depression (0.703) 
loaded onto Factor 1. Factor 3 was primarily represented by the ICECAP-A autonomy 
(0.657) and achievement (0.426), as well as EQ-5D-5L self-care (0.301). A moderate 
correlation was found between Factor 1 and Factor 3 (r = 0.323), whereas a strong 
correlation (r = 0.685) was observed between Factor 3 and Factor 2, despite Factor 2 
comprising EQ-5D-5L items only. 
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Table 5.4. EFA comparing the ICECAP-A with the EQ-5D-5L (3-factor model) a 
 Rotated item loadings 
 Factor 1 Factor 2 Factor 3 
ICECAP-A    
Stability 0.803 0.001 0.147 
Attachment 0.798 -0.054 -0.003 
Autonomy 0.279 0.020 0.657 
Achievement 0.658 -0.015 0.426 
Enjoyment 0.826 0.028 0.132 
EQ-5D-5L    
Mobility -0.137 0.981 0.003 
Self-care -0.008 0.649 0.301 
Usual activities 0.041 0.824 0.112 
Pain/Discomfort 0.002 0.981 -0.234 
Anxiety/Depression 0.703 0.169 -0.020 
  Correlation among factors 
     Factor 1 1.000   
     Factor 2 0.461* 1.000  
     Factor 3 0.323* 0.685* 1.000 
RMSEA 0.074 [90% CI: 0.069 to 0.078] 
CFI 0.993 
TLI 0.983 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative Fit Index, 
TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is underlined.  
* Significant at 5% level. 
 
The HUI-3 (Table 5.5) and SF-6D (Table 5.6) also shared two common factors 
with the ICECAP-A in the respective pairwise comparisons. All five ICECAP-A 
dimensions loaded onto the same factor as a single SF-6D item (energy (0.391)), and two 
HUI-3 items (emotion (0.895) and cognition (0.455)). In both models, ICECAP-A 
autonomy cross-loaded onto a second factor that was shared by ambulation (0.883), 
dexterity (0.576), and pain (0.719) in the HUI-3 EFA, and five items from the physical 
functioning and role limitation dimensions in the SF-6D EFA. Moderate correlations 
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were observed between the shared common factors for the respective pairwise 
comparisons. When comparing the ICECAP-A with SF-6D, a strong correlation (r = 
0.627) was found between factor one (primarily represented by ICECAP-A dimensions) 
and factor three, onto which four SF-6D items loaded onto. 
Table 5.5. EFA comparing the ICECAP-A with the HUI-3 (3-factor model) a  
 Rotated item loadings 
 Factor 1 Factor 2 Factor 3 
ICECAP-A    
Stability 0.860 0.020 -0.096 
Attachment 0.849 -0.217 0.045 
Autonomy 0.448 0.368 -0.013 
Achievement 0.762 0.233 -0.106 
Enjoyment 0.912 -0.023 -0.016 
HUI-3    
Vision -0.016 0.233 0.324 
Hearing -0.014 0.064 0.617 
Speech 0.299 -0.007 0.704 
Ambulation -0.023 0.883 0.090 
Dexterity 0.058 0.576 0.249 
Emotion 0.895 -0.078 0.027 
Cognition 0.455 0.121 0.343 
Pain 0.107 0.719 0.022 
  Correlations among factors 
 Factor 1 1.000   
 Factor 2 0.460* 1.000  
 Factor 3 0.223* 0.282* 1.000 
RMSEA 0.054 [90% CI: 0.051 to 0.058] 
CFI 0.990 
TLI 0.981 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative Fit Index, 
TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is underlined.  
* Significant at 5% level. 
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Table 5.6. EFA comparing the ICECAP-A with the SF-6D (4-factor model) a 
 Rotated item loadings 
 Factor 1 Factor 2 Factor 3 Factor 4 
ICECAP-A     
Stability 0.726 -0.034 -0.150 0.017 
Attachment 0.780 0.130 -0.004 0.066 
Autonomy 0.395 -0.423 -0.102 -0.077 
Achievement 0.777 -0.293 0.023 -0.068 
Enjoyment 0.859 0.009 -0.010 0.094 
SF-6D     
Vigorous activities -0.088 0.738 -0.202 -0.171 
Moderate activities -0.014 0.959 -0.044 -0.030 
Bathing or dressing oneself 0.036 0.735 0.188 -0.002 
Limited in kind of work or other activities 0.098 0.586 0.288 -0.225 
Accomplished less than you would like -0.025 0.311 0.656 0.021 
Frequency health problems interfered with 
social activities 
-0.082 0.279 0.512 -0.187 
Intensity of bodily pain 0.033 -0.075 0.030 0.809 
Extent pain interfered with normal work 0.001 -0.015 -0.057 0.968 
Been very nervous -0.058 -0.027 0.743 -0.004 
Felt downhearted and depressed -0.230 -0.025 0.729 -0.015 
Have a lot of energy 0.391 -0.250 -0.097 0.166 
  Correlations among factors 
                                        Factor 1 1.000    
                                        Factor 2 -0.372* 1.000   
                                        Factor 3 -0.627* 0.312* 1.000  
                                        Factor 4 0.374* -0.734* -0.387* 1.000 
RMSEA 0.075 [90% CI: 0.073 to 0.078] 
CFI 0.985 
TLI 0.971 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative Fit Index, 
TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is underlined.  
* Significant at 5% level. 
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5.3.3. Robustness of the preferred factor model 
Comparing the extent of overlap in the preferred factor models against alternative 
(larger or smaller) factor models identified differences in overlap for the pairwise 
analyses comprising the 15D, EQ-5D-5L and HUI-3 (see Appendices 5.12 – 5.14, 
respectively). For the 15D, a three-factor model suggested a higher degree of overlap 
with the ICECAP-A than the preferred four-factor model. For the three-factor 15D 
model, four 15D items (depression (0.691), distress (0.619), vitality (0.439), and sleeping 
(0.314)) and all five ICECAP-A dimensions were explained by Factor 1. For the EQ-5D-
5L, a two-factor model confirmed the strong loading of anxiety/depression onto Factor 1, 
but the remaining four EQ-5D-5L dimensions now shared a common factor with 
ICECAP-A autonomy, which loaded onto both common factors. Differences with regard 
to autonomy were also observed for the HUI-3. Unlike the preferred three-factor model, a 
four-factor model showed that autonomy loaded strongly on a factor that was not shared 
by any HUI-3 items. 
5.3.4. Comparison across seven disease groups 
Supplementary analyses, comparing the results of the EFA using pooled data with 
EFA conducted for each disease group, are reported in Table 5.7. Findings from the 
pooled sample were compared with the findings of seven disease areas in terms of the 
number of factors suggested by different selection criteria (i.e., Kaiser criterion, RMSEA, 
CFI/TLI, and a clean factor structure), the number of shared factors between the HRQoL 
measures and the ICECAP-A, and the number of items with loadings greater than 0.3 on 
the respective shared factors. Overall, results from the disease-specific analyses were 
consistent with the pooled data analysis. Notable deviations were observed in the 
depression group. Only one shared factor was identified for the 15D, EQ-5D-5L, and SF-
6D in the respective pairwise comparisons with the ICECAP-A, indicating a low overlap 
that was also supported by factor loadings. Whereas the extent of overlap remained high 
for the AQoL-8D in the depression subgroup (i.e., three shared factors as in the pooled 
analysis), a fourth shared factor was identified for the HUI-3 EFA.  
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Table 5.7. Comparison of EFA results for the pooled data (n=6,756) and the seven disease areas 
 Pooled (n=6,756) Asthma (n=726) Cancer (n=692) Depression (n=777) 
15D     
# factors a 4 4 4 4 
# shared FL > 0.3 b 2 (F2 & F4) 2 (F2 & F4) 2 (F2 & F4) 1 (F3) 
ICECAP-A F2= 1 F4=1 F2=1 F4=1 F2=2 F4=1 F3=1 
15D F2=8 F4=5 F2=7 F4=4 F2=7 F4=4 F3=5 
AQoL-8D     
# factors a 5 5 7 7 
# shared FL > 0.3 b 3 (F1, F2, F3) 3 (F1, F2, F3) 3 (F1, F2, F3) 3 (F1, F2, F4) 
ICECAP-A F1=4 F2=1 F3=2 F1=2 F2=2 F3=2 F1= 3 F2=2 F3= 2 F1= 3 F3=2 F4=2 
AQoL-8D F1= 18 F2= 14 F3=6 F1= 13 F2= 20 F3=7 F1= 20 F2=7 F3= 11 F1= 18 F3=5 F4=9 
EQ-5D-5L     
# factors a 3 2 2 2 
# shared FL > 0.3 b 2  2 2 1 
ICECAP-A F1=4 F3=2 F1=4 F2=1 F1=5 F2=1 F1=5 
EQ-5D-5L F1=1 F3=1 F1=1 F2=4 F1=1 F2=4 F2=1 
HUI-3     
# factors a 3 4 4 4 
# shared FL > 0.3 b 2 (F1 & F2) 2 (F2 & F4) 3 (F1, F2, F3) 3 (F1, F2, F3) 
ICECAP-A F1=5 F2=1 F2=4 F4=2 F1=4 F2=2 F3=2 F1=4 F2=1 F3=2 
HUI-3 F1=2 F2=3 F2=2 F4=2 F1=1 F2=1 F3=3 F1=1 F2=5 F3=2 
SF-6D     
# factors a 4 4 4 4 
# shared FL > 0.3 b 2 (F1, F2) 2 (F1, F2) 1 (F2) 1 (F1) 
ICECAP-A F1=5 F2=1 F1=5 F2=1 F2=1 F1=5 
SF-6D F1=1 F2=5 F1=1 F2=4 F2=6 F1=1 
a # factors refers to the number of factors suggested by the Kaiser criterion, RMSEA, CFI/TLI, and a clean factor structure.  
b # shared FL > 0.3 refers to the number of common factors shared by both instruments with factor loadings (FL) greater than 0.3.  
F1, F2, F3, and F4 refer to the shared factors in the respective pairwise comparisons, indicating the number of items (of the ICECAP-A and the HRQoL measure) 
loading onto the shared factors.   
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Table 5.7 Continued 
 Diabetes (n=781) Hearing problems (n=717) Arthritis (n=799) Heart disease (n=792) 
15D     
# factors a 4 3 4 4 
# shared FL > 0.3 b 2 (F2 & F4) 1 (F2) 3 (F1, F2, F4) 1 (F2) 
ICECAP-A F2=1 F4=1 F2=1 F1=5 F2= 1 F4=1 F2=1 
15D F2=4 F4=4 F2=11 F1=1 F2= 8 F4=5 F2=7 
AQoL-8D     
# factors a 6 7 5 5 
# shared FL > 0.3 b 3 (F1, F2, F3) 4 (F1, F2, F3, F4) 3 (F1, F2, F3) 3 (F1, F2, F3) 
ICECAP-A F1=4 F2=2 F3=2 F1=4 F2=1 F3=1 F4=1 F1=4 F2=2 F3=2 F1=3 F2=2 F3=2 
AQoL-8D F1=16 F2=11 F3=4 F1=5 F2=11 F3=12 F4=5 F1=19 F2=13 F3=6 F1=17 F2=14 F3=7 
EQ-5D-5L     
# factors a 2 2 2 2 
# shared FL > 0.3 b 2 (F1 & F2) 2 (F1 & F2) 2 (F1 & F2) 2 (F1 & F2) 
ICECAP-A F1=5 F2=1 F1=5 F2=1 F1=5 F2=1 F1=4 F1=1 
EQ-5D-5L F1=1 F2=4 F1=1 F2=4 F1=1 F2=4 F1=1 F2=4 
HUI-3     
# factors a 4 3 3 3 
# shared FL > 0.3 b 1 (F1) 1 (F1) 2 (F1 & F3) 2 (F1 & F3) 
ICECAP-A F1=4 F1=5 F1=5 F3=1 F1=5 F3=1 
HUI-3 F1=1 F2=1 F1=2 F3=3 F1=1 F3=3 
SF-6D     
# factors a 4 4 2 2 
# shared FL > 0.3 b 2 (F1 & F2) 2 (F1 & F2) 2 (F1 & F2) 2 (F1 & F2) 
ICECAP-A F1=5 F2=2 F1=4 F2=1 F1=2 F2=5 F1=5 F2=1 
SF-6D F1=1 F2=6 F1=1 F2=6 F1=9 F2=5 F1=5 F2=8 
a # factors refers to the number of factors suggested by the Kaiser criterion, RMSEA, CFI/TLI, and a clean factor structure.  
b # shared FL > 0.3 refers to the number of common factors shared by both instruments with factor loadings (FL) greater than 0.3.  
F1, F2, F3, and F4 refer to the shared factors in the respective pairwise comparisons, indicating the number of items (of the ICECAP-A and the HRQoL measure) 
loading onto the shared factors.
 121 
A greater overlap between the HUI-3 and the ICECAP-A was also observed for 
the cancer group, where three shared factors similarly influenced HUI-3 items and 
ICECAP-A dimensions. On the contrary, for these two disease groups (depression and 
cancer), the SF-6D showed the lowest overlap with the ICECAP-A. For individuals with 
hearing problems, the 15D and HUI-3 shared only one common factor with the ICECAP-
A, while a fourth shared factor was observed for the AQoL-8D EFA. 
5.4. Discussion 
The ICECAP-A was developed to overcome perceived limitations associated with 
existing preference-based instruments that focus primarily (but not only) on health-
related aspects of QoL. Analyses in this chapter have shown that the ICECAP-A provides 
information over-and-above that garnered from several commonly used preference-based 
HRQoL instruments. However, the level of overlap with the ICECAP-A varied across 
instruments. Compared with other preference-based HRQoL instruments, more common 
factors were identified between the ICECAP-A and the AQoL-8D. Based on item 
loadings, these three common factors can be described as reflecting aspects of wellbeing 
(Factor 1), physical health (Factor 2), and relationships (Factor 3). Some but not all of 
these common factors emerged from other pairwise comparisons. The third factor, 
relationships, was not identified when comparing the ICECAP-A with the SF-6D, EQ-
5D-5L, or HUI-3. Only one factor explained overlap with the 15D, which was related to 
aspects of physical health.  
Compared with other studies, similar results were identified by recent studies that 
conducted an EFA with the ICECAP-A and the EQ-5D-3L (Keeley et al., 2016), as well 
as with the ICECAP-O and EQ-5D-3L (Davis et al., 2013). In these studies, the 
respective ICECAP instrument and the EQ-5D-3L measured two separate but correlated 
factors, with the majority of the EQ-5D-3L items loading onto one factor and the 
majority of the respective ICECAP items loading onto the second. Only EQ-5D-3L 
anxiety/depression loaded strongly onto the same factor as four dimensions of the 
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ICECAP-A (stability, attachment, achievement, and enjoyment) and ICECAP-O 
(attachment, security, role, and enjoyment), while ICECAP-A autonomy and ICECAP-O 
control loaded moderately onto both factors. The authors of the two previous EFA studies 
conclude that the EQ-5D-3L and ICECAP instruments provide complementary 
information and, therefore, should not be treated as substitute outcome measures. Specific 
to the EQ-5D-5L, these findings are confirmed by the current study due to the relatively 
minimal overlap observed with the ICECAP-A. Similar conclusions can be drawn about 
the 15D, HUI-3 and SF-6D, where relatively few items loaded onto the same common 
factor(s) as the ICECAP-A items. In contrast, the AQoL-8D provided good coverage of 
the three factors it shared with the ICECAP-A, with 18 AQoL-8D items loading on 
Factor 1 (wellbeing), 14 AQoL-8D items loading on Factor 2 (physical health), and six 
AQoL-8D items loading on Factor 3 (relationships). 
The observed differences in overlap across instruments may be due, inter alia, to 
differences in the framing of items (e.g., question formats, response options, or recall 
time), based on evidence of previous comparative studies of preference-based HRQoL 
instruments (Richardson et al., 2015b; Whitehurst & Bryan, 2011; Whitehurst et al., 
2014a). The combination of different health issues within a single item (e.g., anxiety and 
depression (EQ-5D-5L); downhearted and depressed (SF-6D); and sad, melancholic, or 
depressed (15D)) may also contribute to the differences observed between instruments. 
More generally, the fact that the instruments included in this study differ in the way they 
conceptualize HRQoL (Karimi & Brazier, 2016), and in their coverage of domains to 
define health states, is likely to be a primary reason for the variation in study findings 
(Richardson et al., 2015b; Richardson et al., 2014a). To illustrate, compared with other 
instruments, the AQoL-8D has a strong focus on the psycho-social domain (25 of 35 
items) and contains questions in its descriptive system that have the greatest ability to 
capture the concept of capability wellbeing, or wellbeing in general. As has been shown 
in a previous publication using data from the MIC study, which compared three 
subjective wellbeing instruments (Satisfaction with Life Scale, Personal Wellbeing Index, 
and the Integrated Household Survey of the Office for National Statistics) with 
preference-based HRQoL instruments, the AQoL-8D accounted for variation in 
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subjective wellbeing to a greater extent than the other preference-based HRQoL 
instruments (Richardson et al., 2015a), particularly in individuals with depression. Also 
the comparison analyses across seven disease groups in this chapter have shown that the 
AQoL-8D had the greatest overlap with the ICECAP-A in the depression group, whereas 
all other measures (except for the HUI-3) seemed to tap into different constructs than the 
ICECAP-A. It has been previously reported that the AQoL-8D correlates highly with 
depression-specific instruments (Mihalopoulos et al., 2014), indicating that both the 
AQoL-8D and the ICECAP-A are sensitive to aspects that are predominantly important to 
individuals with depression. 
5.4.1. Implications and directions for further research 
The analyses performed in this chapter have shown that the ICECAP-A, when 
compared directly to the 15D, EQ-5D-5L, HUI-3 and SF-6D, provides additional, 
complementary information about an individual’s capability wellbeing. Recent studies 
have demonstrated that the choice of outcome measure for economic evaluation – i.e., 
selecting a capability measure or a HRQoL measure – is not a trivial issue (Goranitis et 
al., 2017; Makai et al., 2015). In an economic evaluation of an integrated care model for 
frail seniors, Makai and colleagues found the intervention had a higher probability of 
being cost-effective when using the ICECAP-O when compared with use of the EQ-5D-
3L. This direct comparison of cost-effectiveness findings was made possible because (i) 
ICECAP-O responses were used to define ‘capability QALYs’ (which is in tension with 
the intent of the ICECAP measures) and (ii) the same range of willingness to pay (WTP) 
values was applied in the analysis of capability QALYs and QALYs derived from EQ-
5D-3L responses. Despite the use of identical economic evaluation approaches, Makai 
and colleagues go on to highlight that there are no estimates of WTP for a capability 
QALY, and state that it is unlikely that valid comparisons can be made between the 
ICECAP-O and EQ-5D-3L at a given level of WTP. A second example examined the 
cost-effectiveness of psychological interventions for drug addiction (Goranitis et al., 
2017), concluding that under the health maximization principle (using EQ-5D-5L), the 
results yielded different treatment recommendations when compared with the application 
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of the ‘sufficient capability’ approach developed by Mitchell and colleagues (using 
ICECAP-A) (Mitchell et al., 2015b).  
Although methodologies to operationalize the use of ICECAP instruments in 
economic evaluation are still in their infancy (Mitchell et al., 2015b), findings such as 
those in the above examples support the use of ICECAP instruments alongside 
preference-based HRQoL instruments to triangulate results and evaluate the robustness of 
conclusions regarding cost-effectiveness. However, the use of different metrics to value 
different health care interventions raises questions about the objective for resource 
allocation decisions in health care (Mitchell et al., 2015a). For example, does health or 
wellbeing (or both) enter the objective function, and is the form of this function 
consistent with the current emphasis on maximization (rather than sufficiency)? To 
answer this question, further research is needed to determine whether a society is willing 
to sacrifice health outcomes for improvements in dimensions of wellbeing. 
The use of ICECAP instruments within the current QALY-based paradigm for 
economic evaluation also requires further attention in health economics research. As 
mentioned above, the ICECAP-A is anchored on a ‘full capability’ and ‘no capability’ 
scale and the instrument was not intended to be used within the QALY framework (Flynn 
et al., 2015). Recent advances in this area have proposed to adjust the ICECAP-A for 
time, to enable the assessment of gains in terms of ‘years of full capability equivalence’ 
(Flynn et al., 2015), and an approach that focuses on the objective of achieving 
‘sufficient capability’ (Mitchell et al., 2015b). Outside the ICECAP instruments, 
Cookson suggested an application of the capability approach to economic evaluation by 
re-interpreting the QALY, referred to the ‘capability QALY’ (Cookson, 2005b). Cookson 
argued that, in practice, HRQoL instruments incorporate some elements of capability 
because health affects an individual’s freedom to choose non-health activities. Compared 
with the ‘health QALY’, this operationalization of the ‘capability QALY’ represents 
individuals’ entire wellbeing (not just the health component) and, therefore, reflects the 
value of the capability set. Concerns over using preference-based HRQoL instruments as 
the base of a capability QALY because they may neglect non-health dimensions of 
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wellbeing led Cookson to conclude that, “…the QALY approach is compatible with the 
capability approach only insofar as the health state descriptive systems used for 
generating QALYs pay close attention to proxy capability variables that cover a wide 
range of health and non-health dimensions of wellbeing” (Cookson, 2005a, p.1288). 
Results from the current chapter suggest the AQoL-8D could be a measure that best fits 
Cookson’s notion of a capability QALY because of the overlap with the ICECAP-A and 
the presence of non-health items in the AQoL-8D descriptive system.  
In a recent review, Karimi and colleagues conclude that existing capability 
measures (including ICECAP instruments) have important limitations since they do not 
elicit capability as originally proposed by Sen (Karimi et al., 2016). Accordingly, if the 
added value of capability instruments in health economics is based solely on broadening 
the evaluative space to extend beyond a narrow focus on health, the findings provide 
evidence that such benefits can be potentially captured by the AQoL-8D (i.e., not only 
through the aggregation of outcomes collected by ‘complementary’ health-related and 
capability measures). However, the findings do not imply the AQoL-8D and ICECAP-A 
are interchangeable instruments. Further work is needed to build on these findings and 
explore unanswered question, such as whether individuals are able to distinguish between 
their capabilities and functionings, and the comparative performance of the ICECAP-A 
and AQoL-8D with regard to capturing the wellbeing impacts of interventions in different 
clinical contexts. It is also important to note that ICECAP instruments are not the only 
capability measures that could be combined with QALYs derived from HRQoL 
instruments to provide a broader assessment of the benefit of interventions. For example, 
the Adult Social Care Outcomes Toolkit (ASCOT) (Netten et al., 2012) is designed to 
capture information about an individual's social care-related quality of life and further 
research is needed to explore the relationships (including overlap) between the ASCOT, 
ICECAP instruments and preference-based HRQoL instruments. 
5.4.2. Strengths & limitations 
A major strength of this work is the inclusion of multiple preference-based 
instruments. While previous studies explored overlap between ICECAP instruments and 
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the EQ-5D-3L (using much smaller samples (Davis et al., 2013; Keeley et al., 2016)), the 
analyses reported in this chapter provide EFA results comparing the ICECAP-A with five 
preference-based HRQoL instruments. Conducting an EFA that uses data from the 
descriptive systems only (i.e., item-level response data) is a further strength because there 
is no reliance on country-specific index scores, where variations across national valuation 
studies could influence the results (Engel et al., 2016; Xie et al., 2013). Given that 
‘overlap’ between instruments can be explored within the descriptive systems or health 
state valuations, this item-level analysis complements previous work that used correlation 
analyses and regression-based techniques to assess index scores from the MIC study 
(Mitchell et al., 2017b). The analysis also addressed the potential problem of factor 
under- or over-extraction (Prieto et al., 2003) by investigating alternative factor models to 
examine the robustness of the ‘preferred’ factor models (see section 5.3.3). Potential 
limitations associated with using data from a multinational survey include issues with the 
validity of instrument translations and the representation of the respective populations 
(for example, participants were required to have Internet access). Survey bias resulting 
from the repetition of similar items should also be acknowledged due to the 
administration of seven preference-based HRQoL instruments. 
5.5. Conclusion 
The ICECAP-A has the potential to capture benefits of interventions and 
treatments that go beyond those measured by many of the traditional health-focused 
preference-based instruments, such as the 15D, EQ-5D-5L, HUI-3 and SF-6D. 
Substantial overlap was observed between the ICECAP-A and AQoL-8D. Researchers 
and decision makers should be aware that there is a risk of double counting when using 
the ICECAP-A as a complementary measure, but the level of such a risk varies 
depending on the choice of HRQoL measure. Further investigations are needed to explore 
the extent and implications of double counting, particularly when applying the ICECAP-
A alongside the AQoL-8D, which will be the focus of the next chapter. 
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Chapter 6. The relationship between health-related 
quality of life, capability wellbeing, and subjective 
wellbeing in the context of spinal cord injury – a path 
analysis 
6.1. Introduction 
The analyses conducted in Chapter 5 examined the relationship between 
preference-based HRQoL measures that are used within the existing QALY framework 
and the ICECAP-A, which is rooted in the capability theory. The findings have shown 
that the ICECAP-A contains domains in its descriptive system that are not captured by 
preference-based HRQoL measures. The exception was the AQoL-8D, where a 
substantial degree of overlap was observed with the ICECAP-A. While the previous 
chapter examined the underlying content of alternative measures, further work is needed 
to analyze whether illness, symptoms and functional limitations have a different impact 
on HRQoL and capabilities. Given that existing preference-based HRQoL measures aim 
to assess a person’s functionings, while the ICECAP-A focuses on a person’s capability 
wellbeing, the ability of alternative instruments to capture the full impact of an 
intervention can differ despite conceptual overlap between measures. A previous study 
compared the impact of seven major health conditions on health status (using the EQ-5D-
5L) and capability (using the ICECAP-A) and found that diseases were associated with 
relatively different impacts on health and capability (Mitchell et al., 2015a). For 
example, the study found that the impact of depression on capability is much greater than 
on health when compared across other conditions. The authors of the study concluded 
that the relative importance of preventing and treating different conditions would differ 
depending on whether the focus is on capability or health status.     
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Although there is an increasing interest for capturing broader benefits of health 
care interventions, the conceptualization of such a broader approach does not need to be 
necessarily in terms of capabilities. As was discussed in Chapter 3, another alternative is 
the measurement of subjective wellbeing (SWB) or happiness for informing policy 
decisions (Dolan, 2011; van de Wetering et al., 2016). It has been argued that SWB better 
reflects the ‘utility experienced’ from changes in health status (van de Wetering et al., 
2016), in which context the term utility can be equated with hedonic experience 
(Kahneman & Sugden, 2005). Compared with preference-based HRQoL measures, SWB 
uses individuals’ own values and not those of the general population, as is predominantly 
the case within the current QALY framework (Versteegh & Brouwer, 2016). Rather than 
placing participants in hypothetical scenarios to value different states of health, known as 
‘decision utility’, the focus is entirely on the measurement of an individual’s real 
happiness, life satisfaction, or SWB (Coast et al., 2008d). Hence, decision utility is an ex 
ante concept (Brazier et al., 2005), whereas experienced utility is an ex post concept 
because it reflects the hedonic experiences that result from acts of choices (Kahneman & 
Sugden, 2005). Dolan et al. have criticized the measurement and valuation of health 
within the current QALY approach based on two reasons: (i) describing health in terms of 
a fixed and simplified descriptive system may fail to capture what is important to people 
in terms of their health and important benefits of health care, and (ii) valuing health in 
terms of hypothetical preferences may fail adequately to anticipate the real impact that 
different health states have on our lives (Dolan et al., 2012). Since all descriptive systems 
have a fixed, limited number of dimensions and response levels for practical reasons, the 
advantage in SWB is that individuals can decide which factors are important for them and 
the magnitude of these factors. Therefore, SWB accounts for the domains of health that 
matter most in the experience of people’s lives (Dolan et al., 2012). 
With this current spread of different measurement approaches for the evaluation 
of health care interventions, it remains unclear which ‘objects of value’ should be 
considered in an economic evaluation. Originally introduced by Sen (Sen, 1993), objects 
of value relate to what should be valued (the domains) and why it should be valued (its 
consequences) that define ultimately the evaluative space of the economic evaluation 
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(Sampson, 2016). Although it is known that measures of HRQoL, capability and SWB 
differ in terms of the domains in their descriptive systems and their consequences 
(functionings, capabilities, or satisfaction), it is not fully understood how diseases 
influence different objects of value. These three measures under consideration were 
previously discussed in different contexts. Greco and colleagues outlined methodological 
challenges for the identification and measurement of broader outcomes of public health 
interventions in economic evaluations in low-income and middle-income countries 
(Greco et al., 2016). Also within the context of patients without capacity, which includes 
dementia, Round and colleagues discussed these three outcome measures and highlighted 
existing limitations around these measures when applying to individuals with severely 
restricted capacity (Round et al., 2014). Generally, little is known about the comparative 
performance of these measurement approaches. Therefore, the aim of this chapter is to 
provide further evidence on the relationships between HRQoL, capability wellbeing, and 
SWB. These relationships will be explored within a particular clinical context – here the 
context of spinal cord injury (SCI), which can be considered as a case study.  
Given the improvement in survival rates following injury, measuring QoL 
(however defined) in individuals with SCI has become an important outcome measure 
(Strauss et al.). As perceived QoL changes, the measurement of QoL requires appropriate 
measures and a recent panel of experts have recommended the use of the International 
SCI QoL Basic Data Set, consisting of three questions concerned with the (i) satisfaction 
with general QoL, (ii) satisfaction with physical health, and (iii) satisfaction with 
psychological health (Charlifue et al., 2012). While this measure closely aligns with the 
concept of SWB that reflects the hedonic experiences of SCI, previous research 
emphasized the use of conventional preference-based HRQoL measures, in particular, 
when evaluating the cost-effectiveness of interventions in SCI (Whitehurst & Mittmann, 
2013; Whitehurst et al., 2012). Additionally, Sen’s capability approach is gaining 
increasing attention in the disability literature, which emphasizes the need to assess what 
individuals are able to do in their real-life environment (capabilities) rather than capacity 
or functional status (Mitra, 2006; Welch Saleeby, 2006). Given this interest in different 
 130 
outcome measures, the clinical context of SCI provides a great opportunity for further 
exploration of the relationships between such measures. 
QoL in individuals with SCI is influenced to a great extent by the presence of 
secondary health conditions (SHCs) (Craven et al., 2012). SHCs are defined as physical 
or psychological health conditions that are influenced directly or indirectly by the 
presence of a disability or underlying physical impairment (Jensen et al., 2012). These 
include, for example, pressure sores, spasticity, and pain. Prevention, early diagnosis and 
treatment of SHCs are seen as critical for limiting these complications, improving 
survival, and enhancing QoL (Sezer et al., 2015). In order to further explore the 
relationship between different measurement approaches in SCI, a better understanding of 
the impact of SHCs is needed. Therefore, the objectives of this work are twofold: (i) to 
examine the effect of SHCs simultaneously on HRQoL, capability wellbeing, and SWB 
through direct and mediated pathways within the same model; and (ii) to consider the 
implications for outcome measurement in health economic evaluation.   
6.2. Methods 
6.2.1. Data source 
Data were used from a study that explored the validity of alternative preference-
based HRQoL measures in the context of SCI (Whitehurst et al., 2016). Study 
participants were identified from a list of individuals who participated previously in a 
Canada-wide SCI research project, known as the Spinal Cord Injury Community Survey 
(SCICS) (Noreau et al., 2014). A market research company, in collaboration with the 
research team, invited by email those individuals who indicated a willingness to be 
contacted for further related research studies during the consent procedure in the SCICS 
study. Individuals were included if they were 19 years or older, were able to understand 
the English language, and had an SCI (regardless of the type and cause of injury). Data 
were collected online through the administration of a survey and participants were 
reimbursed upon completion of the survey in the form of a $25 gift card. The study was 
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approved by the University of British Columbia Behavioural Research Ethics Board 
(H12-01138) and Vancouver Coastal Health Authority (Research Study #V12-01138). 
6.2.2. Instruments 
The survey consisted of five sections: (i) demographics, (ii) SCI classifications 
and characteristics, (iii) secondary health complications and conditions, (iv) quality of 
life, and (v) SCI-specific functioning in activities of daily living. Study participants were 
expected to respond to all questions (in all five sections), in the order they were 
presented, with the option to return to previous questions for amendments. To prevent 
order-effect bias, the appearance of standardized outcome measures included in section 
four were randomized (Perreault, 1976). Although four preference-based HRQoL 
instruments were included in the survey (Assessment of Quality of Life 8-dimension 
(AQoL-8D) (Richardson et al., 2009), EQ-5D-5L (Herdman et al., 2011), Health Utilities 
Index Mark (HUI) (Feeny et al., 2002), and SF-6D (based on the 36-item Short Form 
health survey version 2 (SF-36v2) (Ware et al., 2008)) (Brazier et al., 2002)), the analysis 
reported in this chapter focuses on two instruments only; the EQ-5D-5L and AQoL-8D. 
The EQ-5D-5L was selected because the previous three-level version, the EQ-5D-3L, is 
the most often used instrument (Richardson et al., 2015c; Wisløff et al., 2014). The 
AQoL-8D was chosen as a comparator measure of HRQoL because qualitative evidence 
indicates that individuals with SCI perceived it to be the most relevant instruments to be 
administered within the SCI population (Michel et al., 2016; Whitehurst et al., 2014b). 
Previous studies have also shown that the AQoL-8D generates different results compared 
with the EQ-5D-5L, mainly due to variation in the descriptive systems (Richardson et al., 
2015b; Whitehurst et al., 2016). This was also observed in the previous chapter, where a 
different degree of overlap was found between the EQ-5D-5L and ICECAP-A when 
compared with the overlap between the AQoL-8D and the ICECAP-A. While results of 
the HUI-3 and SF-6D were similar to those of the EQ-5D-5L, the EQ-5D-5L and AQoL-
8D seem to deviate most on their descriptive systems, which enables further exploration 
within this chapter. The Canadian tariff was used for the EQ-5D-5L (Xie et al., 2016) 
 132 
while for the AQoL-8D only an Australian tariff exist, which was applied in this work 
(Richardson et al., 2014b).  
Capability wellbeing was assessed using the ICECAP-A (Al-Janabi et al., 2012), 
based on UK societal preferences (Flynn et al., 2015). Further details about the ICECAP-
A were provided in the previous Chapter 5. SWB was assessed by a single item, which 
asks: “Using a scale of 0 to 10, where 0 means "very dissatisfied" and 10 means "very 
satisfied", how do you feel about your life as a whole right now?” Respondents were 
asked to tick one of eleven boxes (0 to 10), which were presented vertically on screen 
(see Appendix 6.1). The same question format has been used in waves of the Canadian 
Community Health Survey (CCHS) (Statistics Canada, 2010). For the assessment of 
SHCs, a modified version of the Spinal Cord Injury Secondary Conditions Scale (SCI-
SCS) was used (Kalpakjian et al., 2007), based on a combination of items from the SCI-
SCS and additional conditions that were selected by members of the Research Team from 
the Rick Hansen Institute (see Appendix 6.2). Although some conditions (e.g., arthritis) 
are not of ‘secondary’ nature, the majority of the health conditions included in Appendix 
6.2 are directly or indirectly influenced by the presence of SCI and, as such, summarized 
under the umbrella term SHCs. In total, sixteen SHCs were assessed, each on a four-point 
ordinal scale, with scores ranging from 0 (not experienced/insignificant problem) to 3 
(significant/chronic problem). A sum score was created with total scores ranging from 0 
(no SHCs) to 48 (significant/chronic problem in all sixteen SHCs). 
6.2.3. Statistical analyses 
Descriptive analyses were performed in STATA 14.1 (StataCorp, 2015) for 
frequency, means, standard deviations, median, and minimum and maximum values of all 
outcome measures (AQoL-8D, EQ-5D-5L, ICECAP-A, SHCs, and SWB). The primary 
analyses consisted of two path analysis models that were both conducted in Mplus 7 
(Muthén & Muthén, 1998-2015). A path analysis is a multivariate regression model, 
which is a regression analysis that simultaneously considers multiple dependent (and 
often multiple independent) variables (Geiser, 2013). In other words, equations are solved 
simultaneously to determine parameter estimates. It is an extension of multiple regression 
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analysis in the sense that it is not restricted to a single dependent variable. In a path 
model, a variable can be a dependent variable in one relationship and an independent 
variable in another. Given the example in Figure 6.1, if one wants to analyze the effect of 
X on Z through Y, Y is an independent variable to Z but a dependent variable to X. 
Different terminology is used in path analysis compared with a multiple 
regression analysis, where a distinction is made between exogenous variables and 
endogenous variables. Exogenous variables are referred to as independent variables 
because variability in these variables is not explained by other variables in the model. 
Variables that are regressed on one or more other variables are called endogenous 
variables (i.e., dependent variables). Endogenous variables, that serve as independent and 
dependent variables at the same time, are called intermittent or mediator variables 
(Geiser, 2013). In a path analysis, hypotheses can be tested with regard to the direct and 
indirect effects of variables on each other. While direct effects are effects of one variable 
on another, indirect effects are effects that are mediated through other variables and are 
therefore also referred to as mediated effects. Mediated effects are present in a path 
model when the model contains one or more variables that are dependent and 
independent variables at the same time.  
 
 
 
Figure 6.1. Example of a path analysis model 
 
Two separate models were conducted in this chapter; one that measured HRQoL 
using the EQ-5D-5L (Model 1) and a second model that measured HRQoL using the 
AQoL-8D (Model 2). For each model the relationship between SHCs, HRQoL, capability 
wellbeing, and SWB was examined through direct and mediated pathways (further model 
details are provided in the next section). All paths in the model were adjusted for sex, 
X Y Z 
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age, education, type of injury (paraplegia or tetraplegia), and living arrangements (living 
alone or living with someone) based on previous evidence (Noonan et al., 2008; Post et 
al., 1998; Putzke et al., 2002; van Leeuwen et al., 2012). It is generally recommended 
that the final model in a path analysis should contain only parameters that are statistically 
significant, i.e., a parsimonious model. Therefore, after running the initial hypothesized 
model in Mplus, the model was further refined by removing non-significant parameters to 
yield a parsimonious final model (Raykov & Marcoulides, 1999). 
For a path analysis that contains one or more indirect effects, there is often an interest in 
effect decomposition, where the total effect is split into the sum of all indirect effects plus 
the direct effect. For the analyses conducted in this chapter, the MODEL INDIRECT 
command was used in Mplus to estimate the total, direct, and indirect effects. The default 
maximum likelihood (ML) estimation was applied. Running a path analysis generates 
path coefficients that characterize the strength of the influence of one variable on another. 
These coefficients are equivalent to slope coefficients in linear regression analysis 
(Geiser, 2013). Both unstandardized and standardized beta coefficients are reported (the 
standardized coefficients enable comparisons to be made across independent variables 
due to being scaled on the same standardized metric). While a direct effect is expressed 
by one coefficient, an indirect effect is a product of two or more regression coefficients. 
Therefore, if one wants, for example, analyze the effect of X on Z through Y, the indirect 
effect of X on Z is the increase we would see in Z while holding X constant and 
increasing Y to whatever Y would attain under a unit increase of X (Pearl, 2012). Given 
that the indirect effect is the product of two or more regression coefficients, the product is 
often not normally distributed, meaning the application of conventional tests of 
significance can be problematic (Geiser, 2013). Accordingly, the bias-corrected bootstrap 
method (1,000 samples) was applied to verify the significance of indirect effects 
(MacKinnon, 2008). Same model fit indices were used as in the previous chapter. Model 
fit was deemed to be good given a non-significant chi-square test, an RMSEA ≤ 0.5, and 
a CFI/TLI > 0.95 (Geiser, 2013). Significance level was set at p < 0.05. 
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6.2.4. Conceptual framework 
Path analysis is, generally, considered as a model-testing approach and not a 
model-building approach (Streiner, 2005). This implies that analysts should not include 
variables just because they are available; instead the selection of variables should be 
based on theory or empirical evidence. For this reason, having a model that fits the data 
does not prove that the model is correct. The major criterion for accepting or rejecting the 
model is the underlying theory. The conceptual model used for this analysis is presented 
in Figure 6.2. The model considers SWB as an endogenous variable, SHCs as exogenous 
variables, and HRQoL (i.e., AQoL-8D or EQ-5D-5L) and capability (ICECAP-A) as 
mediating variables. Each path (indicated by capital letters) in the conceptual model was 
based on a series of theory-driven hypotheses. The construction of a priori hypotheses 
required careful considerations of key differences between the outcome measures and 
their theoretical foundation. Table 6.1 provides an overview of the main differences 
between these three measurement approaches under consideration (i.e., HRQoL, 
capability wellbeing and SWB). 
 
 
Figure 6.2. Hypothesized conceptual model of the effects of SHCs on HRQoL, 
capability, and SWB 
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Table 6.1. Key characteristics of the three measurement approaches under consideration a 
 Question to be addressed Decision 
metric 
Objects of value (what is valued?) Consequences 
(why it is valued?) 
Source of 
values 
HRQoL Which health states are more 
preferred? 
Preferences Fixed descriptive system 
EQ-5D-5L (Mobility, Self-care, Usual 
activities, Pain/discomfort, 
Anxiety/depression) 
AQoL-8D (Independent living, Senses, 
Pain, Mental health, Happiness, Self 
Worth, Coping, Relationships) 
 
Functionings Society 
Capability What is the effect of these 
health states on individual’s 
capability to function? 
Perceived 
capabilities 
Fixed descriptive system 
ICECAP-A (Attachment, Stability, 
Achievement, Enjoyment, Autonomy) 
Capabilities Society 
SWB What is the actual experience 
of the various health states? 
Experiences No fixed descriptive system Satisfaction Affected 
individual 
HRQoL=health-related quality of life, SWB=subjective wellbeing. 
a The description of the characteristics is specific to the outcome measures applied in this chapter and may deviated from other measures. 
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Driven by these underlying differences, a-priori hypotheses were formulated, 
which are presented in Table 6.2. Hypothesis #1 proposed that SHCs would impact 
HRQoL negatively, as highlighted by a previous model of HRQoL (Wilson & Cleary, 
1995) and empirical evidence in SCI (Craven et al., 2012; Rivers et al., 2017). 
Hypothesis # 2 also suspected a negative impact of SHCs on SWB (Rivers et al., 2017). 
However, previous evidence has shown that individuals with SCI use coping strategies 
that are associated with greater life satisfaction (Anderson et al., 2008). As such, 
compared with the effect of SHCs on HRQoL, the effect on SWB is hypothesized to be 
of a smaller magnitude (Hypothesis #3). This hypothesis is based on societal preferences 
reflected in the preference-based HRQoL measures, where the general public might not 
adequately forecast the coping strategies and adaptation one might experience in such a 
health state (Versteegh & Brouwer, 2016).  
 
Table 6.2. List of hypotheses tested in the path analysis 
# Path Hypothesis 
1 A SHCs impact HRQoL negatively 
2 B SHCs impact SWB negatively  
3 A vs. B SHCs have a less negative effect on SWB than on HRQoL 
4 A C There is an indirect effect of SHCs on SWB mediated through HRQoL 
5 D SHCs impact capability wellbeing negatively 
6 A vs. D SHCs have a less negative impact on capability wellbeing than on 
HRQoL  
7 B vs. D SHCs have a less negative effect on SWB than on capability wellbeing 
8 D E There is an indirect effect of SHCs on HRQoL mediated through 
capability wellbeing 
9 D E C 
 
The indirect effect of SHCs on SWB is mediated through capability 
wellbeing and health functionings 
10 D F  There is an indirect effect of SHCs on SWB mediated through capability 
wellbeing 
a HRQoL=health-related quality of life, SHCs=secondary health conditions, SWB=subjective wellbeing. 
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In addition to the direct effect of SHCs on SWB, an indirect effect mediated 
through HRQoL was also hypothesized (Hypothesis #4). Broome previously discussed 
that the harm done by disease should not be understood in terms of the consequences for 
health but the contribution health makes to wellbeing (Broome, 2002). The rationale 
behind this notion is that the extent to which a person’s wellbeing is affected by the 
various elements of their health depends on other non-health factors that are unlikely to 
be included in measures of HRQoL (such as the EQ-5D-5L or AQoL-8D).  
Additional evidence-based hypotheses were formulated around the impact of 
SHCs on capability wellbeing. Hypothesis #5 proposed a negative relationship between 
SHCs and capability wellbeing (Keeley et al., 2015; Mitchell et al., 2015a). As none of 
the ICECAP-A dimensions (stability, attachment, autonomy, achievement, and 
enjoyment) are directly related to health (Kinghorn, 2015), the effect of SHCs on 
capability wellbeing focuses on the extent to which SHCs will affect a person’s freedom 
to choose non-health activities and states (i.e., non-health capabilities). As previous 
evidence has indicated that certain conditions have a greater effect on health than the 
impact on capability wellbeing (Mitchell et al., 2015a), the model explored in this 
analysis also hypothesized (Hypothesis #6) that the impact of SHCs on HRQoL will be 
greater than on capability wellbeing. Another hypothesis was made with regard to the 
impact on capability wellbeing when compared with the impact on SWB (Hypothesis 
#7). Similar to Hypothesis #3, a greater negative impact of secondary health conditions 
on capability wellbeing was hypothesized than on SWB because of the adaptation process 
reflected in SWB measures. 
Hypothesis #8 assumed that there would be an indirect effect of SHCs on HRQoL 
mediated through capability wellbeing. Kinghorn previously discussed different 
interpretations of the capability approach in a health care context (Kinghorn, 2015). One 
important consideration is whether health should be treated as the ‘end goal’ or as a 
‘means to an end’. If health is to be treated as the end goal, the assessment of capability 
will be based upon an assessment of the capability to exercise good health. If health is 
treated as a means, the assessment of capability will be based on a broader capability set, 
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which is influenced by health and the social care system (Kinghorn, 2015). Given the fact 
that the ICECAP-A does not include any dimension directly related to health, this model 
will consider health as an end goal. As such, the model assumed that health achievements 
observed would depend on the capability to achieve good health. In addition, it was 
assumed that this indirect effect would also influence SWB (Hypothesis #9). It was 
assumed that if SHCs lead to a decrease in capability wellbeing, it would also decrease 
the levels of health functionings, which will decrease a person’s SWB. Finally, Hypothsis 
#10 proposed an indirect effect of SHCs on SWB, mediated through capability wellbeing 
only. The rationale behind this hypothesis is that secondary health conditions could 
impact a person’s capability wellbeing that influence their SWB, irrespective of the 
achieved levels of health functionings. For example, secondary health conditions could 
impact SWB through non-health capabilities (e.g., achievement) independently of 
HRQoL.  
6.3. Results 
The total sample size comprised 364 individuals. Characteristics of the study 
population are provided in Table 6.3. The majority of the study population was male 
(63%), with 90% self-identifying as Caucasian. With regard to levels of education, 33% 
of the study population had a Bachelor degree and above. The population contained 
slightly more individuals with paraplegia (52%) than tetraplegia. The majority of the 
study population (70%) had lived with their injury for at least 10 years.  
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Table 6.3. Characteristics of the study population – values are numbers 
(percentages) unless states otherwise (n=364) 
Gender - Male 229 (62.9) 
Age (mean (SD)) 50.4 (13.2) 
Ethnicity 
Caucasian 
Other 
 
328 (90.1) 
36 (9.9) 
Living with someone - Yes 269 (73.9) 
Education level 
High school/GED and below 
Diploma/Certificate 
Bachelor degree and above 
 
102 (28.0) 
140 (38.5) 
119 (32.7) 
Type of injury 
Tetraplegia 
Paraplegia 
 
175 (48.1) 
189 (51.9) 
Time since injury 
1-10 years 
10+ years 
 
109 (29.9) 
225 (70.1) 
GED=General Educational Development, SD=standard deviation. 
 
Table 6.4 reports the results of the descriptive statistics for the instruments under 
consideration. Total scores of SHCs, indicating frequency and magnitude of conditions, 
ranged from 2 to 40 with a mean of 18. Mean HRQoL based on the AQoL-8D was higher 
(0.573) compared with the EQ-5D-5L (0.492). Mean scores for the ICECAP-A and SWB 
were 0.761 and 6.319 respectively. 
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Table 6.4. Descriptive statistics for instruments under consideration 
Instrument  N Mean SD Min Max Range of possible scores 
SHCs  364 18.363 7.731 2 40 [0; 48] 
ICECAP-A  364 0.761 0.182 0.149 1.000 [0; 1] 
EQ-5D-5L  364 0.492 0.196 -0.066 0.911 [-0.148; 0.974] 
AQoL-8D  363 0.573 0.197 0.134 0.995 [0.09; 1] 
SWB  364 6.319 2.248 0 10 [0; 10] 
SD=standard deviation, Min=minimum, Max=maximum, SHCs=secondary health conditions, 
SWB=subjective wellbeing. 
 
The initial model structures (considering all paths and parameters) for Model 1 
and Model 2 are provided in Appendix 6.3 and Appendix 6.4 respectively, showing all 
parameter estimates (A) and only significant parameter estimates (B). After removing 
non-significant parameters, the final models for Model 1 and Model 2 are presented in 
Figure 6.3 and Figure 6.4, respectively. A solid line in Figure 6.3 and 6.4 indicates a 
direct effect (β coefficients are underlined) and a dashed line indicates an indirect effect 
(β coefficients are italicized). Abbreviations of the parameters included in the model are 
provided in Appendix 6.5. For presentation purposes, covariates in Model 1 (type of 
injury and living arrangements) and Model 2 (type of injury, living arrangements, and 
age) are not displayed. Model 1 showed an ‘acceptable’ fit to the data (x2 = 6.365, df(3), 
p = 0.0951; RMSEA=0.056; CFI=0.995; TLI=0.979), while Model 2 yielded a ‘good’ 
model fit (x2 = 8.002, df(7), p = 0.3324; RMSEA=0.020; CFI=0.999; TLI=0.998).    
 142 
 
 
 
 
 
 
Figure 6.3. Model 1: Path model of the effect of SHCs on HRQoL, capability 
wellbeing and SWB  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4. Model 2: Path model of the effect of SHCs on HRQoL, capability 
wellbeing and SWB  
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Standardized (β) and unstandardized (B) parameter estimates for Model 1 and 
Model 2 are presented in Table 6.5 and Table 6.6, respectively. An overview of all 
hypotheses that were (not) confirmed is provided in Table 6.7. With regard to Model 1, 
seven hypotheses were confirmed, whereas Hypotheses #4, #6, and #9 were not 
confirmed. SHCs impacted all outcome measures (confirming Hypotheses #1, #2, and #5) 
but had the greatest negative impact on individuals’ capability wellbeing, as indicated by 
the β-coefficients (βICECAP-A= -0.480, βEQ-5D-5L= -0.375, βSWB= -0.146). While the impact 
on SWB was lower than on HRQoL and capability wellbeing (confirming hypotheses #3 
and #7), the impact was higher on capability wellbeing than HRQoL (hypothesis #6 not 
confirmed). Capability wellbeing ‘partly’ mediated the effect of SHCs on HRQoL 
(βindirect= -0.179), meaning that the direct effect was greater than the indirect effect. 
However, when looking at the indirect effect of SHCs on SWB, capability wellbeing 
‘fully’ mediated the effect on SWB (βindirect= -0.332), which means that the indirect effect 
exceeded the direct effect. Both hypotheses # 8 and #10 were confirmed. The indirect 
effect of SHCs on SWB through HRQoL was not statistically significant and as such, 
hypotheses #4 and #9 could not be confirmed.  
Compared with Model 1, all except two hypotheses (#2 and #6) were confirmed 
in Model 2. The effect of SHCs on capability wellbeing in Model 2 was similar to the 
effect on HRQoL (βICECAP-A= -0.480, βAQoL-8D= -0.411) yet still greater on capability 
wellbeing, which did not confirm hypothesis #6. Capability wellbeing again mediated the 
effect of SHCs on HRQoL (βindirect= -0.260). While no direct effect of SHCs on SWB was 
observed in Model 2 (i.e., hypothesis #2 could not be confirmed), three indirect effects of 
SHCs on SWB were found mediated through capability (βindirect= -0.207), HRQoL 
(βindirect= -0.183), and both capability and HRQoL (βindirect= -0.116). 
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Table 6.5. Parameter estimates for Model 1 a  
Path β (SE) B (SE) p 95%-CI 
SHC  SWB     
Direct -0.146 (0.038) -0.043 (0.011) <0.001 [-0.063; -0.025] 
Indirect     
SHC  Capability  SWB -0.332 (0.032) -0.097 (0.011) <0.001 [-0.115; -0.077] 
SHC  HRQoL  SWB - b - b - b - b 
SHC  Capability  HRQoL  SWB - b - b - b - b 
     
SHC  HRQoL     
Direct -0.375 (0.042) -0.009 (0.001) <0.001 [-0.011; -0.007] 
Indirect     
SHC  Capability  HRQoL -0.179 (0.026) -0.005 (0.001) <0.001 [-0.006; -0.003] 
     
SHC  Capability     
Direct -0.480 (0.040) -0.011 (0.001) <0.001 [-0.013; -0.009] 
β=standardized coefficient; SE = standard error; B=unstandardized coefficient, CI=confidence interval, SHC=secondary health conditions, SWB=subjective wellbeing. 
a Model fit: x2 (df=3)=6.365 (p=0.0951); RMSEA=0.056 (p=0.375); CFI=0.995; TLI=0.979. Covariates included in the model: type of injury and living arrangements. R2 
SWB=0.601; R2 HRQoL=0.456; R2 Capability=0.235.  
b No results are presented for this path because it was not significant in the initial ‘full’ model and as such removed from the final model to yield a parsimonious model. 
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Table 6.6. Parameter estimates for Model 2 a  
Paths β (SE) B (SE) p 95%-CI 
SHC  SWB     
Direct: - b - b - b - b 
Indirect:     
SHC  Capability  SWB -0.207 (0.027) -0.060 (0.009) <0.001 [-0.080; -0.046] 
SHC  HRQoL  SWB -0.183 (0.024) -0.053 (0.007) <0.001 [-0.064; -0.042] 
SHC  Capability  HRQoL  SWB -0.116 (0.016) -0.034 (0.005) <0.001 [-0.042; -0.026] 
     
SHC  HRQoL     
Direct: -0.411 (0.033) -0.010 (0.001) <0.001 [-0.012; -0.009] 
Indirect:      
SHC  Capability  HRQoL -0.260 (0.026) -0.007 (0.001) <0.001 [-0.008; -0.006] 
     
SHC  Capability     
Direct -0.480 (0.040) -0.011 (0.001) <0.001 [-0.013; -0.010] 
β=standardized coefficient; SE = standard error; B=unstandardized coefficient, CI=confidence interval, SHC=secondary health conditions, SWB=subjective wellbeing. 
a Model fit: x2 (df=7)=8.002 (p=0.3324); RMSEA=0.020 (p=0.797); CFI=0.999; TLI=0.998. Covariates included in the model: age, type of injury and living arrangements. 
R2 SWB=0.673; R2 HRQoL=0.676; R2 Capability=0.235. 
b No results are presented for this path because it was not significant in the initial ‘full’ model and as such removed from the final model to yield a parsimonious model. 
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Table 6.7. Overview of hypotheses that were (not) confirmed by Model 1 and 
Model 2 
# Path Hypothesis Model 
1 
Model 
2 
1 A SHCs impact HRQoL negatively ✓ ✓ 
2 B SHCs have a negative impact on SWB ✓ — 
3 A vs. B SHCs have a less negative effect on SWB than on 
HRQoL 
✓ ✓ 
4 A C There is an indirect effect of SHCs on SWB mediated 
through HRQoL 
— ✓ 
5 D SHCs have a negative impact on capability wellbeing ✓ ✓ 
6 A vs. D SHCs have a greater negative impact on HRQoL than 
on capability wellbeing 
— — 
7 B vs. D SHCs have a less negative effect on SWB than on 
capability wellbeing 
✓ ✓ 
8 D E There is an indirect effect of SHCs on HRQoL mediated 
through capability wellbeing 
✓ ✓ 
9 D E C 
 
The indirect effect of SHCs on SWB is mediated 
through capability wellbeing and health functionings 
— ✓ 
10 DF  There is an indirect effect of SHCs on SWB mediated 
through capability wellbeing 
✓ ✓ 
HRQoL=health-related quality of life, SHCs=secondary health conditions, SWB=subjective wellbeing, — 
hypothesis not confirmed, ✓ hypothesis confirmed. 
 
6.4. Discussion 
This chapter has highlighted the different effects of SHCs on distinct 
measurement approaches. The results suggest that individuals living with SCI 
experienced the greatest negative impact of SHCs on their capability wellbeing, which 
means that SHCs influenced what individuals were able to do and be (what was possible 
for them). Capability wellbeing also meditated the relationship between SHCs and 
HRQoL as well SWB, which implies that whether or not individuals with SHCs can 
achieve good levels of HRQoL and be satisfied with their life depends on their 
capabilities – in this study non-health capabilities, such as stability, autonomy, and 
achievement. 
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In contrast to the strong influence of SHCs on individuals’ capability wellbeing, 
both models showed that SHCs have only a small (Model 1) or no direct effect (Model 2) 
on SWB. Compared with other types of outcome measures, SWB is different in two 
respects: (i) SWB uses individuals’ values and not those of the general population, and 
(ii) it is not based on a fixed and simplified descriptive system. With regard to the first 
point, when studying disabilities, such as SCI, researchers have often found that 
individuals report high levels of SWB despite living with severe conditions (Schulz & 
Decker, 1985; van Leeuwen et al., 2012). This is based on individuals’ adaptation 
process (i.e., the process of adjustment to new or changed circumstances) (Kahneman & 
Sugden, 2005). A previous study by Peeters et al. demonstrated that the effect of 
adaptation seems to be mediated by mental health domains of QoL (Peeters et al., 2010). 
Given that the ICECAP-A, EQ-5D-5L, and AQoL-8D are all based on societal values, the 
general public might not adequately forecast such coping strategies and adaptation one 
might experiences in a health state. As such, this has resulted in lower SWB scores or no 
effects at all. 
Secondly, SWB was measured by a single life satisfaction item, which allowed 
individuals to focus on any aspects of their lives and captures what actually matters to 
them with respect to their health (Dolan et al., 2012). Whereas fixed descriptive systems 
can be criticized in that they restrict the individual’s ability to provide an accurate 
description of their health state, the findings showed that some descriptive systems 
included in this study can explain variability in SWB that cannot be explained by SHCs 
directly. This suggests that when individuals are directly asked to report their level of 
satisfaction with life, individuals do not necessarily think of their conditions. However, 
SHCs still matter for their SWB because of the decreased level of health functionings and 
capabilities. As such, descriptive systems appear to be helpful to remind respondents of 
various aspects of their lives that matter for their level of wellbeing. Nevertheless, when 
comparing the direct effect of SHCs on SWB and the indirect effect mediated through 
HRQoL, differences between the two models were observed. Model 1 resulted in a 
significant direct effect but no indirect effect through the EQ-5D-5L. This suggests that 
SHCs lead to a loss in SWB not because it leads to poor health states but because of other 
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reasons not captured by the EQ-5D-5L descriptive system. A recent study, examining the 
extent to which the EQ-5D-3L is able to capture the effect of mental and physical health 
of life satisfaction in older adults, showed that the EQ-5D-3L does not adequately capture 
mental health status on life satisfaction (Sexton et al., 2016). Another study confirming 
that mental health dimensions have a large association with SWB (Mukuria & Brazier, 
2013), highlights that the EQ-5D-3L measure gives more weight to physical functionings 
that are however less associated with SWB. Such information could also explain the 
findings in this chapter, where SHCs had no indirect effect on SWB through the EQ-5D-
5L. This was the opposite in Model 2, where the loss in SWB was completely mediated 
through the AQoL-8D and implies that the descriptive system contains dimensions that 
reflect what is important for an individual’s wellbeing. This finding is consistent with a 
previous study that showed that compared with the EQ-5D-5L, the AQoL-8D has a 
greater ability to predict SWB (Richardson et al., 2015a).   
Differences were also observed between the direct effects of SHCs on the two 
HRQoL measures and the ICECAP-A. Whereas the direct effect of SHCs on EQ-5D-5L 
was smaller than on the ICECAP-A, in Model 2 the direct effects on the AQoL-8D and 
the ICECAP-A were similar. It appears that the AQoL-8D and the ICECAP-A measure 
similar constructs that are affected in a similar way by SHCs, which would support the 
conclusion in the previous Chapter 5. The similar mediating effects of the ICECAP-A 
and AQoL-8D on SWB can further support this statement. In addition to this direct effect, 
differences were also found for the mediating effect of capability wellbeing on HRQoL. 
The hypothesized model treated HRQoL as the end goal, mediated through individual’s 
non-health capabilities. It can be argued that HRQoL measures employ broad 
descriptions of health dimensions that either explicitly or implicitly relate to a wide range 
of non-health capabilities. While, for example, ‘usual activities’ or ‘self-care’ of the EQ-
5D-5L cannot be answered without giving thought to non-health capabilities, such as 
autonomy (an ability to be independent), the AQoL-8D has even more such dimensions 
in its descriptive system. This could explain the strong mediating effect of capability 
wellbeing on the AQoL-8D, which is also in line with Cookson’s idea of a ‘capability 
QALY’ (Cookson, 2005b), that was suggested in the previous chapter. Given the strong 
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mediating effect of capability on AQoL-8D, it can be argued that the descriptive system 
of the AQoL-8D  “pays close attention to proxy capability variables that cover a wide 
range of health and non-health dimensions of wellbeing” (Cookson, 2005a, p.1288).  
In view of the fact that the total effect of SHCs on HRQoL could not be explained 
by the direct effect only, suggests that the ICECAP-A mediated some effects of SHCs on 
the HRQoL that could not be captured by HRQoL directly. This could be explained by 
the different focus on capabilities vs. functionings. It is often criticized that compared 
with capabilities, functionings would ‘hide’ information because it is not clear if an 
individual, for example, does not enjoy ‘close relationships’ because he/she has not been 
given the opportunity for social interaction or because of personal choice (influenced by 
external factors such as social forces like stigma or attitudes). The ICECAP-A, that 
explicitly tries to capture what a person is able to do/be given his/her current 
circumstances and innate abilities, pays close attention to such conversion factors (i.e., 
the factors that determine how resources are converted to functionings). By rephrasing 
the questions in ‘are you able to’ or ‘can you’, the intention of the ICECAP-A measure is 
to consider such external characteristics, which may explain the mediating effect found in 
this work. In other words, in addition to the direct effect of SHCs on HRQoL, the 
ICECAP-A explained another portion of the variability in the HRQoL scores by paying 
close attention to external characteristics that were not captured by measures of HRQoL.   
6.4.1. Implications and directions for further research 
Low impact of SHCs on SWB is a reflection of individual’s ability to adapt to 
their conditions. This has implications for resource allocation decisions. The adaptation 
process is often considered as one of the criticisms in applying an experience-based 
method, such as SWB, for resource allocation decisions because the more individuals 
adapt to their conditions the less priority will be given to them (Dolan & Kaheman, 
2008). However, while it is generally known that people with long-term health conditions 
or who are physically disabled are more likely to adapt, mental health conditions, on the 
other hand, are the hardest to adapt to (Dolan et al., 2012). As a consequence, mental 
health patients value their own health state lower than the general public (Papageorgiou 
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et al., 2015; Pyne et al., 2009), which would disadvantage them unfairly compared with 
physical health conditions. Therefore, particularly in relation to mental health it has been 
suggested to replace or supplement QALYs with SWB in the assessment of health 
services because SWB would place a greater emphasis on mental health conditions 
(Dolan et al., 2012). A contrary view has been provided by a later study that showed that 
the impact of mental health conditions on a person’s life as a whole and upon a person’s 
wellbeing can be better assessed by the general public if the descriptive systems of 
HRQoL measures contain more concepts that capture the domains that matter most in the 
experiences of people’s lives (Richardson et al., 2015a). As was shown in the study by 
Richardson et al. the AQoL-8D had the greatest ability to account for variation in SWB. 
Future studies are warranted to provide further evidence on the direct implications for 
resource allocation decisions when applying a SWB or a QALY approach for both 
physical and mental conditions. 
The findings in this chapter highlight that the capability approach requires more 
attention in health care decision-making. Applied to the health care context, the 
evaluation of health care interventions should distinguish between observable health 
achievements and the capability to achieve good health. Particularly in the disability 
literature the capability approach is gaining increasingly attention. The disability research 
has shifted away from focusing merely on the individual at the body level (impairment) 
towards understanding the contextual situation of the individual in his/her environment 
(e.g., social, economic, political) (Mitra, 2006; Welch Saleeby, 2006). In other words, the 
capability approach emphasizes the need to move beyond actual functionings (outcomes 
or achievements) to promoting capabilities (opportunities or potential) (Welch Saleeby, 
2006). Opportunity can be understood as the range of valuable activities and experiences 
available to individuals, such as opportunity for social interaction, recreation or 
enjoyment. Therefore, what is important for persons with disabilities is not what they 
have already achieved, but what they potentially could achieve with the removal of 
barriers and creation of opportunities (Trani et al., 2011). For example, a physically 
impaired person requires more resources to achieve the functioning of mobility than a 
person who has no physical impairment. However, factors influencing the resources 
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available and the possibilities to use them may not only originate from the health sector 
but non-health sectors as well, such as the sector for infrastructure and transport or 
housing. As such, applying the capability approach in health care would not only require 
a shift from functionings to capabilities but also moving beyond the health care sector. 
Although NICE has recently included the use of capability instruments into its 
guidelines for evaluating social care, the operationalization of the capability approach to 
guide resource allocation decisions is still in their infancy. Mitchell et al. introduced the 
latest decision-rule for the capability approach based on ‘shortfall sufficiency’ (Mitchell 
et al., 2015b).  In doing so, the anchoring of the existing scale for the ICECAP 
instruments is adjusted, such that zero is equivalent to no capability but one is equal to 
‘sufficient capability’, where individuals have at least ‘a lot’ of capability on all attributes 
of the ICECAP instrument (i.e., scoring of 33333). In order to estimate sufficient 
capability over time, years of sufficient capability are then generated, where a year of life 
in sufficient capability has the value of one (Mitchell et al., 2015b). Applying the 
sufficient capability approach in practice implies that the evaluation of health care 
intervention would shift away from efficiency toward prioritizing patient groups who are 
below the poverty level (i.e., moving from maximization to sufficiency). Such approach 
would require valid and sensitive measures of a person’s capability. However, one of the 
shortcomings of the ICECAP instruments is that they provide information about 
perceived rather than actual capabilities. There is a potential risk that individuals may not 
recognize their own lack of capability because they have adapted to their situation, which 
may result in lower priority in resources allocation decisions.  
The future use of the capability approach in resource allocation decisions remains 
unclear. Cookson emphasized, the best start in applying the capability approach to health 
economics, is to maintain a QALY type framework but to select a QALY instrument that 
pays closer attention to non-health dimensions of wellbeing (Cookson, 2005a). In this 
context, the QALY will be re-interpreted as a capability QALY. Others have also argued 
that if the intention is to look for a health capability account that can be used to inform 
resource allocation decisions, instruments like the EQ-5D is ‘not a bad starting point’, 
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even if it is not a capability measure per se (Wolff et al., 2012). Wolff and colleagues 
even proposed that the EQ-5D measure could be used to measure experienced utility, 
given that the five dimensions of the EQ-5D are all either aspects of a patient’s 
experience or will affect their experience. However, this work showed that there are 
differences in effects of SHCs on these three different outcome measures and use of 
HRQoL instruments as a proxy for capability or experienced utility is not 
straightforward. As such, the findings suggest that these three measurement approaches 
cannot be used as substitutes but rather as complements. Given that many jurisdictions 
focus on achieved health outcomes based on QALYs, the complementary use of the 
capability measure would extend the QALY framework by considering the ability to 
pursue health as well as assessing health outcomes (Kinghorn, 2015). 
6.4.2. Strengths & limitations  
The choice of an outcome measure for use in economic evaluation was discussed 
a number of times in the literature (Coast et al., 2008d; Dolan et al., 2012; Lorgelly, 
2015). Compared with these previous studies, which were mainly concerned with 
normative issues (i.e., identifying an appropriate maximand for resource allocation 
decisions), this chapter provides empirical evidence about the impact of SHCs on these 
different measurement approaches. The context of SCI in this work plays particularly an 
important role, as the ability of adaptation is an important consideration in outcome 
measurement. The conduct of a path analysis, which can be seen as an extension of a 
regression analysis, is another strength of this study that allowed not only the analyses of 
direct effects but also indirect effects, which have offered further insights into the 
relationship between the measures. Given that all paths were analyzed simultaneously, 
issues related to multiple hypotheses testing were avoided. Finally, the application of two 
models that used different measures of HRQoL makes the analysis stronger and increases 
the confidence in the findings. On the contrary, differences were found between Model 1 
and Model 2, which suggest that further studies are needed to replicate the analysis using 
other measures of HRQoL, capability and SWB. There is an increasing interest in the 
capability approach to outcome measurement and other instruments of capability outside 
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the ICECAP family include the OCAP-18, OxCAP-MH for use in mental health, and the 
ASCOT for use in social care (Lorgelly, 2015). Also, different experience-based 
measures exist that do not necessarily consist of one question, which was the case in this 
work, but measure the level of satisfaction for different domains of life.  
The biggest limitation of this study is the cross-sectional design of the study, 
which is why longitudinal studies are needed to confirm the effects found in this study. 
Given that the sensitivity of instruments that have a broader evaluative space is not 
perfectly established, it could be that, compared with a measure of health, broader 
measures may be insensitive to changes in health alone. A recent study found that the 
EQ-5D-5L is more responsive than the ICECAP-O among individuals at risk of mobility 
impairment among adults aged ≤ 70 (Davis et al., 2016) but further studies are needed. 
Finally, it needs also to be acknowledged that path analysis cannot be used to establish 
causality. Causality is generally established through the design of the study and not its 
analysis (Streiner, 2005). 
6.5. Conclusion 
The choice of an outcome measure to guide resource allocation decisions in health 
care requires careful consideration. This study has shown that SHCs have different 
impacts on HRQoL, capability and SWB. The results suggest that the ability of 
individuals with SHCs to achieve good health functionings depends on their level of 
capability. Complementing QALY results with individuals’ capability wellbeing can 
better inform economic evaluations, focusing not only on ‘observed health’ but the 
‘capability to achieve good health’, which takes into account personal factors (e.g., 
impairment) and circumstantial characteristics (e.g., environment). Further studies are 
needed to replicate the analysis using other measures of HRQoL, capability and SWB. 
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Chapter 7. Thesis summary and conclusions 
The aim of this thesis was to examine methodological considerations regarding 
the use of outcome measures that extend beyond HRQoL in the context of QALY-based 
economic evaluation. In addition, this thesis examined implications for policy and 
practice when broadening the evaluative space of the QALY. Through a series of studies, 
this thesis explored the following research questions:  
• What are the potential challenges in broadening the evaluative space of the QALY? 
• What is understood by ‘benefits beyond health’?  
• What information is captured by ICECAP measures over and above the information 
garnered by existing preference-based HRQoL measures? 
Chapter 7 provides a summary of the key findings and contributions to the existing 
literature. Strengths and limitations of the analytic approaches are discussed, followed by 
a reflection of the extent to which the challenges identified in Chapter 2 have been 
addressed by this thesis, and which challenges require further research. The thesis ends 
with some concluding remarks.  
7.1. Key findings and contributions to existing knowledge 
This section summarizes the key findings of this thesis and the contributions to 
existing knowledge concerned with the evaluative space of the QALY. It will outline (i) 
if it is possible to broaden the evaluative space of the QALY, (ii) provide a better 
understanding of benefits beyond the health-related QALY, and (iii) if there is a need to 
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broaden the evaluative space, given that the QALY may not be as health-focused as 
claimed.  
7.1.1. Can we broaden the evaluative space of the QALY? 
Chapter 2 explored whether the evaluative space of the QALY can be broadened, 
and set out associated challenges. The breakdown of challenges into theoretical, 
normative, conceptual, methodological, and practical issues allowed for the identification 
of areas that require specific attention. The chapter provided clarity about the theoretical 
concept of extra-welfarism and has highlighted that it is possible to include benefits into 
the QALY framework that extend beyond health. Advantages of adopting an extra-
welfarism approach include the use of outcomes other than utility and the use of sources 
of valuation other than the affected individuals. There is no theoretical barrier to 
extending the evaluative space of the QALY beyond health outcomes. Instead, 
identifying an appropriate maximand and dealing with normative issues around the scope 
of the evaluative space of the QALY are the main challenges. The chapter reflected on 
previous literature and outlined two normative considerations for broadening the 
evaluative space of the QALY: (i) whether individuals value non-health benefits and (ii) 
whether or not considering such broader outcomes can potentially impact resource 
allocation decisions. An important observation in this chapter was the ambiguity of the 
term ‘non-health benefit’. The chapter concluded that conceptual issues need to be solved 
first (i.e., what do we mean by benefits beyond health?). In addition, this chapter 
highlighted the need for further examination of the extent to which existing preference-
based HRQoL instruments already capture benefits beyond health. These two 
considerations shaped the rest of the thesis. The extent to which other challenges 
identified in this chapter were addressed by analyses conducted in this thesis are 
discussed in Section 7.3. 
7.1.2. What is understood by benefits beyond the health-related QALY? 
Chapter 3 provided important insights through the conceptualization of benefits 
beyond the health-related QALY. Although non-health benefits have been extensively 
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discussed in the literature, no previous studies have tried to bring all evidence together 
and to conceptualize the relationships between such broader benefits. Considering the 
current debates to move beyond the health-related QALY (Brazier & Tsuchiya, 2015), a 
better understanding of such broader benefits was needed and the chapter identified four 
types of non-health benefits: (i) benefits affecting wellbeing (psychological wellbeing, 
subjective wellbeing, capability wellbeing, and empowerment); (ii) benefits derived from 
the process of health care delivery (process utility); (iii) benefits beyond the treated 
individual (e.g., option value, externalities, spillover effects, and equity); and (iv) benefits 
beyond the health care sector. Chapter 3 concluded that the exclusion of benefits beyond 
health does not appear to be problematic for the QALY metric per se and, instead, 
embracing such an approach raises a number of issues for health care decision-making 
(e.g., identifying an appropriate maximand for resource allocation decision-making). 
Chapter 3 also highlighted that QALYs are defined by what is measured (e.g., HRQoL, 
using the EQ-5D-5L) rather than the conceptual origin (Goebbels et al., 2012; Whitehurst 
& Engel, 2017). Given that preference-based HRQoL measures differ greatly in their 
coverage of HRQoL dimensions, Chapter 3 cautioned that the extent to which existing 
preference-based HRQoL measures are able to ‘pick up’ non-health benefits is currently 
unknown and any attempt to measure health and non-health benefits simultaneously 
could potentially result in double counting. This notion was explored further in the 
subsequent chapters.   
7.1.3. Is the evaluative space of the QALY limited to health? 
Whether or not the evaluative space of the QALY is limited to health alone was 
explored by three empirical analyses in this thesis. The approach taken to address this 
question was through direct comparisons of preference-based HRQoL measures that are 
used to derive QALYs with outcome measures that adopt a broader evaluative space.  
Chapter 4 was an application of the EQ-5D-5L outside the conventional clinical 
context. Exploring the ability of the EQ-5D-5L to capture broader environmental benefits 
was the first attempt to investigate how sensitive the EQ-5D-5L is to aspects that are not 
directly related to health. Given that the analyses in Chapter 4 were also applied to a 
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measure of capability wellbeing, the ICECAP-O, it was possible to examine whether the 
ICECAP-O measures something different compared with the EQ-5D-5L. Results from 
the Walk-The-Talk study showed that older adults’ capability wellbeing (based on the 
ICECAP-O) was associated with street connectivity and social cohesion, while no 
statistically significant associations were found between environmental factors and 
HRQoL (based on the EQ-5D-5L). While such findings demonstrate differences between 
the ICECAP-O and the EQ-5D-5L in terms of the extent to which the respective index 
scores were explained by environmental features, exactly what was driving the 
differences could not be answered by this chapter and was subsequently explored in 
Chapters 5 and 6. 
Chapter 5 investigated the underlying descriptive content of the EQ-5D-5L and 
the adult version of the ICECAP through the conduct of an exploratory factor analysis. 
Results indicated that the EQ-5D-5L and the ICECAP-A measured tapped into distinct 
factors and provide complementary information, which confirmed previous studies that 
explored the overlap between the ICECAP measures (ICECAP-A and ICECAP-O) and 
the EQ-5D-3L (Davis et al., 2013; Keeley et al., 2016). Findings of the exploratory factor 
analysis also helped to explain differences found between the EQ-5D-5L and the 
ICECAP-O in the previous chapter. An important contribution of this chapter was the 
extension of the analyses beyond the EQ-5D-5L – including other preference-based 
HRQoL measures available in the MIC dataset (15D, AQoL-8D, HUI-3, and SF-6D) – 
where results indicated a substantial degree of overlap between the AQoL-8D and the 
ICECAP-A. Although the ICECAP-A was developed to overcome perceived limitations 
with the evaluative space of the QALY, such findings suggest that broader benefits, as 
defined by the ICECAP-A, could potentially be captured by the AQoL-8D. In this 
context, the potential risk of double counting was highlighted when applying ICECAP 
measures alongside HRQoL measures. Despite the conceptual overlap between the 
AQoL-8D and the ICEACP-A, the comparative performance of these two measures was 
unknown and was explored further in the final empirical analysis of the thesis. 
Chapter 6 introduced another outcome measurement approach that was compared 
with preference-based HRQoL measures – the concept of subjective wellbeing (SWB). 
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SWB accounts for the domains of health that matter most in the experience of people’s 
lives by using individuals’ own values and not describing health in terms of a fixed and 
simplified descriptive system. Chapter 6 was the first empirical analysis in the field of 
outcome measurement in economic evaluation that looked at all three outcome 
measurement approaches (HRQoL, capability wellbeing, and SWB) within the same 
dataset. Findings from this analysis showed that secondary health conditions (here, in the 
context of spinal cord injury) have different impacts on HRQoL, capability and SWB. 
However, when measuring HRQoL using the AQoL-8D, a similar impact of secondary 
health conditions was observed on the ICECAP-A and the AQoL-8D. Furthermore, the 
AQoL-8D fully mediated the impact of secondary health conditions on SWB, which 
implies that the descriptive system contains dimensions that reflect what is important for 
an individual’s wellbeing. Such findings confirm that the evaluative space of the QALY 
is not limited to health, given that the AQoL-8D seems to measure aspects of wellbeing. 
However, in view of the fact that the effect of secondary health conditions on the AQoL-
8D was partly mediated by the ICECAP-A suggests that observed functionings in the 
AQoL-8D depend on a person’s capability wellbeing. In terms of the evaluative space of 
the QALY, this finding implies that although the ‘objects of value’ are similar between 
the AQoL-8D and ICECAP-A, differences exist in what respect they are valued (i.e., 
functionings versus capabilities). It was proposed that the complementary use of a 
capability measure would extend the QALY framework, focusing not only on ‘observed 
health’ but the ‘capability to achieve good health’. 
While the thesis was largely focused on methodological considerations when 
using outcome measures in health economic evaluation that extend beyond HRQoL for 
the estimation of QALYs, each chapter also discussed the implications for policy and 
practice. The findings of this thesis have particular relevance for national HTA bodies 
that set guidelines for the conduct of economic evaluation – some of which have recently 
recommended the use of broader outcome measures. Key points for decision makers are 
summarized in Table 7.1. 
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Table 7.1. Key points for decision makers 
#1 The adoption of a broader definition of the extra-welfarism framework is 
recommended, which would extend the maximization of outcomes beyond health 
#2 The evaluative space of the QALY is not necessarily limited to health and is 
largely driven by dimensions included in preference-based HRQoL measures 
#3 Non-health benefits can be incorporated into the QALY framework, although 
further research is needed to address normative and methodological concerns 
#4 Using the ICECAP measures as complementary measures in resource allocation 
decisions may result in double-counting, depending on the choice of HRQoL 
measure 
#5 If the allocation of health care resources should be informed by the impact of 
interventions on broader benefits, the selection of a preference-based HRQoL 
measure should not be limited to the EQ-5D-5L but left open to measures that are 
more sensitive to such broader benefits (e.g., the AQoL-8D) 
#6 Compared with preference-based HRQoL, the use of SWB to guide health care 
allocation decisions requires careful considerations and further research  
#7 The use of the capability approach has the potential to provide additional 
information to support health care decision-making (i.e., reporting individuals’ 
true opportunities to achieve good health) 
#8 Arguments for the use of capability measures in health economic evaluation 
should not be in terms of their extension of the evaluative space ‘beyond health’ 
but rather in moving away from functionings ‘towards capabilities’ 
 
7.2. Strengths & limitations 
While strengths and limitations were reported in the individual chapters, there are 
some key aspects that apply to the thesis overall. The main objective of the three 
empirical analyses (Chapters 4, 5, and 6) was to gain a better understanding of the 
relationships between preference-based HRQoL and measures that extend beyond health. 
On that note, a key strength of this thesis was the application of different methods that 
addressed different components of the overall research question: (i) regression analysis 
compared the sensitivity of a HRQoL measure and a capability measure towards 
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environmental features; (ii) exploratory factor analysis looked explicitly at the descriptive 
systems of preference-based HRQoL measures and a capability measure by exploring the 
underlying constructs; and (iii) path analysis allowed for the exploration of direct and 
indirect effects between three outcome measurement approaches. While preference-based 
measures (regardless of whether related to HRQoL or capability wellbeing) consist of a 
descriptive system and a valuation system, the methods outlined above looked at both 
systems, which allowed for a deeper understanding of the relationships between HRQoL 
and broader preference-based measures.  
Previous literature has repeatedly stated that public health interventions require 
broader measures of outcome (Lorgelly et al., 2010). This thesis was able to inform these 
discussions further through the examination of a capability measure in the context of 
public health. Furthermore, the opportunity for exploration of the capability approach in 
older adults and individuals with spinal cord injury can be seen as another strength, given 
that the distinction between capabilities and functionings is likely to be more evident in 
these two groups compared with other population groups (Mitra, 2006). Another strength 
of this thesis is the consideration of several preference-based HRQoL measures rather 
than just the EuroQol instruments. Previous research has highlighted numerous 
differences between preference-based HRQoL measures (Richardson et al., 2015b) and, 
as such, it was essential to address the research questions taking not only the frequently 
used EQ-5D-5L into account. 
The selection of preference-based HRQoL measures in this thesis requires a 
further note. While the availability of datasets that collect multiple preference-based 
HRQoL measures and/or multiple measures of wellbeing is limited, a strength of this 
thesis is the use of two datasets (Chapter 5 and Chapter 6) that comprise such outcome 
measures. Yet, despite the existence of a number of measures, not all were included in the 
analyses. In Chapter 5, no exploratory factor analysis was conducted comparing the 
ICECAP-A with the QWB-SA. This was due to the scaling properties of the QWB-SA, 
which were not suitable for an exploratory factor analysis (see page 100). In Chapter 6, 
besides the availability of the AQoL-8D and the EQ-5D-5L, this dataset also contained 
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the SF-36v2 and the HUI. The motivation to focus on the AQoL-8D and EQ-5D-5L only 
was driven by previous research that supported the use of the AQoL-8D in the context of 
spinal cord injury (Michel et al., 2016; Whitehurst et al., 2016) and the findings of the 
exploratory factor analysis, where a strong overlap was observed between the ICECAP-A 
and the AQoL-8D. As such, further exploration of the AQoL-8D was a natural course of 
action. The focus on the EQ-5D in all three empirical analyses in this thesis was driven 
by its widespread use, the preference of some decision makers for this measure (NICE, 
2013; Richardson et al., 2015c), and its availability in all three datasets. 
With regard to capabilities, this thesis focused exclusively on the ICECAP-A and 
ICECAP-O measures. While this allowed for a better exploration of the ICECAP 
instruments using different methodological approaches, this thesis is not able to draw any 
conclusions for other measures that offer a broader evaluative space for outcome 
measurement in economic evaluation. An instrument that should be explored further is 
the ASCOT (Netten et al., 2012). Although the ASCOT is a measure of social care-
related QoL, it was developed based on the same motivational grounds as the ICECAP 
instruments, namely the incorporation of broader benefits within economic evaluation. 
Furthermore, throughout the thesis, there is often reference made to the ‘ICECAP 
instruments’. This reflects the fact that the ICECAP instruments considered in this thesis 
(ICECAP-A and ICECAP-O) were developed by the same research team at the 
University of Birmingham (UK), comprise similar domains, and are characterized by the 
same language. However, it needs to be acknowledged that the ICECAP-A and the 
ICECAP-O are two distinct measures. Thus, findings reported about the ICECAP-O do 
not necessarily apply to the ICECAP-A and vice versa.    
A further limitation of this thesis is in regard to the data used in the three 
empirical analyses. All three datasets consisted of cross-sectional data, meaning that the 
investigation of the research questions in a longitudinal context was not possible. While 
this may be less of an issue for Chapter 5 (i.e., the exploratory factor analysis), Chapters 
4 and 6 would have benefited from further longitudinal explorations. In view of the fact 
that the ICECAP-O and the ICECAP-A are relatively new instruments, their 
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responsiveness to change has not fully been explored and contradictive findings have 
been reported across studies that have looked at responsiveness to change (Davis et al., 
2016; Keeley et al., 2015). These issues need to be considered when judging the 
generalizability of the study findings and drawing conclusions for current practice.  
7.3. Challenges addressed and areas for further research 
Chapter 2 discussed numerous challenges that require further attention in 
broadening the evaluative space of the QALY. This section will reflect on these 
challenges and outline to what extent these were addressed by this thesis and which 
challenges require further research. To begin with, while an important contribution of this 
thesis was the exploration of the relationship between preference-based HRQoL measures 
and measures of capability wellbeing, existing problems associated with the 
operationalization of the capability approach for outcome measurement outlined in 
Chapter 2 (i.e., identification, measurement and valuation of capabilities) still require 
further research. Other considerations when using the capability approach to inform 
resource allocation decisions are discussed below. 
7.3.1. Using the capability approach to inform resource allocation 
decisions 
The use of the capability approach to inform resource allocation decisions 
remains an issue of debate. While it is gaining attention within the context of public 
health, social care and end-of-life care, Lorgelly has suggested that the capability 
approach could also be of benefit to evaluations of pharmacotherapies and other 
technologies (Lorgelly, 2015). In contrast, it has been argued that the capability approach 
seems unclear and insufficiently justified to be used to inform resource allocation 
decisions (Sampson, 2016). The ways in which researchers have operationalized the 
capability approach suggests that its primary goal in health economics is the extension of 
the evaluative space of the health-related QALY. Sampson has argued that moving 
‘beyond health’ rather than ‘towards capabilities’ has received less discussion, suggesting 
there have been fewer arguments provided in favour of such an extension to the 
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evaluative space (Sampson, 2016). It is a fair question to consider what the benefit of 
using the capability approach is compared with using preference-based HRQoL 
measures. For this reason, the underlying factor structure of the capability approach was 
examined in Chapter 5, where the exploratory factor analysis indicated conceptual 
overlap between the AQoL-8D and the ICECAP-A. Yet, Chapter 5 was only concerned 
with the value of objects (what is valued (the domains)) and less with the consequences 
(why is it valued (in terms of capabilities or functionings)).  
When moving the evaluative space from functionings to capabilities, another way 
to explore the role of the capability approach is in regard to the evaluation of 
interventions to inform resource allocation decisions. It can be argued that the focus on 
capabilities is more appropriate than on functionings because the provision of health care 
interventions can generally only create opportunities for individuals to realize certain 
functionings, such as the ability to enjoy close relationships (Al-Janabi, 2014). Health 
care policy cannot force individuals to enjoy close relationships, as it is the individuals’ 
decision to choose the life they want to live. This becomes particularly important for 
public health interventions, such as environmental interventions, where places are created 
to provide opportunity for people for social interaction regardless of whether or nor they 
would like to be involved in social activities. What matters is that environmental 
interventions contribute to a person’s wellbeing because individuals know they have an 
opportunity for social interaction. However, it is not self-evident how interventions 
should be evaluated based on the changes in possible (not actual) enjoyment of close 
relationships (Karimi et al., 2013). While the ICECAP instruments attempt to measure 
capabilities through the use of particular wording to measure a person’s capabilities (such 
as what a person ‘can do’ or ‘is able to do’), whether individuals are able to truly 
recognize their opportunities remains an area for further research. Also, considering the 
concept of opportunity cost, whether resources should be taken away to help someone to 
increase their capability for social interaction, even though they do not like to be socially 
engaged, is debatable. For decision makers, a focus on measuring functionings may 
appear more appropriate. 
Another notion that warrants further investigation is whether the capability 
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approach should replace the current health-related QALY approach, or if there are ways 
to combine these two measurement approaches (i.e., treat them as complements). The 
findings from Chapter 6 show that the ability of individuals with secondary health 
conditions to achieve good health functionings was influenced by their level of 
capability. Therefore, complementing QALY results with individuals’ capability 
wellbeing can better inform economic evaluations, focusing not only on ‘observed health’ 
but the ‘capability to achieve good health’, which takes into account personal factors 
(e.g., impairment) and circumstantial characteristics (e.g., environment). This becomes 
particularly important for the population groups explored in this thesis (older adults and 
individuals with spinal cord injury), where individuals may have mobility issues but 
policy can change the environment to accommodate such problems. 
In order to use the capability approach for resource allocation decisions, there are 
other points that require attention. Firstly, it is generally known in the capability literature 
that the selection of capabilities needs to be context specific, and derived from a 
participatory approach (Kinghorn, 2015). Therefore, the application of the UK-developed 
ICECAP measures globally can be challenged. In this context, the emphasis of future 
studies could be on the justification of selected functionings or capabilities. Secondly, in 
order to determine the value of a capability improvement, further research needs to 
explore the cost-effectiveness threshold level to value the improvements in capability 
gains or for a sufficient capability level (Mitchell et al., 2015b). Finally, there remains 
scope for qualitative research in this area in terms of the exploration of individuals’ 
abilities to distinguish between capabilities and functionings. The think-aloud study by 
Al-Janabi et al. showed that individuals were able to self-report their capabilities and also 
identified how their capabilities diverged from their level of functionings (Al-Janabi et 
al., 2013a). However, the study also showed that some participants still understood the 
ICECAP-A questions in terms of their functionings and had difficulties with the 
capability concept. 
 165 
7.3.2. Is it time to redefine health? 
This thesis explored the methodological and practical implications in going 
beyond health-related QoL for outcome measurement in economic evaluation. While the 
main focus was on non-health rather than health benefits, the conceptualization of non-
health benefits in Chapter 3 was ultimately driven by the definition of health. Following 
the WHO typology, which states that health problems result in impairment, disability and 
participation, existing preference-based HRQoL measures have based their descriptive 
systems on these concepts, although differences between measures exist (Richardson et 
al., 2014a). Nevertheless, some researchers have criticized existing preference-based 
HRQoL for not measuring patients’ health as defined by the WHO definition (de Vries et 
al., 2016). Others have challenged the WHO definition itself and proposed to define 
health as ‘the ability to adapt and to self-manage’, which is a better reflection of the 
human capacity to cope autonomously with life’s changing physical, emotional, and 
social challenges, and to function with fulfilment and a feeling of wellbeing (Huber et al., 
2011). An important argument that Huber and colleagues provide is that this definition is 
more meaningful for health policy, where health gain in terms of survival may be less 
relevant than societal participation, and an increase in coping capacity may be more 
relevant and realistic than complete recovery. It is likely that adopting such a broad 
definition of health would close the gap between HRQoL and QoL (Wichmann et al., 
2017). Removing the health-related aspect of HRQoL would also no longer disadvantage 
interventions that do not primarily focus on improving HRQoL (Wichmann et al., 2017). 
Sampson, furthermore, argued that Huber and colleagues’ definition implies capabilities 
as a consequence (Sampson, 2016). Therefore, the focus on people’s ability to adapt and 
to self-manager provides a concept of health that would take capabilities into account.  
One of the reasons why Huber and colleagues find the WHO definition 
counterproductive is that it classifies people with chronic diseases and disabilities as ill 
(Huber et al., 2011). The WHO definition does not reflect people’s ability to develop 
strategies for coping, and evidence has shown that impaired functioning does not 
necessarily change people’s QoL (von Faber et al., 2001). This was also observed in 
Chapter 6, where secondary health conditions had no impact (or only a small negative 
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impact) on individuals’ SWB. This finding highlights the fact that individuals with spinal 
cord injury can be satisfied with their lives despite being impaired and having secondary 
health conditions. In order to apply Huber and colleagues’ definition of health in health 
economic evaluations, a preference-based HRQoL measure would be required that 
reflects individuals’ ability to adapt and to self-manage. While a previous study showed 
that adaptation is mediated by mental health domains of QoL (Peeters et al., 2010), 
findings in Chapter 6 also indicated that effects of secondary health conditions on SWB 
were mediated by the AQoL-8D, indicating that the AQoL-8D accounts for adaptation. 
Richardson and colleagues have previously stated that the AQoL-8D is sensitive to 
changes in the dimensions that drive adaptation, given the psychosocial component of the 
descriptive system (Richardson et al., 2014b). Further evidence to support the ability of 
the AQoL-8D to account for adaptation can be drawn from a previous publication, which 
showed that the AQoL-8D allowed individuals with spinal cord injury to report health 
state values at the upper end of the 0-1 scale, despite their significant mobility 
impairments (Whitehurst et al., 2016). As the authors of this study stated, this is most 
likely because of the definition of mobility employed by the AQoL-8D, which is not 
limited to individuals’ capacity to walk. 
7.3.3. Consistency and pragmatism in health care decision making 
Making resource allocation decisions in health care is a challenging task and the 
need to maintain methodological consistency is important (NICE, 2013). In the past 
decades, decision makers have based their decisions on cost per QALY gains, where 
QALY weights were often derived from the EQ-5D (-3L or -5L). Moving away from the 
current definition of health and the preference-based instruments that are widely used is 
associated with challenges. The empirical analyses conducted in Chapters 5 and 6 
showed that the AQoL-8D is a promising measure. The AQoL-8D extends beyond the 
narrow focus on HRQoL and combines health and non-health outcomes. This 
combination has been previously suggested to be an important characteristic of measures, 
from which one could derive capability-QALYs (Cookson, 2005b). The AQoL-8D also 
seems to better reflect Huber and colleagues’ definition of health in terms of the ability to 
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adapt and to self-manage (Huber et al., 2011). Yet, as was shown in a recent review, the 
AQoL-8D has received less attention in the health economics literature outside of its 
country of origin (Australia) (Richardson et al., 2015c). Compared with other preference-
based HRQoL measures, a unique feature of the AQoL-8D is that each dimension has 
more than one item. While this feature draws upon psychometric theory, which suggests 
a minimum of three items per dimension (Richardson et al., 2014a), the number of items 
included in the AQoL-8D is likely to be associated with challenges in terms of 
practicality, due to the length of the questionnaire and the valuation of health states. A 
previous focus group study found that the length of a questionnaire is not a negative 
feature per se, when compared with perceived relevance (Whitehurst et al., 2014b). 
However, the importance of the length of questionnaires for use in clinical practice and 
research will differ depending on the context, although some measures that are 
commonly used have more items than the AQoL-8D (e.g., the SF-36v2 (Ware et al., 
2008)). Another challenge when using a measure with a more comprehensive descriptive 
system relates to the valuation exercise. While it is usually recommended that health 
states contain no more than nine attributes (Brazier et al., 2017), the valuation of the 
AQoL-8D involved the valuation of health states described using all 35 items 
(Richardson et al., 2014b). Although a number of approaches were employed to make the 
AQoL-8D valuation task more palatable, the task does appear more complex compared 
with those completed for other preference-based instruments (Brazier et al., 2017). 
At this stage it remains unclear if any changes to the AQoL-8D would result in 
improved uptake. The fact that UK and Dutch guidelines prefer explicitly the EQ-5D 
(NICE, 2013; Zorginstituut Nederland, 2016) indicates that at least in these jurisdictions 
the use of another measure is more challenging. Although the latest Canadian guidelines 
do not indicate such a preference for the EQ-5D (CADTH, 2017), the fact that the EQ-5D 
(3L or 5L) is the most often used measure (Richardson et al., 2015c) suggests that 
analysts and decision makers may still be reluctant to embrace a new measure. The 
primary reason for this is the need for some degree of pragmatism in health care decision-
making. Decision makers may be aware of limitations of the EQ-5D-5L but, without 
strong evidence to the contrary, the continued use of ‘conventional’ methods will prevail. 
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The dominant position of the EQ-5D-5L may also be the reason why there is interest in 
addressing the problem of non-health benefits in terms of developing bolt-ons to the EQ-
5D (3L or 5L) rather than new measures. While the AQoL-8D contains health and non-
health outcomes, it is currently unknown if one comprehensive measure is preferred in 
decision-making over a combination of HRQoL and wellbeing measures. Employing 
multiple measures would allow for the separation of HRQoL and non-health benefits, 
where decisions could be explored separately and where, for example, different 
thresholds for HRQoL and non-health benefits could be applied. On the other hand, 
decision makers may find it more challenging to judge the relative value of HRQoL and 
non-health outcomes. Ultimately, to better inform decision makers, it is necessary to 
formally identify what patients and citizens fundamentally want from their health service, 
and whether society is willing to give up health gains for improvements in non-health 
benefits. 
7.4. Concluding remarks 
This thesis has focused on the evaluative space of the QALY and examined the 
relationships between preference-based HRQoL measures and broader measures of 
wellbeing. It has shown that the application of broader wellbeing measures in economic 
evaluation requires careful considerations due to the risk of double counting. The 
conceptual overlap between the ICECAP-A and the AQoL-8D has demonstrated that 
broader non-health outcomes are not necessarily excluded from the QALY metric per se, 
and that descriptive systems of preference-based HRQoL measures determine the 
evaluative space of the QALY. The focus on capability measures in this thesis provided 
support for the use of the capability approach to inform resource allocation decisions in 
health care. However, the operationalization of this approach and other non-health 
benefits identified in this thesis, within or outside the QALY framework, requires further 
research. 
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Appendices to Chapter 3 
Appendix 3.1. Characteristics of the included papers 
Author(s), year Type of work Objective Concept of interest 
Core papers (n=21) 
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paper 
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scope of QALYs – going 
beyond the patient 
Care-related quality of life 
Al-Janabi et al., 
2012 
Empirical 
analysis 
To develop the ICECAP-A Capability wellbeing  
Birch & 
Donaldson, 
2003 
Discussion 
paper 
To discuss the welfarism and 
the extra-welfarism approach 
Welfarism/ extra-welfarism 
Brennan & 
Dixon, 2013 
Review To summarize studies that 
provide an empirical measure 
of process utility 
Process utility 
Brouwer et al., 
2008 
Discussion 
paper 
To compare welfarism and 
extra-welfarism 
Welfarism/ extra-welfarism 
Chisholm et al., 
1997 
Discussion 
paper 
To discuss strengths and 
shortcomings of QALYs in 
the context of mental health 
QALYs in mental health 
Coast et al., 
2008a 
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paper 
To discuss the evaluative 
framework for the ICEPOP 
Capability and the quality of 
life of older people; unpaid 
care for older people; and 
end-of-life care for older 
people 
Coast et al., 
2008d 
Discussion 
paper 
To discuss welfarism, extra-
welfarism, and the capability 
approach for use in health 
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Welfarism/ extra-welfarism/ 
capability approach 
Cookson, 2005b Discussion 
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To discuss the application of 
the capability approach in 
QALYs 
Capability QALY 
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Donaldson & 
Shackley, 1997 
Empirical 
analysis 
To proof the existence of 
process utility in health care 
Process utility 
Dowie, 2001 Discussion 
paper 
To analyze health outcomes Health outcomes 
Gandjour, 2001 Discussion 
paper 
To discuss the role of 
subjective wellbeing for 
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Subjective wellbeing 
Goebbels et al., 
2012 
Qualitative 
research 
To explore non-health 
outcomes in health promotion 
Non-health outcomes 
Lorgelly et al., 
2010 
Review To review outcome measure 
used in public health and to 
discuss the role of the 
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Capability approach 
Mooney, 1998 Discussion 
paper 
To discuss outcome beyond 
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2010 
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Payne et al., 
2013 
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Round et al., 
2014 
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Ryan et al., 2014 Review & 
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Discussion 
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Benefits of health care 
Simon et al., 
2013 
Empirical 
analysis 
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capability approach in mental 
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Capability approach 
1st wave of search (n=47) 
Al-Janabi et al., 
2013b 
Empirical 
analysis 
To investigate the construct 
validity of the ICECAP-A 
Capability wellbeing 
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To explore consumer 
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non-health outcomes of 
health promotion 
Non-health outcomes in 
health promotion 
Ali & Ronaldson, 
2012 
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Annemans et al., 
2013 
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Pharmacoeconomic 
evaluations 
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Coast, 2014 Discussion 
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of end of life care could be 
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End of life care 
Connell et al., 
2014 
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quality of life that are 
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mental health problems 
Mental health 
Coulter et al., 
2013 
Discussion 
paper 
Expert panel views on   
Economic analysis of 
complementary, alternative, 
and integrative medicine 
Complementary, alternative, 
and integrative medicine 
Crosignani et al., 
2015 
Discussion 
paper 
To discuss the economic 
aspects of infertility care 
Infertility care 
Davidson & 
Levin, 2010 
Discussion 
paper 
To analyze how relatives’ 
costs and effects could be 
measured, valued and 
incorporated into a cost-
effectiveness analysis 
Relatives’ QALY  
(R-QALY) 
Davis et al., 2013 Empirical 
analysis 
To compare the ICECAP-O 
with the EQ-5D 
EQ-5D vs. ICECAP-O 
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Dirksen, 2014 Discussion 
paper 
To provide an overview of the 
issues and controversies 
related to the use of research 
evidence on patient 
preferences 
Patient preferences 
Edwards et al., 
2013 
Review To examine what guidance 
currently exists in the field of 
economic evaluations of 
public health economics 
Economic evaluation in 
public health 
Essink-Bot et al., 
2003 
Discussion 
paper  
To apply the CUA framework 
in prostate cancer screening 
Prostate cancer screening 
Gandjour, 2014 Letter to the 
Editor 
To discuss disutility from 
waiting times 
Waiting times 
Grosse et al., 
2008 
Review To discuss the relative merits 
of different economic 
measures and methods to 
inform recommendations 
relative to genetic testing for 
risk of disease 
Genetic testing 
Hausman, 2012 Discussion 
paper 
To discuss whether the global 
burden of diseases, injuries, 
and risk factors should be 
measured in terms of their 
consequences for health or in 
terms of their consequences 
for wellbeing 
Measuring burden of 
disease 
Herlitz & Horan, 
2016 
Discussion 
paper 
To measure needs for priority 
setting in healthcare planning 
and policy 
Needs 
Hoefman et al., 
2013 
Discussion 
paper 
To discuss how to Include 
Informal Care in Economic 
Evaluations 
Informal care 
Howard et al., 
2008 
Empirical 
analysis 
To elicit the utilities of women 
of screening age for different 
management approaches for 
the evaluation of an Pap 
smear result 
Process utility 
Kotzian, 2009 Discussion 
paper 
To discuss why existing health 
care system efficiency 
evaluations fail to take fully 
into account the effect of 
preferences and their 
variation 
Health System Efficiency 
 207 
Laxminarayan et 
al., 2014 
Discussion 
paper 
To describe the pros and cons 
of using benefit-cost analysis 
and cost-effectiveness 
analysis in the context of 
vaccine priorities 
Valuing vaccines 
Makai et al., 
2012 
Empirical 
analysis 
To validate the ICECAP-O in 
psycho-geriatric elderly in 
nursing homes 
Capabilities and quality of 
life in nursing homes 
Makai et al., 
2014b 
Review To assess the usefulness of 
HRQoL and wellbeing 
instruments for economic 
evaluations in older people 
Economic evaluation in 
older adults 
Makai et al., 
2013a 
Empirical 
analysis 
To validate the ICECAP-O in 
post-hospitalized older 
people  
Capability wellbeing 
McAllister et al., 
2012 
Discussion 
paper 
To discuss why patient 
empowerment itself is a 
directly measureable patient 
reported outcome for chronic 
conditions.  
Patient empowerment 
Netten et al., 
2012 
Empirical 
analysis  
To develop a preference-based 
measure of social care 
outcome 
Social care-related quality 
of life 
Nyman, 2011 Discussion 
paper 
To discuss whether to include 
survivor consumption and 
leisure forgone should be 
included in a cost-utility 
analysis 
Survivor consumption and 
leisure forgone 
Olsen & Smith, 
2001 
Review To outline the arguments 
advanced for the superiority 
of WTP over QALYs 
WTP versus QALYs 
Ong et al., 2009 Discussion 
paper 
To propose an alternative to 
cost-based equity weight for 
use in economic evaluation 
Equity weights 
Petrou & 
Wolstenholme, 
2000 
Review To review alternative 
approaches to healthcare 
resource allocation 
Healthcare resource 
allocation 
Rogowski et al., 
2014 
Discussion 
paper 
To assess substantive ethical 
and economic criteria to 
prioritize genetic services 
Genetic services 
Round, 2012 Discussion 
paper 
To discuss the QALY at the 
end of life 
End of life 
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Ryan, 1999 Empirical 
analysis 
To demonstrate the use of 
conjoint analysis in health 
services research 
Conjoint analysis 
Salkeld, 1998 Discussion 
paper 
To explore the concept of 
process utility in the context 
of preventive goods 
Process utility and 
preventive goods 
Salkeld et al., 
2004 
Empirical 
analysis 
To outline the nature of the ex 
ante and ex post perspective 
in valuing beneﬁts and the 
presence of process utility 
and the utility of gambling in 
individual’s utility function 
for preventive health care 
Process utility and 
preventive goods 
Schlander et al., 
2014 
Discussion 
paper 
To discuss issues in using the 
QALY approach to evaluate 
interventions for ultra-rare 
disorders 
Ultra-rare disorders 
Schulz et al., 
2014 
Empirical 
analysis 
To assess the cost-
effectiveness and cost-utility 
of a sequential and a 
simultaneous Web-based 
computer-tailored lifestyle 
intervention for adults 
Web-Based Tailored 
Lifestyle Intervention 
Shackley et al., 
2001 
Empirical 
analysis 
To investigate whether and to 
what extent vascular patients 
are willing to trade expected 
health outcomes for 
improvements in non-health 
benefits 
Non-health outcomes 
Stanczyk et al., 
2014 
Empirical 
analysis 
To investigate the cost-
effectiveness and cost-utility 
of two web-based computer-
tailored smoking cessation 
interventions 
Web-based computer-
tailored smoking cessation 
intervention 
Swan et al., 2016 Discussion 
paper 
To develop a patient-centered 
model for the experience of 
radiologic care 
Patient experiences 
Swan et al., 2003 Empirical 
analysis 
To use WTT method to 
evaluate preferences of 
patients for magnetic 
resonance angiography and 
conventional x-ray 
angiography 
Waiting trade-off (WTO) 
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Swan et al., 2010 Empirical 
analysis 
To develop a temporary utility 
index and to test it within the 
context of diagnostic testing 
Temporary Utility Index 
(TUI) 
Thorn et al., 
(2014) 
Discussion 
paper 
To provide an overview of 
advances in methodology that 
guides health economists 
working on applied economic 
evaluations  
Trial-based economic 
evaluations 
Torgerson & 
Raftery, 1999 
Discussion 
paper 
To provide an overview of 
outcomes for different types 
of economic evaluation 
Outcomes in economic 
evaluations 
2nd wave of search (n=31) 
Bajaj & 
Veenstra, 2013 
Empirical 
analysis 
To assess the benefits, risks, 
and personal utility of factor 
V Leiden mutation testing 
Genomics 
Bayoumi, 2004 Review To review the theory and 
conduct of contingent 
valuation studies 
Contingent Valuation 
Benning et al., 
2015 
Empirical 
analysis 
To investigating the relative 
importance of non-health 
outcomes in a health 
promotion context 
Non-health outcomes in 
health promotion 
Bobinac et al., 
2011 
Empirical 
analysis 
To investigate the occurrence 
of the family and care-giving 
effect 
Family and care-giving 
effect 
Borghi & Jan, 
2008 
Empirical 
analysis 
To explore the use of the 
contingent valuation (CV) 
method to value the broader 
benefits in health promotion 
programs 
CV in health promotion 
Brouwer et al., 
2005 
Empirical 
analysis 
To test the hypothesis that 
informal caregivers derive 
utility not only from the 
outcome of informal care, but 
also from the process of 
providing informal care 
Process utility from 
providing informal care 
Buchanan & 
Wordsworth, 
2015 
Review To evaluate the potential for 
the choice of economic 
evaluation approach to 
impact on the adoption 
decisions 
Welfarism vs Extra-
welfarism 
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Buchanan et al., 
2013 
Review To summarize the 
methodological issues 
associated with conducting 
economic evaluations of 
genomic interventions 
Economic evaluations of 
genomic interventions 
Coast et al., 2015 Discussion 
paper 
To discuss the development of 
capability measures in health 
economics 
Capability measures 
Davis et al., 2015 Empirical 
analysis 
To determine the factors that 
predict change in well-being 
over time 
ICECAP-O 
Ding et al., 2011 Discussion 
paper 
To examine current related 
work on imaging 
expenditures for incidental 
findings 
Incidental findings 
Eden et al., 2013 Empirical 
analysis 
To explore if contingent 
valuation (CV) method can 
be used to value the benefits 
of genetic testing 
Genetic testing 
Edwards et al., 
2015 
Discussion 
paper 
Design of Economic 
Evaluations of Mindfulness-
Based Interventions 
Mindfulness-Based 
Interventions 
Grosse et al., 
2010 
Review To address critical evidentiary, 
economic, and ethical issues 
that arise in the appraisal of 
screening tests 
Screening tests 
Grosse et al., 
2009 
Discussion 
paper 
Personal utility and genomic 
information 
Personal utility 
Higgins et al., 
2014 
Review To systematically review the 
existing literature on the 
value associated with 
convenience in health care 
delivery, 
Process utility 
Liljas, 2011 Discussion 
paper 
To discuss survivor 
consumption and leisure 
forgone and whether or not 
future non-medical cost 
should be included 
Survivor consumption and 
leisure forgone 
Lippert-
Rasmussen & 
Lauridsen, 2010 
Discussion 
paper 
Discussion about the 
distribution of indirect, non-
health benefits in allocating 
healthcare resources 
Indirect non-health effects 
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Lorgelly, 2015 Discussion 
paper 
To provide an introduction to 
the capability approach and 
to review the measures that 
are available for use in an 
economic evaluation 
Capability approach 
Lorgelly et al., 
2015 
Empirical 
analysis 
To operationalize the 
capability approach as an 
outcome measure in public 
health and the development 
of the OCAP-18 
OCAP-18 
Lu & Cohen, 
2015 
Discussion 
paper 
To discuss the potential 
economic impact of genomic 
medicine and the challenges 
Genomic medicine 
Makai et al., 
2014a 
Empirical 
analysis 
To validate the ICECAP-O 
capability wellbeing 
measure’s German translation 
in older people with dementia 
living in a nursing home 
Application of the ICECAP-
O in residents with 
dementia 
McNamee & 
Seymour, 2008 
Empirical 
analysis 
To explore the implications of 
incorporating process 
preferences within the QALY 
framework 
Process preferences 
Neumann et al., 
2012 
Empirical 
analysis 
To assess how much people 
would pay for a laboratory 
test that predicted their future 
disease status 
Value of predictive tests 
Rogowski & 
Schleidgen, 
2015 
Discussion 
paper 
To develop a prioritization 
score for genetic tests to 
facilitate equitable allocation 
based on need-based claims 
Needs-based framework 
Sach et al., 2007 Review To develop a League Table of 
Contingent Valuation Results 
Contingent Valuation 
Sutton & Coast, 
2014 
Empirical 
analysis 
To develop of a supportive 
care measure for economic 
evaluation of end-of-life care 
End-of-life 
Tinelli et al., 
2013 
Empirical 
analysis 
To test the sensitivity of the 
EQ-5D and SF-6D within 
pharmacy 
Benefits in Pharmacy 
Towse & 
Garrison, 2013 
Discussion 
paper 
To identify implications for 
the economic incentives for 
evidence generation 
 
Personalized medicine 
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van Mastrigt et 
al., 2015 
Empirical 
analysis 
To investigate expert views 
regarding the incorporation 
of NHOs into the economic 
evaluations of public health 
interventions 
Non-health outcomes 
Veenstra et al., 
2010 
Discussion 
paper 
To present a risk-benefit 
framework for assessing the 
health-related utility of 
genomic tests 
Genomic tests 
Reference list search (n=10) 
Baker et al., 
2010 
HTA report To identify characteristics of 
beneficiaries of health care 
over which relative weights 
should be derived and to 
estimate relative weights to 
be attached to health gains 
according to characteristics 
of recipients of these gains  
Social value of a QALY 
Beale et al., 2012 Empirical 
analysis 
To provide a summary of 
economic appraisals for 
investing in environmental 
interventions to encourage 
physical activity 
Environmental interventions 
Bobinac et al., 
2010 
Empirical 
analysis 
To establish the existence of 
the caregiving and family 
effect 
Spillover effects 
Brazier et al., 
2009 
Discussion 
paper 
To review the role of patient 
preferences within the 
framework of cost-
effectiveness analysis 
Patient preferences 
Brouwer et al., 
1997 
Response 
letter 
To comment on the published 
guidelines of the Washington 
Panel on incorporation of 
indirect non-medical costs 
Productivity costs 
Jacobsson et al., 
2005 
Empirical 
analysis 
To compare caring 
externalities and internal 
preferences of health states 
with different severity levels 
Caring externalities 
Kinghorn et al., 
2015 
Qualitative 
research 
To identify important 
capabilities in patients with 
chronic pain 
 
Capability approach in 
chronic pain 
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Labelle & 
Hurley, 1992 
Discussion 
paper 
To explore the implications of 
omitting external effects from 
cost-utility studies 
Externalities 
Singer et al., 
1995 
Discussion 
paper 
To discuss the issue of double 
jeopardy in using QALYs 
Double jeopardy 
Williams, 1997 Discussion 
paper 
To discuss the concept of fair 
innings 
Fair innings 
CUA=cost-utility analysis; CV=contingent valuation; NHO=Non-health outcomes; OCAP-18=18-item 
capability measure; QALY=Quality-adjusted life year; R-QALY=Relatives’ quality-adjusted life year; SF-
6D=Short Form six Dimensions; TUI=Temporary Utility Index; WTO=waiting trade-off; 
WTP=willingness to pay. 
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Appendix 3.2. Thematic framework of benefits beyond the health-related QALY  
Theme Construct Attribute/domain/item Source (First author (Year)) 
Wellbeing Subjective wellbeing Activity, Leisure Al-Janabi (2011), Connell (2014), 
Cookson (2005b), Davis (2013) 
Body satisfaction Alayli-Goebbels (2013), Goebbels 
(2012) 
Burden Coast (2008a), Coast (2014) 
Creativity and play Benning (2015), Davis (2013), Makai 
(2014b), 
Cleanliness (& comfort) Goebbels (2012) 
Disappointment Salkeld (2004) 
Emotions van Mastrigt (2015) 
Endurance Alayli-Goebbels (2013), Goebbels 
(2012) 
Environment Makai (2014b), Ong (2009), van 
Mastrigt (2015) 
Family, family life Cookson (2005b), van Mastrigt (2015) 
Financial risk protection/ financial 
wellbeing, wealth 
Davis (2013), Hoefmann (2013), 
Laxminarayana (2014), Makai 
(2014b) 
Happiness, optimism Benning (2015), Higgings (2014), 
Hoefmann (2013), Thorn (2014) 
Motivation Goebbels (2012) 
Religion, spirituality Coast (2008a), Coast (2014), Cookson 
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(2005b), Ong (2009), Round (2012) 
Relationships, social 
interaction/maintaining friendships, 
companionship; social participation; 
social live, one’s place in society 
Chisholm (1997), Connell (2014), 
Coast (2008a), Davis (2013), 
Goebbels (2012), Hausman (2012), 
Lorgelly (2010), Makai (2014b), van 
Mastrigt (2015) 
Regret Salkeld (1998), Salkeld (2004) 
Relaxation, stress reduction Alayli-Goebbels (2013), Benning 
(2015), Goebbels (2012) 
Satisfaction Schulz (2014), Stanczyk (2014) 
Security and safety Ali (2012), Makai (2014b)  
Sexual performance Benning (2015) 
Subjective wellbeing, general wellbeing, 
quality of life, view of life 
Benning (2015), Davis (2015), 
Gandjour (2001), Hoefman (2013), 
Makai (2014a), Thorn (2014) 
Support Benning (2015) 
Psychological 
wellbeing 
Autonomy Mooney (1998), Ryan (1995) 
Cope Payne (2013) 
Control Benning (2015), van Mastrigt (2015) 
Freedom Makai (2014b) 
Goals Goebbels (2012) 
Hope and hopelessness Connell (2014), Salkeld (1998) 
Independence Chisholm (1997), Makai (2014b), 
Makai (2013a) 
Purpose in life and achievement Makai (2014b) 
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Self-confidence Benning (2015), Borghi (2008), van 
Mastrigt (2015) 
Self-esteem Borghi (2008), Cookson (2005b), 
Hausman (2012) 
Self-efficacy Borghi (2008) 
Self-respect Coast (2008d) 
Capabilities Access Simon (2013) 
Accommodation cleanliness & comfort Lorgelly et al. (2015), Netten (2012), 
Simon (2013) 
Achievement, accomplishment Al-Janabi (2012), Al-Janabi (2013b), 
Cookson (2005b) 
Assaults Lorgelly et al. . (2015), Simon (2013) 
Attachment, love & support, love & 
social exclusion, love & affection 
Al-Janabi (2012), Al-Janabi (2013b), 
Coast (2008a), Kinghorn (2015), 
Lorgelly  et al. (2015), Makai 
(2014b), Simon (2013), Sutton (2014) 
Autonomy (social autonomy) and choice, 
independence & autonomy 
Al-Janabi (2012), Al-Janabi (2013b), 
Coast (2015), Kinghorn (2015), 
Netten (2012), Sutton (2014) 
Capabilities Buchanan (2015), Crosignani (2015), 
Lorgelly et al. (2015), Thorn (2014) 
Choice Sutton (2014) 
Control, control over daily life Al-Janabi (2011), Coast (2008a), 
Netten (2012) 
Cleanliness Netten (2012) 
Daily activities, activities or employment Lorgelly et al. (2015), Simon (2013) 
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Dignity Coast (2015), Netten (2012), Sutton 
(2014) 
Discrimination Lorgelly et al. (2015), Simon (2013) 
Employment discrimination Lorgelly et al. (2015) 
Enjoyment Al-Janabi (2012), Al-Janabi (2013b), 
Coast (2008a), Kinghorn (2015) 
Food & Drink Netten (2012) 
Freedom for expression Lorgelly et al.  (2015), Simon (2013) 
Imagination and creativity Lorgelly et al.  (2015), Simon (2013) 
Influence local decisions Lorgelly et al.  (2015), Simon (2013) 
Love Coast (2015) 
Life expectancy Lorgelly et al. (2015), Simon (2013) 
Nature Lorgelly et al. (2015), Simon (2013) 
Neighbourhood safety Lorgelly et al. (2015), Simon (2013) 
Occupation Netten (2012) 
Physical and mental health Kinghorn (2015), Sutton (2014) 
Planning one’s life Lorgelly et al. (2015), Simon (2013) 
Preparation (for death) Coast (2008a), Coast (2014), Coast 
(2015), Round (2012), Sutton (2014) 
Property ownership Lorgelly et al. (2015), Simon (2013) 
Recreation Lorgelly et al. (2015), Simon (2013) 
Respect and appreciation; respect & 
identity 
Kinghorn (2015), Lorgelly et al. 
(2015), Simon (2013) 
Role, societal and family roles Coast (2008a), Kinghorn (2015) 
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Security (feeling safe), Safety Coast (2008a), Coast (2008d), 
Kinghorn (2015), Netten (2012) 
(Social) support, social networks, social 
participation and involvement 
Al-Janabi (2011), Coast (2015), 
Lorgelly et al. (2015), Netten (2012), 
Simon (2013), Sutton (2014) 
Sleep Lorgelly et al. (2015), Simon (2013) 
Stability Al-Janabi (2012), Al-Janabi (2013b) 
Suffering (physical, emotional) Coast (2015) 
Empowerment Addictions - overcome Goebbels (2012) 
Awareness Goebbels (2012) 
Behaviour change Lorgelly (2015), van Mastrigt (2015) 
Behavioural control McAllister (2012) 
Control Goebbels (2012) 
Cognitive control McAllister (2012) 
Decision-making Goebbels (2012), Payne (2013), Ryan 
(2014) 
Decisional control McAllister (2012) 
Effort Goebbels (2012) 
Emotional regulation McAllister (2012) 
Empowerment Alayli-Goebbels (2013), Coulter 
(2013), Lorgelly (2010), Lorgelly 
(2015), McAllister (2012), Payne 
(2013), Schulz (2014) 
Health literacy Benning (2015) 
Hope for the future McAllister (2012) 
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Information, knowledge, knowledge 
sharing 
Benning (2015), Borghi (2008), 
Buchanan (2015), Dowie (2001), 
Grosse (2008), Mooney (1998), 
Payne (2013), Ryan (1995), Ryan 
(1999), Salkeld (2004) 
Participation Essink-Bot (2003) 
Self-management capacities Benning (2015) 
Process utility Intervention 
characteristics 
Accuracy  Payne (2013) 
Administration Ali (2012) 
Frequency Ali (2012), Brouwer (2008a) 
Complications, morbidity Swan (2003), Swan (2010), Swan 
(2016) 
Invasiveness Alayli-Goebbels (2013), Opmeer 
(2010)  
Tailored Alayli-Goebbels (2013), Grosse 
(2008) 
Provider characteristics Attitudes, Relationship to the healthcare 
provider 
Alayli-Goebbels (2013), Coulter 
(2013), Ryan (1999), Payne (2013), 
Ryan (2014)  
Communication, competence Annemans (2013), Grosse (2008), 
Swan (2016) 
Recommendation Annemans (2013) 
Non-medical reasons for visiting the 
doctor 
Ryan (1995) 
Structural Access/ Location/ Distance Ali (2012), Benning (2015), Birch 
(2003), Dowie (2001), Grosse (2008), 
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characteristics Payne (2013), Petrou (2000), Ryan 
(1999), Ryan (2014), Shackley 
(2001), Swan (2010), Swan (2016) 
Accommodation Kotzian (2009), Birch & Donaldson 
(2003) 
Coordination with services Swan (2016) 
Cost, affordability Ali (2012), Benning (2015), Swan 
(2016), Swan (2010) 
Cleanliness  Ali (2012), Swan (2016) 
Follow-up care, continuity of care Ryan (1999), Shackley (2001) 
Services Ali (2012), Grosse (2008) 
Treatment environment Shackley (2001) 
Process characteristics Anxiety, fear before or during process Borghi (2008), Ding (2011), Salkeld 
(1998), Swan (2016), Swan (2010) 
Adherence  Towse (2013) 
Burden Brouwer (2005) 
Comfort, discomfort Al-janabi (2012), Birch (2003), 
Cookson (2005b), Kotzian (2009), 
Makai (2014b), Makai (2013a), 
Opmeer (2010) 
Convenience/ inconvenience Ding (2011), Higgings (2014) 
Embarrassment Borghi (2008), Opmeer (2010), Swan 
(2016) 
Good death, end-of-life aspects van Mastrigt (2015) 
Care  Brouwer (2005), Davidson (2010), 
Mooney (1998) 
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Choice Ali (2012), Brouwer (2005), Kotzian 
(2009), Ryan (1995) 
Control  Petrou (2000) 
Cosmetic Opmeer (2010) 
Dignity  Ali (2012), Al-Janabi (2012), Coast 
(2008a), Coast (2008d), Coast 
(2014), Cookson (2005b), Donaldson 
(1997), Makai (2014b), Makai 
(2013a), Mooney (1998), Sutton 
(2014), Netten (2012), Ryan (1995), 
Ryan (2014), Ryan (1999), Schlander 
(2014), Torgerson (1999) 
Duration, time  Alayli-Goebbels (2013), Dowie 
(2001), Grosse (2008), Opmeer 
(2010), Payne (2013), Ryan (2014), 
Ryan (1999), Shackley (2001), Swan 
(2010), Swan (2016) 
Information, health-related utility Bajaj (2013), Birch (2003), Buchanan 
(2013), Donaldson (1997), Eden 
(2013), Grosse 2009, Grosse (2010), 
Howard (2008), Lu (2015), Neumann 
(2012), Ryan (1995), Swan (2003), 
Towse (2013), Veesntra (2010) 
Physical and mental health after 
treatment 
Swan (2016) 
Pleasure/ pleasantness  Brennan (2013), Brouwer et al. 
(2008), Donaldson (1997), Makai 
(2014b) 
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Process of treatment (process utility; 
process attributes; process 
characteristics; process preferences; 
quality of care)/ non-outcome attributes 
Ali (2012), Annemans (2013), Birch 
(2003), Birch & Donaldson, Brouwer 
et al. (2008), Brouwer (2006), 
Brouwer (2005), Coast (2008a), 
Crosignani (2015), Dirksen (2014), 
Donaldson (1997), Dowie (2001), 
Essink-Bot (2003), Gandjour (2014), 
Howard (2008), Higgings (2014), 
Kotzian (2009), McNamee (2008), 
Mooney (1998), Opmeer (2010), 
Olsen (2001), Payne (2013), Round 
(2014), Petrou (2000), Ryan (1995), 
Ryan (2014), Salkeld (1998), Salkeld 
(2004), Swan (2003), Sach (2007)  
Privacy  Ryan (2014) 
Satisfaction/ Experience Brazier (2009), Buchanan (2015), 
Dirksen (2014), Ryan (2014), Swan 
(2016), Tinelli (2013) 
Stress Ding (2011) 
Reassurance Cookson (2005b), Donaldson (1997), 
Grosse (2008), Howard (2008), Ryan 
(1999), Ryan (2014), Ryan (1995), 
Salkeld (1998), Swan (2003) 
Uncertainty Opmeer (2010) 
Benefits beyond the 
affected individual 
Spillover effects Family members/ spillover effects/ 
caregiving effect/ family effect/ process 
utility from providing informal care, 
population level benefits 
Ali (2012), Al-Janabi (2011), Bobinac 
(2010) Bobinac (2011), Brouwer 
(2005), Brouwer (2006), Brouwer 
(2008a), Coast (2014), Coulter 
(2013), Davidson (2010), Eden 
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(2013), Grosse (2008), Hoefmann 
(2013), Lu (2015), Rogowski (2014), 
Mooney (2000) 
Externalities Externalities (existence or non-use 
value), altruism, passive use value 
Borghi (2008), Donaldson (1997), 
Jacobsson (2005), Labelle (1992), 
Olsen (2001), Ryan (1995), Sach 
(2007) 
Option value  Borghi (2008), Donaldson (1997), 
Eden (2013), Olsen (2001), Ryan 
(1995), Sach (2007) 
Distributional benefits Equity, fairness and need Baker (2010), Hansen (2012), Herlitz 
(2016), Lippert-Rasmussen (2010), 
Rogowski (2015), Schlander (2014), 
Singer (1995), Williams (1997)  
Benefits outside the 
health care sector 
 Other sectors, Survivor consumption and 
survivor forgone leisure 
Ali (2012), Bayoumi (2004), Benning 
(2015), Beale (2012), Coast (2008a), 
Coulter (2013), Edwards (2013), 
Edwards (2015), Gandjour (2001), 
Hausman (2012), Laxminarayana 
(2014), Lorgelly (2010), Lorgelly 
(2015), Lorgelly et al. (2015), Lu 
(2015), Liljas (2011), Nyman (2009), 
van Mastrigt (2015) 
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Appendices to Chapter 4  
Appendix 4.1. Histogram of the EQ-5D-5L index scores (n=160) 
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Appendix 4.2. Histogram of the ICECAP-O index scores (n=158) 
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Appendix 4.3. Correlation analyses between environmental features 
 A: 
Residential 
density 
B: Land use 
(diversity) 
C: Land use 
(access) 
D: Street 
connectivity 
F: 
Aesthetics 
G: 
Traffic 
Hazardsa 
H: 
Crimea 
J: Lack 
of cul-
de-sacs 
K: 
Hilliness
a 
L: 
Physical 
Barriersa 
SC-5PT SSWS 
A: Residential density 1            
B: Land use (diversity) 0.666 1           
C: Land use (access) 0.449 0.589 1          
D: Street connectivity 0.266 0.298 0.354 1         
F: Aesthetics 0.284 0.254 0.358 0.286 1        
G: Traffic Hazards a -0.108 0.088 0.031 0.056  0.102  1       
H: Crime a -0.110 -0.046 -0.091 -0.131  -0.106  0.224 1      
J: Lack of cul-de-sacs 0.062 0.043 0.045 0.175 -0.003  -0.026  -0.009  1     
K: Hilliness a 0.024 -0.098 -0.124 -0.018  -0.085  0.166*  0.248 0.077  1    
L: Physical Barriers a -0.043 -0.119 -0.025 -0.144  -0.099  0.098  0.287 -0.081  0.408 1   
SC-5PT 0.099 0.034 0.136 0.215 0.163 -0.065  -0.187 -0.017  0.018  0.089  1  
SSWS 0.534 0658 0.612 0.317 0.169 0.128 -0.019 0.143 0.069 -0.003  0.097 1 
Letters refer to the NEWS-A subscales; SC-5PT=Sampson’s 5-item measure of collective efficacy; SSWS=Street Smart Walk Score. 
a NEWS-A subscales: Reverse codes for these scales; higher score = less pedestrian friendly. 
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Appendix 4.4. Correlation analyses between environmental features and the EQ-5D-
5L and ICECAP-O 
 EQ-5D-5L a ICECAP-O b 
A: Residential density 0.131  0.011 
B: Land use (diversity) 0.214  0.041 
C: Land use (access) 0.158  -0.006 
D: Street connectivity 0.079  -0.017 
F: Aesthetics -0.062  -0.086 
G: Traffic Hazards c -0.152  -0.007 
H: Crime c  -0.172  -0.027 
J: Lack of cul-de-sacs -0.002  0.000 
K: Hilliness c -0.183 0.019 
L: Physical Barriers c -0.146  0.058 
SC-5PT d 0.071  0.293 
Street Smart Walk Score e 0.104  0.022 
Letters refer to the NEWS-A subscales. 
a EQ-5D-5L index score: the higher the score, the better an individuals‘ HRQoL.  
bICECAP-O index score: the higher the score, the better an individual’s' capability wellbeing. 
c Reverse codes for these scales; higher score = less pedestrian friendly. 
d SC-5PT: the higher the score, the better the perceived collective efficacy. 
e Street Smart Walk Score: the higher the score, the greater the walkability.  
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Appendix 4.5. Missing value analysis of the variables used in the analyses 
Variable # missing % missing 
Outcome variables   
EQ-5D-5L index score 0 0 
ICECAP-A index score 2 1.3 
Covariates   
Sex 0 0 
Age 0 0 
Live with someone 0 0 
Functional Comorbidity Index 2 1.3 
Loneliness  0 0 
Gait Speed 0 0 
Ambulatory  0 0 
Exploratory variables   
NEWS-A (A): Residential density 3 1.9 
NEWS-A (B): Land-use mix (diversity) 2 1.3 
NEWS-A (C): Land-use (access) 2 1.3 
NEWS-A (D): Street connectivity 4 2.5 
NEWS-A (F): Aesthetics 0 0 
NEWS-A (G): Traffic hazards 5 3.1 
NEWS-A (H): Crime 8 5.0 
NEWS-A (J): Lack of cul-de-sacs 1 0.6 
NEWS-A (K): Hilliness 1 0.6 
NEWS-A (L): Physical barriers 1 0.6 
SC-5PT 4 2.5 
SSWS 0 0 
NEWS-A=Neighbourhood Environment Walkability Scale – Abbreviated, SC-5PT= 
Sampson’s 5-item measure of collective efficacy, SSWS=Street Smart Walk Score. 
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Appendix 4.6. Backward stepwise OLS regression analysis (complete case analysis) a 
    
 EQ-5D-5L (n=137)  ICECAP-O (n=135) 
 β (SE) 95% CI p  β (SE) 95% CI p 
Constant 0.508 (0.201) (0.111, 0.906) 0.013  1.036 (0.140) (0.759, 1.314) <0.001 
Covariates       
Sex (1=female) -0.011 (0.030) (-0.056, 0.034) 0.638 0.024 (0.016) (-0.007, 0.056) 0.133 
Age 0.002 (0.002) (-0.001, 0.006) 0.161 -0.002 (0.001) (-0.004, 0.001) 0.216 
Living with someone (1=yes) 0.009 (0.026) (-0.043, 0.060) 0.742 0.019 (0.018) (-0.017, 0056) 0.292 
Functional Comorbidity Index -0.026 (0.005) (-0.036, -0.015) <0.001 -0.003 (0.004) (-0.010, 0.004) 0.386 
Loneliness  -0.041 (0.024) (-0.087, 0.006) 0.086 -0.139 (0.017) (-0.174, -0.106) <0.001 
Gait Speed -0.04 (0.029) (-0.043, 0.035) 0.836 0.014 (0.014) (-0.013, 0.041) 0.322 
Ambulatory  0.043 (0.007) (0.030, 0.058) <0.001 0.016 (0.005) (0.005, 0.026) 0.004 
Perceived built environment (NEWS-A)     
A: Residential density - - - - - - 
B: Land-use mix (diversity) - - - - - - 
C: Land-use (access) 0.028 (0.014) (0.000, 0.056) 0.049 - - - 
D: Street connectivity - - - - - - 
F: Aesthetics -0.038 (0.016) (-0.069, -0.007) 0.017 -0.032 (0.011) (-0.054,  -0.011) 0.003 
G: Traffic hazards b - - - - - - 
H: Crime b - - - - - - 
J: Lack of cul-de-sacs -0.024 (0.010) (-0.043, -0.005) 0.016 - - - 
K: Hilliness b - - - - - - 
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L: Physical barriers b - - - - - - 
Social cohesion       
SC-5PT - - - 0.033 (0.011) (0.011, 0.053) 0.003 
Objective built environment       
Street Smart Walk Score - - - - - - 
Statistics        
BIC -164.369    -256.707   
AIC -196.489    -291.570   
LR chi2 (p-value) 109.24 (<0.001)    157.79 (<0.001)   
β=Beta coefficient, SE=standard error, CI=confidence interval, NEWS-A=Neighbourhood Environment Walkability Scale – Abbreviated, SC-5PT=Sampson’s 5-
item measure of collective efficacy, SSWS=Street Smart Walk Score, AIC=Akaike information criterion, BIC=Bayesian information criterion, LR chi2= 
likelihood ratio chi-square test.  
a Backward stepwise elimination was used to remove variables relating to the built and social environments; p > 0.1 was the criterion for removal. Covariates 
were not eligible for removal.  
b Reverse coding, where higher scores indicates ‘less pedestrian friendly’.  
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Appendix 4.7. Backward stepwise Tobit regression analysis (complete case analysis) a 
    
 EQ-5D-5L (n=137)  ICECAP-O (n=135) 
 β (SE) 95% CI p  β (SE) 95% CI p 
Constant 0.459 (0.225) (0.014, 0.905) 0.043  1.098 (0.133) (0.836, 1.361) <0.001 
Covariates       
Sex (1=female) -0.010 (0.028) (-0.066, 0.046) 0.720 0.021 (0.017) (-0.012, 0.054) 0.210 
Age 0.003 (0.002) (-0.001, 0.007) 0.195 -0.002 (0.001) (-0.004, 0.001) 0.152 
Living with someone (1=yes) 0.016 (0.032) (-0.047, 0.080) 0.614 0.020 (0.019) (-0.018, 0057) 0.296 
Functional Comorbidity Index -0.030 (0.006) (-0.043, -0.017) <0.001 -0.005 (0.004) (-0.012, 0.003) 0.225 
Loneliness  -0.048 (0.029) (-0.105, 0.008) 0.094 -0.139 (0.017) (-0.174, -0.105) <0.001 
Gait Speed -0.021 (0.056) (-0.133, 0.090) 0.705 0.039 (0.034) (-0.027, 0.106) 0.246 
Ambulatory  0.050 (0.009) (0.032, 0.068) <0.001 0.014 (0.006) (0.003, 0.025) 0.011 
Perceived built environment (NEWS-A)     
A: Residential density - - - - - - 
B: Land-use mix (diversity) - - - - - - 
C: Land-use (access) 0.038 (0.017) (0.005, 0.071) 0.026 - - - 
D: Street connectivity - - - - - - 
F: Aesthetics -0.043 (0.019) (-0.081, -0.006) 0.025 -0.038 (0.011) (-0.060,  -0.017) 0.001 
G: Traffic hazards b - - - - - - 
H: Crime b - - - - - - 
J: Lack of cul-de-sacs -0.027 (0.012) (-0.050, -0.003) 0.029 -0.015 (0.007) (-0.029, -0.001) 0.031 
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K: Hilliness b - - - - - - 
L: Physical barriers b - - - - - - 
Social cohesion       
SC-5PT - - - 0.029 (0.011) (0.008, 0.051) 0.008 
Objective built environment       
Street Smart Walk Score - - - - - - 
Statistics        
BIC -9.498    -200.191   
AIC -44.538    -235.054   
LR chi2 (p-value) 88.55 (<0.001)    97.63 (<0.001)   
β=Beta coefficient, SE=standard error, CI=confidence interval, NEWS-A=Neighbourhood Environment Walkability Scale – Abbreviated, SC-5PT=Sampson’s 5-
item measure of collective efficacy, SSWS=Street Smart Walk Score, AIC=Akaike information criterion, BIC=Bayesian information criterion, LR chi2= 
likelihood ratio chi-square test.  
a Backward stepwise elimination was used to remove variables relating to the built and social environments; p > 0.1 was the criterion for removal. Covariates 
were not eligible for removal.  
b Reverse coding, where higher scores indicates ‘less pedestrian friendly’.  
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Appendices to Chapter 5 
Appendix 5.1. Overview of dimensions and items of the preference-based HRQoL 
instruments included in the analysis a  
Instrument Dimension Item 
15D Mobility - 
Vision - 
Hearing - 
Breathing - 
Sleeping - 
Eating - 
Speech - 
Elimination - 
Usual activities - 
Mental function - 
Discomfort and symptoms - 
Depression - 
Distress - 
Vitality - 
Sexual activity - 
AQoL-8D Independent living  3. Getting around 
  15. Mobility 
  19. Self-care 
  30. Household tasks 
 Pain  6. Frequency of pain 
  22. Degree of pain 
  24. Pain interference 
 Senses  11. Communication 
  28. Vision 
  32. Hearing 
 Mental health  5. Sadness 
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  8. Calm 
  12. Sleep 
  14. Anger 
  16. Self-harm 
  18. Worry 
  33. Depression 
  35. Despair 
 Happiness  17. Enthusiasm 
  20. Happiness 
  25. Pleasure 
  27. Contentment 
 Coping  1. Energy level 
  21. Coping 
  29. Control 
 Relationships  2. Social exclusion 
  4. Community role 
  9. Family role 
  10. Close relationships 
  23. Enjoy close relationships 
  31. Social isolation 
  34. Intimacy 
 Self worth  7. Confidence 
  13. Feeling worthless 
  26. Feeling burden 
EQ-5D-5L Mobility - 
Self-care - 
Usual activities  - 
Pain / Discomfort - 
Anxiety / Depression - 
HUI-3b Vision  - 
Hearing - 
Speech - 
Ambulation - 
Dexterity - 
Emotion - 
Cognition - 
 235 
Pain - 
SF-6D 
(SF-36v2) 
Physical functioning 3a.Vigorous activities 
3b. Moderate activities 
3j. Bathing or dressing oneself 
Role limitation 4c. Limited in kind of work or other 
activities 
5b. Accomplished less than you would like 
Social functioning 10. Frequency health problems interfered 
with social activities 
Pain 7. Intensity of bodily pain 
8. Extent pain interfered with normal work 
Mental health 9b. Been very nervous 
9f. Felt downhearted and depressed 
Vitality 9e. Have a lot of energy 
a The 15D and EQ-5D-5L contain only one item per dimension. Numbers in the item column refer to the 
number of the item in the respective questionnaire. 
b Typically, HUI-3 index scores are derived from 12 of the 15 items comprising the HUI questionnaire. In 
the MIC study, these 12 items were collapsed to reflect the eight dimensions of the HUI-3 and only those 
eight questions were part of the survey. 
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Appendix 5.2. Descriptive indices of model fit comparing the ICECAP-A with the 
15D 
 Eigenvalues > 1 CFI TLI RMSEA Clean 
structure 
Chosen 
factor 
solution 
 3      
1 Factor  0.886 0.873 0.124 n/a  
2 Factors  0.959 0.948 0.079 n/a  
3 Factors  0.978 0.969 0.061 No  
4 Factors  0.991 0.985 0.042 Yes 4 Factors 
5 Factors  0.995 0.991 0.034 Yes  
RMSEA = root mean square error of approximation, CFI = Comparative Fit Index, TLI = Tucker-Lewis 
Index. 
 
 
Appendix 5.3. Scree plot comparing the ICECAP-A with the 15D 
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Appendix 5.4. Descriptive indices of model fit comparing the ICECAP-A with the 
AQoL-8D 
 Eigenvalues > 1 CFI TLI RMSEA Clean 
structure 
Chosen 
factor 
solution 
 5      
1 Factor  0.847 0.839 0.132 n/a  
2 Factors  0.922 0.913 0.097 n/a  
3 Factors  0.948 0.938 0.082 n/a  
4 Factors  0.963 0.954 0.070 n/a  
5 Factors  0.974 0.965 0.061 Yes 5 Factors 
6 Factors  0.980 0.972 0.055 No  
RMSEA = root mean square error of approximation, CFI = Comparative Fit Index, TLI = Tucker-Lewis 
Index. 
 
 
Appendix 5.5. Scree plot comparing the ICECAP-A with the AQoL-8D 
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Appendix 5.6. Descriptive indices of model fit comparing the ICECAP-A with the 
EQ-5D-5L 
 Eigenvalues > 1 CFI TLI RMSEA Clean 
structure 
Chosen 
factor 
solution 
 2      
1 Factor  0.900 0.871 0.210 n/a  
2 Factors  0.987 0.977 0.084 No  
3 Factors  0.993 0.983 0.074 Yes 3 Factors 
4 Factors  0.999 0.997 0.032 No  
RMSEA = root mean square error of approximation, CFI = Comparative Fit Index, TLI = Tucker-Lewis 
Index. 
 
 
 
Appendix 5.7. Scree plot comparing the ICECAP-A with the EQ-5D-5L 
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Appendix 5.8. Descriptive indices of model fit comparing the ICECAP-A with the 
HUI-3 
 Eigenvalues > 1 CFI TLI RMSEA Clean 
structure 
Chosen 
factor 
solution 
 3      
1 Factor  0.897 0.876 0.139 n/a  
2 Factors  0.974 0.961 0.077 n/a  
3 Factors  0.990 0.981 0.054 Yes 3 Factors 
4 Factors  0.996 0.990 0.038 No  
RMSEA = root mean square error of approximation, CFI = Comparative Fit Index, TLI = Tucker-Lewis 
Index. 
  
 
Appendix 5.9. Scree plot comparing the ICECAP-A with the HUI-3 
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Appendix 5.10. Descriptive indices of model fit comparing the ICECAP-A with the 
SF-6D 
 Eigenvalues >1 CFI TLI RMSEA Clean factor 
structure 
Chosen 
factor 
solution 
 3      
1 Factor  0.849 0.826 0.186 n/a  
2 Factors  0.937 0.916 0.129 n/a  
3 Factors  0.969 0.950 0.100 No  
4 Factors  0.985 0.971 0.075 Yes 4 Factors 
5 Factors  0.991 0.977 0.067 No  
RMSEA = root mean square error of approximation, CFI = Comparative Fit Index, TLI = Tucker-Lewis 
Index. 
 
 
Appendix 5.11. Scree plot comparing the ICECAP-A with the SF-6D 
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Appendix 5.12. EFA comparing the ICECAP-A with the 15D (3-factor model) a  
 Rotated item loadings 
 Factor 1 Factor 2 Factor 3 
ICECAP-A    
Stability 0.817 -0.002 0.116 
Attachment 0.800 -0.134 0.028 
Autonomy 0.454 0.362 -0.075 
Achievement 0.784 0.184 -0.086 
Enjoyment 0.895 0.006 -0.014 
15D    
Mobility -0.009 0.919 -0.201 
Vision 0.013 0.435 0.186 
Hearing -0.145 0.417 0.221 
Breathing 0.103 0.603 0.020 
Sleeping 0.314 0.369 0.190 
Eating -0.090 0.698 0.310 
Speech 0.007 0.448 0.431 
Elimination 0.017 0.535 0.155 
Usual activities 0.213 0.805 -0.101 
Mental function 0.268 0.381 0.342 
Discomfort and symptoms 0.098 0.730 -0.010 
Depression 0.691 0.002 0.492 
Distress 0.619 -0.003 0.529 
Vitality 0.439 0.459 0.221 
Sexual activity 0.283 0.492 0.087 
  Correlations among factors 
                 Factor 1 1.000   
                 Factor 2 0.494* 1.000  
                 Factor 3 0.240* 0.245* 1.000 
RMSEA 0.061 [90% CI: 0.060 to 0.063] 
CFI 0.978 
TLI 0.969 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative 
Fit Index, TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is 
underlined.  
* Significant at 5% level. 
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Appendix 5.13. EFA comparing the ICECAP-A with the EQ-5D-5L (2-factor 
model)a 
 Rotated item loadings 
 Factor 1 Factor 2 
ICECAP-A   
Stability 0.867 -0.008 
Attachment 0.837 -0.161 
Autonomy 0.400 0.403 
Achievement 0.740 0.195 
Enjoyment 0.891 0.004 
EQ-5D-5L   
Mobility -0.121 0.991 
Self-care 0.072 0.821 
Usual activities 0.087 0.875 
Pain/Discomfort -0.004 0.801 
Anxiety/Depression 0.739 0.060 
  Correlation among factors 
       Factor 1 1.000  
       Factor 2 0.530* 1.000 
RMSEA 0.084 [90% CI: 0.080 to 0.088] 
CFI 0.987 
TLI 0.977 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative Fit Index, 
TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is underlined.  
* Significant at 5% level. 
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Appendix 5.14. EFA comparing the ICECAP-A with the HUI-3 (4-factor model) a  
 Rotated item loadings 
 Factor 1 Factor 2 Factor 3 Factor 4 
ICECAP-A     
Stability 0.737 0.204 -0.034 -0.011 
Attachment 0.867 -0.133 0.027 -0.062 
Autonomy 0.073 0.635 0.176 0.045 
Achievement 0.540 0.427 0.017 0.045 
Enjoyment 0.854 0.058 -0.003 0.046 
HUI-3     
Vision 0.021 -0.171 0.354 0.234 
Hearing -0.022 -0.278 0.673 0.057 
Speech 0.024 0.020 0.948 -0.236 
Ambulation -0.020 0.156 0.178 0.684 
Dexterity -0.001 0.082 0.332 0.451 
Emotion 0.849 0.002 0.042 0.006 
Cognition 0.308 0.062 0.443 0.028 
Pain 0.221 -0.027 -0.033 0.798 
  Correlations among factors 
 Factor 1 1.000    
 Factor 2 0.578* 1.000   
 Factor 3 0.451* 0.410* 1.000  
 Factor 4 0.268* 0.460* 0.468* 1.000 
RMSEA 0.038 [90% CI: 0.035 to 0.042] 
CFI 0.996 
TLI 0990 
RMSEA=root mean square error of approximation, CI=confidence interval, CFI=Comparative Fit 
Index, TLI=Tucker-Lewis Index.  
a Loadings greater than 0.30 are presented in bold face. The highest loading for each item is 
underlined.  
* Significant at 5% level. 
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Appendices to Chapter 6 
Appendix 6.1. Assessment of subjective wellbeing in the SCI Community Survey 
 
Using a scale of 0 to 10, where 0 means "very dissatisfied" and 10 means "very satisfied", 
how do you feel about your life as a whole right now? 
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Appendix 6.2. Assessment of secondary health conditions in the SCI Community 
Survey 
 
Section C: The following are questions that ask about health conditions and 
complications you may have. 
 
 
For the following 11 health problems, please rate how much each one 
affected your activities and independence in the last 3 months. If you have 
not experienced the health problem in the last 3 months, or if it is an 
insignificant problem for you, please circle ‘‘0.’’ 
Use the following scale to rate each of the health problems. 
0   =   NOT experienced in the last 3 months, or it is an insignificant problem 
1   =   MILD or INFREQUENT problem 
2   =   MODERATE or OCCASIONAL problem 
3   =   SIGNIFICANT or CHRONIC problem 
 
 
Health Problem Description Rating 
  0  1  2  3 
1. Muscle 
Spasms 
(Spasticity) 
Spasticity refers to uncontrolled, jerky muscle 
movements, such as uncontrolled muscle 
twitch or spasm. Often spasticity increases 
with infection or some kind of restriction, like 
a tight shoe or belt. 
       
       
       
2. Depression / 
    Mood 
Problems 
A state of intense sadness that lasts for more 
than two weeks and has advanced to the point 
of interfering with daily life – feeling “down”, 
being tired, or feeling irritable for no apparent 
reason. 
  
     
 
 
 
 
 
 
 
       
3. Pressure 
    Sore(s) 
These develop as a skin rash or redness and 
progress to an infected sore. Also called skin 
ulcers, bedsores, and decubitus ulcers.  
  
     
 
 
 
 
 
 
 
       
4. Bladder 
    Dysfunction  
 
Incontinence, bladder or kidney stones, kidney 
problems, urine leakage and urine back up are 
all symptoms of bladder dysfunction. NOTE: 
  
     
 
 
 
 
 
 
 
 246 
There is a separate item for urinary tract 
infections.  
      
5. Trouble 
    Sleeping 
Difficulty falling asleep, waking during the 
night, pauses in breathing during sleep, etc. 
  
     
 
 
 
 
 
 
 
       
6. Joint and 
    Muscle Pain 
This includes pain in specific muscle groups or 
joints. People who must overuse a particular 
muscle group, such as shoulder muscles, or 
who put too much strain on their joints are at 
risk of developing pain. 
  
     
 
 
 
 
 
 
 
       
7. Neuropathic 
    Pain 
Pain, that is often ongoing and intense, caused 
by damage to nerves, that occurs 
spontaneously or  by light touching and is 
characterized by feelings  of burning, shooting, 
tingling, etc. 
  
     
 
 
 
 
 
 
 
       
8. Sexual 
    Dysfunction 
This includes dissatisfaction with sexual 
functioning. Causes for dissatisfaction can be 
decreased sensation, changes in body image, 
difficulty in movement, and problems with 
bowel   or bladder, like infections. 
  
     
 
 
 
 
 
 
 
       
9. Autonomic 
    Dysreflexia 
Autonomic dysreflexia, sometimes called 
hyperreflexia, results from interference in the 
body’s temperature regulating systems. 
Symptoms of dysreflexia include sudden rises 
in blood pressure and sweating, skin blotches, 
goose bumps, pupil dilation and headache. It 
can also occur as the body’s response to pain 
where an individual doesn’t experience 
sensation. 
  
     
 
 
 
 
 
 
 
       
10. Bowel 
      Dysfunction 
Diarrhea, constipation, “accidents,” and 
associated problems are signs of bowel 
dysfunction. 
  
     
 
 
 
 
 
 
 
       
11. Fatigue Constantly feeling tired, having low energy,   
feeling listless, etc. 
  
     
 
 
 
 
 
 
 
       
12. Fractures A crack or break in the bone. 
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13. Urinary Tract 
Infection 
 
This includes infections such as cystitis and 
pseudomonas. Symptoms include pain when 
urinating, a burning sensation throughout the 
body, blood in the urine and cloudy urine. 
  
     
 
 
 
 
 
 
 
       
14. Respiratory  
      Problems 
 
Symptoms of respiratory infections or problems 
include difficulty in breathing and increased 
secretions. 
  
     
 
 
 
 
 
 
 
       
15. Osteoarthritis 
/ Degenerative 
Arthritis 
“Wear and tear” on joints causing pain, 
swelling, and reduced movement / function of 
the joint. 
  
     
 
 
 
 
 
 
 
       
16. Cerebrovascular 
disease, stroke, 
trans-ischemia 
attack (i.e. TIA) 
Permanent or temporary loss or reduction of 
brain function due to an interruption of 
blood flow to the brain. 
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Appendix 6.3. Initial model structure for Model 1 
A: Initial model structure with standardized parameter estimates
 
B: Initial model structure showing only significant standardized parameter estimates 
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Appendix 6.4. Initial model structure for Model 2 
A: Initial model structure with standardized parameter estimates 
 
B: Initial model structure showing only significant standardized parameter estimates 
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Appendix 6.5. Abbreviations of the parameters included in the model 
Abbreviation Description 
SHC Secondary health condition 
HRQoL Health-related quality of life 
Capa Capability wellbeing 
SWB Subjective wellbeing 
Edu Education 
Sex Sex 
Livwith Living with somebody 
Age Age 
Injury Level of injury (tetraplegia & paraplegia) 
 
 
 
 
